|
OMIM |
Link |
Information gain |
01 |
|
apnea, obstructive sleep
|
[NCBI]
|
0.015839
|
|
|
VRNI
|
[NCBI]
|
0.00745806
|
|
|
RA
|
[NCBI]
|
0.00714744
|
|
|
SLE
|
[NCBI]
|
0.004382
|
|
|
ATHS
|
[NCBI]
|
0.00237218
|
|
|
SHFM3
|
[NCBI]
|
0.00237218
|
|
|
proteus syndrome
|
[NCBI]
|
0.0019087
|
|
|
blood group--lutheran inhibitor
|
[NCBI]
|
0.00179448
|
|
|
AD
|
[NCBI]
|
0.00164936
|
|
|
axenfeld-rieger anomaly with cardiac defects and sensorineural hearing loss
|
[NCBI]
|
0.00137534
|
|
|
van der woude syndrome modifier
|
[NCBI]
|
0.00137534
|
|
|
CMD1F
|
[NCBI]
|
0.00137534
|
|
|
acromegaloid facial appearance syndrome
|
[NCBI]
|
0.00137382
|
|
|
IS1
|
[NCBI]
|
0.00133638
|
|
|
kabuki syndrome
|
[NCBI]
|
0.00113648
|
|
|
gonadal dysgenesis, xy type
|
[NCBI]
|
0.00105832
|
|
|
MDD
|
[NCBI]
|
0.00103096
|
|
|
HP
|
[NCBI]
|
0.00102327
|
|
|
asthma-related traits, susceptibility to, 3
|
[NCBI]
|
0.000963235
|
|
|
noonan syndrome 2
|
[NCBI]
|
0.000963235
|
|
|
charcot-marie-tooth disease, dominant intermediate a
|
[NCBI]
|
0.000963235
|
|
|
OB10P
|
[NCBI]
|
0.000963235
|
|
|
PI
|
[NCBI]
|
0.000957678
|
|
|
dandy-walker-like malformation with atrioventricular septal defect
|
[NCBI]
|
0.000952613
|
|
|
HBFQTL2
|
[NCBI]
|
0.000928596
|
|
|
CMD1H
|
[NCBI]
|
0.000916638
|
|
|
SLI1
|
[NCBI]
|
0.000916638
|
|
|
kaufman oculocerebrofacial syndrome
|
[NCBI]
|
0.000916638
|
|
|
obesity, susceptibility to, on chromosome 4
|
[NCBI]
|
0.000916638
|
|
|
fasting glucose and specific insulin levels
|
[NCBI]
|
0.000916638
|
|
|
SLI3
|
[NCBI]
|
0.000916638
|
|
|
genitopatellar syndrome
|
[NCBI]
|
0.000916638
|
|
|
SLI2
|
[NCBI]
|
0.000916638
|
|
|
NEM6
|
[NCBI]
|
0.000916638
|
|
|
MPD3
|
[NCBI]
|
0.000916638
|
|
|
AUTS8
|
[NCBI]
|
0.000916638
|
|
|
ear, patella, short stature syndrome
|
[NCBI]
|
0.000846247
|
|
|
hypertelorism, teebi type
|
[NCBI]
|
0.000768014
|
|
|
CRC
|
[NCBI]
|
0.000742292
|
|
|
thrombocytopenic purpura, autoimmune
|
[NCBI]
|
0.000730936
|
|
|
ESD
|
[NCBI]
|
0.000713933
|
|
|
VEGF
|
[NCBI]
|
0.000694898
|
|
|
MCDR1
|
[NCBI]
|
0.00066998
|
|
|
PRL
|
[NCBI]
|
0.000665642
|
|
|
keratosis palmoplantaris papulosa
|
[NCBI]
|
0.000634377
|
|
|
ehlers-danlos syndrome, type viii
|
[NCBI]
|
0.000634377
|
|
|
lymphoma, non-hodgkin, familial
|
[NCBI]
|
0.000627807
|
|
|
GC
|
[NCBI]
|
0.000606007
|
|
|
IDDM
|
[NCBI]
|
0.000595731
|
|
|
cataract, autosomal recessive, early-onset, pulverulent
|
[NCBI]
|
0.00056957
|
|
|
macular dystrophy, butterfly-shaped pigmentary, 2
|
[NCBI]
|
0.00056957
|
|
|
gangliosidosis, gm2, type iii, or juvenile type
|
[NCBI]
|
0.00056957
|
|
|
cranioectodermal dysplasia
|
[NCBI]
|
0.00056957
|
|
|
trichohepatoenteric syndrome
|
[NCBI]
|
0.00056957
|
|
|
preauricular fistulae, congenital
|
[NCBI]
|
0.00056957
|
|
|
USH1E
|
[NCBI]
|
0.00056957
|
|
|
LI5
|
[NCBI]
|
0.00056957
|
|
|
IBD6
|
[NCBI]
|
0.00056957
|
|
|
SEMDIT
|
[NCBI]
|
0.00056957
|
|
|
MG
|
[NCBI]
|
0.000554702
|
|
|
holoprosencephaly
|
[NCBI]
|
0.000545803
|
|
|
CF
|
[NCBI]
|
0.000543903
|
|
|
MCOP1
|
[NCBI]
|
0.000533716
|
|
|
DBQD
|
[NCBI]
|
0.000533716
|
|
|
duane retraction syndrome 2
|
[NCBI]
|
0.000533716
|
|
|
SHFM2
|
[NCBI]
|
0.000533716
|
|
|
schimmelpenning-feuerstein-mims syndrome
|
[NCBI]
|
0.000533716
|
|
|
TNF
|
[NCBI]
|
0.000532548
|
|
|
KLK3
|
[NCBI]
|
0.000520916
|
|
|
EGF
|
[NCBI]
|
0.000510826
|
|
|
AVP
|
[NCBI]
|
0.000504439
|
|
|
MFS
|
[NCBI]
|
0.000482283
|
|
|
CDLS1
|
[NCBI]
|
0.000479732
|
|
|
panencephalitis, subacute sclerosing
|
[NCBI]
|
0.000468982
|
|
|
coronary heart disease, susceptibility to, 1
|
[NCBI]
|
0.000458192
|
|
|
polydactyly, preaxial iii
|
[NCBI]
|
0.000458192
|
|
|
RP32
|
[NCBI]
|
0.000458192
|
|
|
HSCR5
|
[NCBI]
|
0.000458192
|
|
|
MSSD
|
[NCBI]
|
0.000458192
|
|
|
foveal hypoplasia and anterior segment dysgenesis
|
[NCBI]
|
0.000458192
|
|
|
microcephaly-micromelia syndrome
|
[NCBI]
|
0.000458192
|
|
|
MRXS11
|
[NCBI]
|
0.000458192
|
|
|
myositis
|
[NCBI]
|
0.000458192
|
|
|
polyneuropathy, lethal neonatal, axonal sensorimotor, autosomal recessive
|
[NCBI]
|
0.000458192
|
|
|
gallbladder disease 3
|
[NCBI]
|
0.000458192
|
|
|
circulating adiponectin quantitative trait locus on chromosome 14
|
[NCBI]
|
0.000458192
|
|
|
diamond-blackfan anemia 2
|
[NCBI]
|
0.000458192
|
|
|
STGD4
|
[NCBI]
|
0.000458192
|
|
|
epiphyseal dysplasia, multiple, with severe proximal femoral dysplasia
|
[NCBI]
|
0.000458192
|
|
|
SCKL3
|
[NCBI]
|
0.000458192
|
|
|
hypertension, essential, susceptibility to, 6
|
[NCBI]
|
0.000458192
|
|
|
heart-hand syndrome, slovenian type
|
[NCBI]
|
0.000458192
|
|
|
circulating adiponectin quantitative trait locus on chromosome 5
|
[NCBI]
|
0.000458192
|
|
|
CMD1Q
|
[NCBI]
|
0.000458192
|
|
|
hypotrichosis simplex
|
[NCBI]
|
0.000458192
|
|
|
polydactyly, postaxial, type a3
|
[NCBI]
|
0.000458192
|
|
|
gene expression, variation in, quantitative trait locus on chromosome 20
|
[NCBI]
|
0.000458192
|
|
|
S EYE
|
[NCBI]
|
0.000458192
|
|
|
olivopontocerebellar atrophy ii, autosomal recessive
|
[NCBI]
|
0.000458192
|
|
|
aortic aneurysm, familial abdominal 1
|
[NCBI]
|
0.000458192
|
|
|
SCA28
|
[NCBI]
|
0.000458192
|
|
|
salivary substance, clostridium botulinum type
|
[NCBI]
|
0.000458192
|
|
|
LAH3
|
[NCBI]
|
0.000458192
|
|
|
gene expression, variation in, quantitative trait locus on chromosome 14
|
[NCBI]
|
0.000458192
|
|
|
OTSC4
|
[NCBI]
|
0.000458192
|
|
|
autoimmune thyroid disease, susceptibility to, 4
|
[NCBI]
|
0.000458192
|
|
|
EMWX
|
[NCBI]
|
0.000458192
|
|
|
GLC1H
|
[NCBI]
|
0.000458192
|
|
|
3q29 microdeletion syndrome
|
[NCBI]
|
0.000458192
|
|
|
PNKD2
|
[NCBI]
|
0.000458192
|
|
|
SPAX3
|
[NCBI]
|
0.000458192
|
|
|
aortic aneurysm, familial abdominal 2
|
[NCBI]
|
0.000458192
|
|
|
mesomelic dwarfism of hypoplastic tibia and radius type
|
[NCBI]
|
0.000458192
|
|
|
dwarfism, familial, with muscle spasms
|
[NCBI]
|
0.000458192
|
|
|
CFEOM3A
|
[NCBI]
|
0.000458192
|
|
|
OFD8
|
[NCBI]
|
0.000458192
|
|
|
creatinine clearance quantitative trait locus
|
[NCBI]
|
0.000458192
|
|
|
adenosine triphosphatase deficiency, anemia due to
|
[NCBI]
|
0.000458192
|
|
|
nephropathy, progressive, with deafness
|
[NCBI]
|
0.000458192
|
|
|
XGR
|
[NCBI]
|
0.000458192
|
|
|
acropectorovertebral dysplasia, f-form of
|
[NCBI]
|
0.000458192
|
|
|
DA4
|
[NCBI]
|
0.000458192
|
|
|
tear protein, anodal
|
[NCBI]
|
0.000458192
|
|
|
IBD8
|
[NCBI]
|
0.000458192
|
|
|
GINGF2
|
[NCBI]
|
0.000458192
|
|
|
SPG30
|
[NCBI]
|
0.000458192
|
|
|
DYTCA
|
[NCBI]
|
0.000458192
|
|
|
abdominal obesity-metabolic syndrome quantitative trait locus 2
|
[NCBI]
|
0.000458192
|
|
|
acropectoral syndrome
|
[NCBI]
|
0.000458192
|
|
|
FEB5
|
[NCBI]
|
0.000458192
|
|
|
cardioneuromyopathy with hyaline masses and nemaline rods
|
[NCBI]
|
0.000458192
|
|
|
BMND7
|
[NCBI]
|
0.000458192
|
|
|
CTPP5
|
[NCBI]
|
0.000458192
|
|
|
theophylline biotransformation
|
[NCBI]
|
0.000458192
|
|
|
basaloid follicular hamartoma syndrome, generalized, autosomal dominant
|
[NCBI]
|
0.000458192
|
|
|
gallbladder disease 2
|
[NCBI]
|
0.000458192
|
|
|
cerebrooculonasal syndrome
|
[NCBI]
|
0.000458192
|
|
|
peripheral cone dystrophy
|
[NCBI]
|
0.000458192
|
|
|
cataract, ataxia, short stature, and mental retardation
|
[NCBI]
|
0.000458192
|
|
|
asthma-related traits, susceptibility to, 4
|
[NCBI]
|
0.000458192
|
|
|
high density lipoprotein cholesterol level quantitative trait locus 2
|
[NCBI]
|
0.000458192
|
|
|
AMCX5
|
[NCBI]
|
0.000458192
|
|
|
epiphyseal dysplasia, multiple, with miniepiphyses
|
[NCBI]
|
0.000458192
|
|
|
maxillofacial dysostosis
|
[NCBI]
|
0.000458192
|
|
|
larsen-like syndrome
|
[NCBI]
|
0.000458192
|
|
|
hypertension, essential, susceptibility to, 5
|
[NCBI]
|
0.000458192
|
|
|
ETM3
|
[NCBI]
|
0.000458192
|
|
|
short stature, mental retardation, callosal agenesis, heminasal hypoplasia, microphthalmia, and atypical clefting
|
[NCBI]
|
0.000458192
|
|
|
coronary heart disease, susceptibility to, 4
|
[NCBI]
|
0.000458192
|
|
|
FEB9
|
[NCBI]
|
0.000458192
|
|
|
HDLCQ1
|
[NCBI]
|
0.000458192
|
|
|
czech dysplasia, metatarsal type
|
[NCBI]
|
0.000458192
|
|
|
DFNA53
|
[NCBI]
|
0.000458192
|
|
|
skin creases, multiple benign ring-shaped, of limbs
|
[NCBI]
|
0.000453973
|
|
|
gordon syndrome
|
[NCBI]
|
0.000453973
|
|
|
short rib-polydactyly syndrome, type iii
|
[NCBI]
|
0.000453973
|
|
|
CCK
|
[NCBI]
|
0.00045343
|
|
|
RTT
|
[NCBI]
|
0.000443386
|
|
|
EXT3
|
[NCBI]
|
0.000422713
|
|
|
RP6
|
[NCBI]
|
0.000422713
|
|
|
HBFQTL3
|
[NCBI]
|
0.000422713
|
|
|
methylmalonic aciduria and homocystinuria, cbld type
|
[NCBI]
|
0.000422713
|
|
|
obesity quantitative trait locus on chromosome 20
|
[NCBI]
|
0.000422713
|
|
|
RP24
|
[NCBI]
|
0.000422713
|
|
|
hypobetalipoproteinemia, familial, 2
|
[NCBI]
|
0.000422713
|
|
|
POADS
|
[NCBI]
|
0.000422713
|
|
|
CMT2B2
|
[NCBI]
|
0.000422713
|
|
|
PN
|
[NCBI]
|
0.000422713
|
|
|
velocardiofacial syndrome
|
[NCBI]
|
0.000416984
|
|
|
AS
|
[NCBI]
|
0.000415591
|
|
|
FSHMD1A
|
[NCBI]
|
0.000396183
|
|
|
adrenoleukodystrophy, autosomal neonatal form
|
[NCBI]
|
0.000394186
|
|
|
asthma, susceptibility to
|
[NCBI]
|
0.000388923
|
|
|
mohr syndrome
|
[NCBI]
|
0.000388778
|
|
|
SMS
|
[NCBI]
|
0.000386712
|
|
|
PD
|
[NCBI]
|
0.00037786
|
|
|
DGS
|
[NCBI]
|
0.000375593
|
|
|
isoniazid inactivation
|
[NCBI]
|
0.000375182
|
|
|
ACHE
|
[NCBI]
|
0.000351597
|
|
|
ST3
|
[NCBI]
|
0.000347051
|
|
|
PBD
|
[NCBI]
|
0.000344444
|
|
|
PTH
|
[NCBI]
|
0.000343205
|
|
|
ZS
|
[NCBI]
|
0.000335248
|
|
|
varadi-papp syndrome
|
[NCBI]
|
0.000334319
|
|
|
NS1
|
[NCBI]
|
0.000334137
|
|
|
CRH
|
[NCBI]
|
0.000333166
|
|
|
SHFM5
|
[NCBI]
|
0.000327624
|
|
|
hemifacial microsomia with radial defects
|
[NCBI]
|
0.000327624
|
|
|
chromosome 10q deletion syndrome
|
[NCBI]
|
0.000327624
|
|
|
IBD3
|
[NCBI]
|
0.000327624
|
|
|
HBD
|
[NCBI]
|
0.000327624
|
|
|
USH2B
|
[NCBI]
|
0.000327624
|
|
|
HTC2
|
[NCBI]
|
0.000327624
|
|
|
graves disease, susceptibility to, 2
|
[NCBI]
|
0.000327624
|
|
|
spondyloepiphyseal dysplasia tarda, autosomal dominant
|
[NCBI]
|
0.000327624
|
|
|
CMD1B
|
[NCBI]
|
0.000327624
|
|
|
CMDR
|
[NCBI]
|
0.000327624
|
|
|
VIP
|
[NCBI]
|
0.000323684
|
|
|
PHS
|
[NCBI]
|
0.00030854
|
|
|
SHFM1
|
[NCBI]
|
0.000302795
|
|
|
APC
|
[NCBI]
|
0.000297569
|
|
|
myoclonic dystonia
|
[NCBI]
|
0.000294058
|
|
|
IBD5
|
[NCBI]
|
0.000288123
|
|
|
hypertelorism with esophageal abnormality and hypospadias
|
[NCBI]
|
0.000282606
|
|
|
EPO
|
[NCBI]
|
0.000279339
|
|
|
CD
|
[NCBI]
|
0.000265767
|
|
|
PEE1
|
[NCBI]
|
0.000264843
|
|
|
NPY
|
[NCBI]
|
0.000263285
|
|
|
hereditary motor and sensory neuropathy v
|
[NCBI]
|
0.000259023
|
|
|
schinzel-giedion midface-retraction syndrome
|
[NCBI]
|
0.000259023
|
|
|
spondyloepimetaphyseal dysplasia with multiple dislocations
|
[NCBI]
|
0.000259023
|
|
|
microtia-anotia
|
[NCBI]
|
0.000259023
|
|
|
EKD2
|
[NCBI]
|
0.000259023
|
|
|
hypertrichotic osteochondrodysplasia
|
[NCBI]
|
0.000259023
|
|
|
SEMDJL
|
[NCBI]
|
0.000259023
|
|
|
megalocornea-mental retardation syndrome
|
[NCBI]
|
0.000259023
|
|
|
ETL2
|
[NCBI]
|
0.000248491
|
|
|
short rib-polydactyly syndrome, type ii
|
[NCBI]
|
0.000248491
|
|
|
LDS
|
[NCBI]
|
0.000248015
|
|
|
WS1
|
[NCBI]
|
0.00024706
|
|
|
MECP2
|
[NCBI]
|
0.000245339
|
|
|
drug metabolism, poor, cyp2d6-related
|
[NCBI]
|
0.00024437
|
|
|
JWS
|
[NCBI]
|
0.000244292
|
|
|
NGFB
|
[NCBI]
|
0.000240432
|
|
|
SCZD3
|
[NCBI]
|
0.00023685
|
|
|
CEACAM5
|
[NCBI]
|
0.000235596
|
|
|
cardiofaciocutaneous syndrome
|
[NCBI]
|
0.000232336
|
|
|
PCNA
|
[NCBI]
|
0.000232144
|
|
|
LGMD2I
|
[NCBI]
|
0.000231579
|
|
|
temporal arteritis
|
[NCBI]
|
0.000231513
|
|
|
pena-shokeir syndrome, type i
|
[NCBI]
|
0.000230996
|
|
|
urogenital adysplasia, hereditary
|
[NCBI]
|
0.000225253
|
|
|
Ii
|
[NCBI]
|
0.000223797
|
|
|
FRNS
|
[NCBI]
|
0.000218864
|
|
|
ALD
|
[NCBI]
|
0.0002176
|
|
|
LGMD2B
|
[NCBI]
|
0.000217064
|
|
|
FEB1
|
[NCBI]
|
0.0002142
|
|
|
hyperbilirubinemia, rotor type
|
[NCBI]
|
0.000211254
|
|
|
malaria, mild, susceptibility to
|
[NCBI]
|
0.000211254
|
|
|
necrotizing encephalopathy, acute, autosomal dominant
|
[NCBI]
|
0.000211254
|
|
|
migraine with or without aura, susceptibility to, 10
|
[NCBI]
|
0.000211254
|
|
|
osteoarthropathy of fingers, familial
|
[NCBI]
|
0.000211254
|
|
|
friedreich ataxia 2
|
[NCBI]
|
0.000211254
|
|
|
prostate cancer aggressiveness quantitative trait locus on chromosome 19
|
[NCBI]
|
0.000211254
|
|
|
WS2B
|
[NCBI]
|
0.000211254
|
|
|
DYT13
|
[NCBI]
|
0.000211254
|
|
|
LGMD1F
|
[NCBI]
|
0.000211254
|
|
|
hyperaldosteronism, familial, type ii
|
[NCBI]
|
0.000211254
|
|
|
brachydactyly, type a1, b
|
[NCBI]
|
0.000211254
|
|
|
CRSA
|
[NCBI]
|
0.000211254
|
|
|
CCAL1
|
[NCBI]
|
0.000211254
|
|
|
breast cancer, 11-22 translocation associated
|
[NCBI]
|
0.000211254
|
|
|
multiple mitochondrial dysfunctions syndrome
|
[NCBI]
|
0.000211254
|
|
|
thyroid carcinoma, papillary, with papillary renal neoplasia
|
[NCBI]
|
0.000211254
|
|
|
DYX8
|
[NCBI]
|
0.000211254
|
|
|
oculootofacial dysplasia
|
[NCBI]
|
0.000211254
|
|
|
atresia of external auditory canal and conduction deafness
|
[NCBI]
|
0.000211254
|
|
|
EA3
|
[NCBI]
|
0.000211254
|
|
|
HRPT3
|
[NCBI]
|
0.000211254
|
|
|
cerebrofaciothoracic dysplasia
|
[NCBI]
|
0.000211254
|
|
|
HCFP2
|
[NCBI]
|
0.000211254
|
|
|
CMD1K
|
[NCBI]
|
0.000211254
|
|
|
AKE
|
[NCBI]
|
0.000211254
|
|
|
psoriasis susceptibility 6
|
[NCBI]
|
0.000211254
|
|
|
thyroid carcinoma, nonmedullary 1
|
[NCBI]
|
0.000211254
|
|
|
diabetes mellitus, noninsulin-dependent, 4
|
[NCBI]
|
0.000211254
|
|
|
cone-rod dystrophy and amelogenesis imperfecta
|
[NCBI]
|
0.000211254
|
|
|
LGMD2L
|
[NCBI]
|
0.000211254
|
|
|
PRS
|
[NCBI]
|
0.000211254
|
|
|
spondyloepiphyseal dysplasia tarda, autosomal recessive
|
[NCBI]
|
0.000211254
|
|
|
VMD1
|
[NCBI]
|
0.000211254
|
|
|
PDB4
|
[NCBI]
|
0.000211254
|
|
|
NNCI
|
[NCBI]
|
0.000211254
|
|
|
CMTX2
|
[NCBI]
|
0.000211254
|
|
|
ataxia, sensory, autosomal dominant
|
[NCBI]
|
0.000211254
|
|
|
nablus mask-like facial syndrome
|
[NCBI]
|
0.000211254
|
|
|
SCA20
|
[NCBI]
|
0.000211254
|
|
|
migraine with or without aura, susceptibility to, 11
|
[NCBI]
|
0.000211254
|
|
|
blepharocheilodontic syndrome
|
[NCBI]
|
0.000211254
|
|
|
dermatoglyphics--fingerprint pattern
|
[NCBI]
|
0.000211254
|
|
|
IBD7
|
[NCBI]
|
0.000211254
|
|
|
burn-mckeown syndrome
|
[NCBI]
|
0.000211254
|
|
|
fibromatosis, gingival, with progressive deafness
|
[NCBI]
|
0.000211254
|
|
|
femur, unilateral bifid, with monodactylous ectrodactyly
|
[NCBI]
|
0.000211254
|
|
|
SMEI
|
[NCBI]
|
0.000209505
|
|
|
PGM1
|
[NCBI]
|
0.000208663
|
|
|
maxillonasal dysplasia, binder type
|
[NCBI]
|
0.00020673
|
|
|
SPG5A
|
[NCBI]
|
0.00020673
|
|
|
inclusion body myositis
|
[NCBI]
|
0.00020673
|
|
|
CFEOM3
|
[NCBI]
|
0.00020673
|
|
|
DA5
|
[NCBI]
|
0.00020673
|
|
|
CAT
|
[NCBI]
|
0.000206162
|
|
|
VHL
|
[NCBI]
|
0.000205163
|
|
|
CMT1A
|
[NCBI]
|
0.000202061
|
|
|
RHN
|
[NCBI]
|
0.000200189
|
|
|
APOE
|
[NCBI]
|
0.000199881
|
|
|
FBN1
|
[NCBI]
|
0.000199417
|
|
|
BRRS
|
[NCBI]
|
0.000197107
|
|
|
NPPA
|
[NCBI]
|
0.000195236
|
|
|
apc gene
|
[NCBI]
|
0.000194271
|
|
|
blood group, p system
|
[NCBI]
|
0.000192364
|
|
|
DFSP
|
[NCBI]
|
0.000185604
|
|
|
leber optic atrophy, susceptibility to
|
[NCBI]
|
0.000184345
|
|
|
sotos syndrome
|
[NCBI]
|
0.000180744
|
|
|
NFNS
|
[NCBI]
|
0.000178564
|
|
|
CFEOM1
|
[NCBI]
|
0.000178564
|
|
|
LMNA
|
[NCBI]
|
0.00017743
|
|
|
amyloidosis vi
|
[NCBI]
|
0.00017581
|
|
|
SCA6
|
[NCBI]
|
0.000175578
|
|
|
osteogenesis imperfecta, type i
|
[NCBI]
|
0.0001737
|
|
|
NPS
|
[NCBI]
|
0.000170584
|
|
|
waardenburg-shah syndrome
|
[NCBI]
|
0.000166922
|
|
|
ASMD
|
[NCBI]
|
0.000166269
|
|
|
iminoglycinuria
|
[NCBI]
|
0.000165537
|
|
|
ANON1
|
[NCBI]
|
0.000165537
|
|
|
gastroesophageal reflux
|
[NCBI]
|
0.000165537
|
|
|
robinow syndrome, autosomal dominant
|
[NCBI]
|
0.000165537
|
|
|
microtia with meatal atresia and conductive deafness
|
[NCBI]
|
0.000165537
|
|
|
neuroticism
|
[NCBI]
|
0.000165537
|
|
|
HTC1
|
[NCBI]
|
0.000165537
|
|
|
MCOPS1
|
[NCBI]
|
0.000165537
|
|
|
HSCR1
|
[NCBI]
|
0.000165116
|
|
|
MPZ
|
[NCBI]
|
0.00016377
|
|
|
HPS
|
[NCBI]
|
0.000162583
|
|
|
FGFR2
|
[NCBI]
|
0.000159493
|
|
|
PCWH
|
[NCBI]
|
0.000158257
|
|
|
d-2-@hydroxyglutaric aciduria
|
[NCBI]
|
0.000158257
|
|
|
alopecia areata 1
|
[NCBI]
|
0.000158232
|
|
|
DURS1
|
[NCBI]
|
0.000158232
|
|
|
AIC
|
[NCBI]
|
0.000158232
|
|
|
LEPR
|
[NCBI]
|
0.000157995
|
|
|
PMP22
|
[NCBI]
|
0.000157441
|
|
|
hurler-scheie syndrome
|
[NCBI]
|
0.000156454
|
|
|
WHS
|
[NCBI]
|
0.000155914
|
|
|
LQT1
|
[NCBI]
|
0.000155168
|
|
|
camptodactyly, tall stature, and hearing loss syndrome
|
[NCBI]
|
0.0001551
|
|
|
DFNB21
|
[NCBI]
|
0.0001551
|
|
|
proopiomelanocortin deficiency
|
[NCBI]
|
0.0001551
|
|
|
NEK1
|
[NCBI]
|
0.0001551
|
|
|
mass syndrome
|
[NCBI]
|
0.0001551
|
|
|
PWS
|
[NCBI]
|
0.000154964
|
|
|
UCMD
|
[NCBI]
|
0.000154572
|
|
|
cystinuria
|
[NCBI]
|
0.0001536
|
|
|
encephalopathy, neonatal severe, due to mecp2 mutations
|
[NCBI]
|
0.000153047
|
|
|
severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-negative, nk cell-negative, due to adenosine deaminase deficiency
|
[NCBI]
|
0.000152692
|
|
|
SCA2
|
[NCBI]
|
0.000151623
|
|
|
EEC1
|
[NCBI]
|
0.00014751
|
|
|
mucopolysaccharidosis type vi
|
[NCBI]
|
0.000146823
|
|
|
PRNP
|
[NCBI]
|
0.000146625
|
|
|
CCD
|
[NCBI]
|
0.000144859
|
|
|
SLOS
|
[NCBI]
|
0.000144844
|
|
|
TF
|
[NCBI]
|
0.000141275
|
|
|
RP12
|
[NCBI]
|
0.000140957
|
|
|
CYP2D6
|
[NCBI]
|
0.000140167
|
|
|
myasthenic syndrome, congenital, associated with acetylcholine receptor deficiency
|
[NCBI]
|
0.000139594
|
|
|
RHCE
|
[NCBI]
|
0.00013854
|
|
|
CFTR
|
[NCBI]
|
0.000138329
|
|
|
MAFD6
|
[NCBI]
|
0.000138149
|
|
|
RHD
|
[NCBI]
|
0.000137997
|
|
|
F3
|
[NCBI]
|
0.000137121
|
|
|
campomelic dysplasia
|
[NCBI]
|
0.000136998
|
|
|
phenylketonuria
|
[NCBI]
|
0.000135231
|
|
|
polydactyly, preaxial iv
|
[NCBI]
|
0.000133447
|
|
|
USH2C
|
[NCBI]
|
0.000133447
|
|
|
CMD1E
|
[NCBI]
|
0.000133447
|
|
|
FANCD1
|
[NCBI]
|
0.000133447
|
|
|
SHFM4
|
[NCBI]
|
0.000133447
|
|
|
BDA2
|
[NCBI]
|
0.000133447
|
|
|
andersen cardiodysrhythmic periodic paralysis
|
[NCBI]
|
0.000132831
|
|
|
GCY
|
[NCBI]
|
0.000132404
|
|
|
IGES
|
[NCBI]
|
0.000132404
|
|
|
spinocerebellar ataxia 29
|
[NCBI]
|
0.000132404
|
|
|
cri-du-chat syndrome
|
[NCBI]
|
0.000131298
|
|
|
KAL2
|
[NCBI]
|
0.000130349
|
|
|
ACLS
|
[NCBI]
|
0.000130349
|
|
|
COL2A1
|
[NCBI]
|
0.000129526
|
|
|
thyroid hormonogenesis, genetic defect in, 4
|
[NCBI]
|
0.000129431
|
|
|
DIH2
|
[NCBI]
|
0.000129431
|
|
|
OFD9
|
[NCBI]
|
0.000129431
|
|
|
erythrokeratodermia variabilis 3
|
[NCBI]
|
0.000129431
|
|
|
schopf-schulz-passarge syndrome
|
[NCBI]
|
0.000129431
|
|
|
cataract, age-related cortical
|
[NCBI]
|
0.000129431
|
|
|
myasthenia gravis with thymus hyperplasia
|
[NCBI]
|
0.000129431
|
|
|
acanthosis nigricans
|
[NCBI]
|
0.000129431
|
|
|
osteogenesis imperfecta, type vi
|
[NCBI]
|
0.000129431
|
|
|
hip dysplasia, beukes type
|
[NCBI]
|
0.000129431
|
|
|
faciodigitogenital syndrome, recessive
|
[NCBI]
|
0.000129431
|
|
|
laterality defects, autosomal dominant
|
[NCBI]
|
0.000129431
|
|
|
body mass index quantitative trait locus on chromosome 6
|
[NCBI]
|
0.000129431
|
|
|
CMTX3
|
[NCBI]
|
0.000129431
|
|
|
klippel-feil syndrome, autosomal recessive
|
[NCBI]
|
0.000129431
|
|
|
MCOPS4
|
[NCBI]
|
0.000129431
|
|
|
cataract, central saccular, with sutural opacities
|
[NCBI]
|
0.000129431
|
|
|
frontofacionasal dysostosis
|
[NCBI]
|
0.000129431
|
|
|
ophthalmoplegia, familial static
|
[NCBI]
|
0.000129431
|
|
|
acromelic frontonasal dysostosis
|
[NCBI]
|
0.000129431
|
|
|
body mass index quantitative trait locus on chromosome 11
|
[NCBI]
|
0.000129431
|
|
|
asthma-related traits, susceptibility to, 6
|
[NCBI]
|
0.000129431
|
|
|
split-hand/foot malformation with sensorineural hearing loss
|
[NCBI]
|
0.000129431
|
|
|
dermal ridges-off-the-end
|
[NCBI]
|
0.000129431
|
|
|
wilms tumor 4
|
[NCBI]
|
0.000129431
|
|
|
macrocephaly with multiple epiphyseal dysplasia and distinctive facies
|
[NCBI]
|
0.000129431
|
|
|
IBD9
|
[NCBI]
|
0.000129431
|
|
|
FGFR3
|
[NCBI]
|
0.000128568
|
|
|
USH1D
|
[NCBI]
|
0.000127532
|
|
|
WBS
|
[NCBI]
|
0.000127512
|
|
|
LAM
|
[NCBI]
|
0.0001266
|
|
|
CFNS
|
[NCBI]
|
0.000126486
|
|
|
RBS
|
[NCBI]
|
0.000125903
|
|
|
SCA10
|
[NCBI]
|
0.000123014
|
|
|
heterotopia, periventricular, x-linked dominant
|
[NCBI]
|
0.000122167
|
|
|
LMS
|
[NCBI]
|
0.000122167
|
|
|
lymphedema-distichiasis syndrome
|
[NCBI]
|
0.000122167
|
|
|
SCS
|
[NCBI]
|
0.000121017
|
|
|
FCHL
|
[NCBI]
|
0.000120738
|
|
|
hypogonadotropic hypogonadism
|
[NCBI]
|
0.000119501
|
|
|
AIS
|
[NCBI]
|
0.00011856
|
|
|
MJD
|
[NCBI]
|
0.000117883
|
|
|
AFP
|
[NCBI]
|
0.000117011
|
|
|
fragile x mental retardation syndrome
|
[NCBI]
|
0.000116487
|
|
|
cutis laxa, x-linked
|
[NCBI]
|
0.000116219
|
|
|
DFNA12
|
[NCBI]
|
0.000116134
|
|
|
marshall syndrome
|
[NCBI]
|
0.000116134
|
|
|
costello syndrome
|
[NCBI]
|
0.000115817
|
|
|
CORD3
|
[NCBI]
|
0.000115765
|
|
|
vacterl association with hydrocephalus
|
[NCBI]
|
0.000115765
|
|
|
MPO
|
[NCBI]
|
0.000115288
|
|
|
cayler cardiofacial syndrome
|
[NCBI]
|
0.000115174
|
|
|
BWS
|
[NCBI]
|
0.000114267
|
|
|
VWS
|
[NCBI]
|
0.000113676
|
|
|
CORD6
|
[NCBI]
|
0.000111613
|
|
|
mental retardation, x-linked, syndromic, jarid1c-related
|
[NCBI]
|
0.000111613
|
|
|
cardiac arrhythmia, ankyrin-b-related
|
[NCBI]
|
0.000111613
|
|
|
coronary heart disease, susceptibility to, 5
|
[NCBI]
|
0.000111613
|
|
|
XS
|
[NCBI]
|
0.000111613
|
|
|
USH1F
|
[NCBI]
|
0.000111613
|
|
|
LGMD2K
|
[NCBI]
|
0.000111613
|
|
|
mevalonic aciduria
|
[NCBI]
|
0.000111613
|
|
|
EV
|
[NCBI]
|
0.000111114
|
|
|
NPC1
|
[NCBI]
|
0.000110269
|
|
|
HFE
|
[NCBI]
|
0.000110192
|
|
|
faciogenital dysplasia
|
[NCBI]
|
0.000109901
|
|
|
hypertrophic neuropathy of dejerine-sottas
|
[NCBI]
|
0.000109515
|
|
|
SCA1
|
[NCBI]
|
0.000107954
|
|
|
DYSF
|
[NCBI]
|
0.000107917
|
|
|
TPMT
|
[NCBI]
|
0.000107861
|
|
|
GNRH1
|
[NCBI]
|
0.000106798
|
|
|
MM
|
[NCBI]
|
0.000106644
|
|
|
LIS1
|
[NCBI]
|
0.000106267
|
|
|
renal cysts and diabetes syndrome
|
[NCBI]
|
0.000106267
|
|
|
PPD2
|
[NCBI]
|
0.000106267
|
|
|
MERRF
|
[NCBI]
|
0.000106267
|
|
|
stiff skin syndrome
|
[NCBI]
|
0.000105397
|
|
|
spatial visualization, aptitude for
|
[NCBI]
|
0.000105397
|
|
|
TOC
|
[NCBI]
|
0.000105397
|
|
|
adrenal hyperplasia, congenital, due to 21-hydroxylase deficiency
|
[NCBI]
|
0.000105311
|
|
|
lipomatosis, multiple
|
[NCBI]
|
0.000105017
|
|
|
SDS
|
[NCBI]
|
0.000104834
|
|
|
USH2A
|
[NCBI]
|
0.00010401
|
|
|
TBX1
|
[NCBI]
|
0.00010349
|
|
|
nephrosialidosis
|
[NCBI]
|
0.000103396
|
|
|
LIS3
|
[NCBI]
|
0.000103396
|
|
|
ichthyosis, cyclic, with epidermolytic hyperkeratosis
|
[NCBI]
|
0.000103396
|
|
|
amelogenesis imperfecta, pigmented hypomaturation type
|
[NCBI]
|
0.000103396
|
|
|
cataract, autosomal dominant
|
[NCBI]
|
0.000103396
|
|
|
GS3
|
[NCBI]
|
0.000103396
|
|
|
xh antigen
|
[NCBI]
|
0.000103396
|
|
|
gombo syndrome
|
[NCBI]
|
0.000103396
|
|
|
heterotopia, periventricular, ehlers-danlos variant
|
[NCBI]
|
0.000103396
|
|
|
WD
|
[NCBI]
|
0.000103396
|
|
|
PTHS
|
[NCBI]
|
0.000103396
|
|
|
MEN4
|
[NCBI]
|
0.000103396
|
|
|
CMT2K
|
[NCBI]
|
0.000103396
|
|
|
GCPS
|
[NCBI]
|
0.000102362
|
|
|
ear wax, wet/dry
|
[NCBI]
|
0.00010202
|
|
|
LADD
|
[NCBI]
|
0.00010202
|
|
|
RNASE3
|
[NCBI]
|
0.000101928
|
|
|
klippel-trenaunay-weber syndrome
|
[NCBI]
|
0.000101565
|
|
|
RYR1
|
[NCBI]
|
0.000101223
|
|
|
SCN4A
|
[NCBI]
|
0.000100105
|
|
|
MNS
|
[NCBI]
|
9.96088e-05
|
|
|
ACP1
|
[NCBI]
|
9.91639e-05
|
|
|
MTTL1
|
[NCBI]
|
9.88358e-05
|
|
|
TG
|
[NCBI]
|
9.84995e-05
|
|
|
neuraminidase deficiency
|
[NCBI]
|
9.82656e-05
|
|
|
PAX3
|
[NCBI]
|
9.81833e-05
|
|
|
GBA
|
[NCBI]
|
9.76749e-05
|
|
|
OPD1
|
[NCBI]
|
9.75998e-05
|
|
|
USH3
|
[NCBI]
|
9.75998e-05
|
|
|
adult syndrome
|
[NCBI]
|
9.75998e-05
|
|
|
FTNS
|
[NCBI]
|
9.75998e-05
|
|
|
WS2A
|
[NCBI]
|
9.75998e-05
|
|
|
TNFSF6
|
[NCBI]
|
9.74554e-05
|
|
|
APOH
|
[NCBI]
|
9.69879e-05
|
|
|
FUT1
|
[NCBI]
|
9.60829e-05
|
|
|
bullous erythroderma ichthyosiformis congenita of brocq
|
[NCBI]
|
9.58939e-05
|
|
|
BDNF
|
[NCBI]
|
9.57445e-05
|
|
|
LGMD2C
|
[NCBI]
|
9.52748e-05
|
|
|
ATRX
|
[NCBI]
|
9.49333e-05
|
|
|
PEX1
|
[NCBI]
|
9.46405e-05
|
|
|
PDS
|
[NCBI]
|
9.43434e-05
|
|
|
migraine with or without aura, susceptibility to, 1
|
[NCBI]
|
9.43313e-05
|
|
|
FA
|
[NCBI]
|
9.35993e-05
|
|
|
GIST
|
[NCBI]
|
9.26643e-05
|
|
|
GUSB
|
[NCBI]
|
9.22963e-05
|
|
|
MC1R
|
[NCBI]
|
9.13787e-05
|
|
|
oculocerebrocutaneous syndrome
|
[NCBI]
|
9.0837e-05
|
|
|
DFNB12
|
[NCBI]
|
9.0837e-05
|
|
|
PC2
|
[NCBI]
|
9.0837e-05
|
|
|
CACP
|
[NCBI]
|
9.0837e-05
|
|
|
LISX2
|
[NCBI]
|
9.0837e-05
|
|
|
niemann-pick disease, type c2
|
[NCBI]
|
9.0837e-05
|
|
|
desmosterolosis
|
[NCBI]
|
9.0837e-05
|
|
|
cd4/cd8 t-cell ratio
|
[NCBI]
|
9.0837e-05
|
|
|
CMD1D
|
[NCBI]
|
9.0837e-05
|
|
|
trismus-pseudocamptodactyly syndrome
|
[NCBI]
|
9.0837e-05
|
|
|
epidermolysis bullosa pruriginosa
|
[NCBI]
|
9.0837e-05
|
|
|
SBS
|
[NCBI]
|
9.08253e-05
|
|
|
immunoosseous dysplasia, schimke type
|
[NCBI]
|
9.08253e-05
|
|
|
sc phocomelia syndrome
|
[NCBI]
|
9.08253e-05
|
|
|
EGFR
|
[NCBI]
|
9.02026e-05
|
|
|
XK
|
[NCBI]
|
9.00817e-05
|
|
|
LPG
|
[NCBI]
|
8.99014e-05
|
|
|
hurler syndrome
|
[NCBI]
|
8.97238e-05
|
|
|
SHH
|
[NCBI]
|
8.91872e-05
|
|
|
RET
|
[NCBI]
|
8.87718e-05
|
|
|
HNFJ
|
[NCBI]
|
8.84804e-05
|
|
|
GJB1
|
[NCBI]
|
8.81895e-05
|
|
|
osteogenesis imperfecta, type iia
|
[NCBI]
|
8.80411e-05
|
|
|
refsum disease, infantile form
|
[NCBI]
|
8.75356e-05
|
|
|
DA2A
|
[NCBI]
|
8.75356e-05
|
|
|
MEN2B
|
[NCBI]
|
8.75356e-05
|
|
|
PYY
|
[NCBI]
|
8.71061e-05
|
|
|
LGMD2A
|
[NCBI]
|
8.68956e-05
|
|
|
ROR2
|
[NCBI]
|
8.48592e-05
|
|
|
TYMS
|
[NCBI]
|
8.45614e-05
|
|
|
EVC
|
[NCBI]
|
8.39109e-05
|
|
|
IGER
|
[NCBI]
|
8.35216e-05
|
|
|
facial ectodermal dysplasia
|
[NCBI]
|
8.32061e-05
|
|
|
AUTS6
|
[NCBI]
|
8.32061e-05
|
|
|
acroosteolysis with osteoporosis and changes in skull and mandible
|
[NCBI]
|
8.32061e-05
|
|
|
SPG4
|
[NCBI]
|
8.30049e-05
|
|
|
EVA
|
[NCBI]
|
8.30049e-05
|
|
|
HCH
|
[NCBI]
|
8.30049e-05
|
|
|
cutis laxa, corneal clouding, and mental retardation
|
[NCBI]
|
8.27064e-05
|
|
|
arthrogryposis multiplex congenita, distal, x-linked
|
[NCBI]
|
8.27064e-05
|
|
|
camptodactyly with muscular hypoplasia, skeletal dysplasia, and abnormal palmar creases
|
[NCBI]
|
8.27064e-05
|
|
|
BWCNS
|
[NCBI]
|
8.27064e-05
|
|
|
CCV
|
[NCBI]
|
8.27064e-05
|
|
|
ICCA
|
[NCBI]
|
8.27064e-05
|
|
|
asperger syndrome, susceptibility to, 1
|
[NCBI]
|
8.27064e-05
|
|
|
opioid dependence, susceptibility to, 1
|
[NCBI]
|
8.27064e-05
|
|
|
autoimmune thyroid disease, susceptibility to, 1
|
[NCBI]
|
8.27064e-05
|
|
|
migraine with or without aura, susceptibility to, 6
|
[NCBI]
|
8.27064e-05
|
|
|
AF8T
|
[NCBI]
|
8.27064e-05
|
|
|
PPPP
|
[NCBI]
|
8.27064e-05
|
|
|
PSNP2
|
[NCBI]
|
8.27064e-05
|
|
|
ALS5
|
[NCBI]
|
8.27064e-05
|
|
|
prognathism, mandibular
|
[NCBI]
|
8.27064e-05
|
|
|
ALSFTD1
|
[NCBI]
|
8.27064e-05
|
|
|
OSCS
|
[NCBI]
|
8.27064e-05
|
|
|
ARVD5
|
[NCBI]
|
8.27064e-05
|
|
|
peeling skin syndrome
|
[NCBI]
|
8.27064e-05
|
|
|
ARVD3
|
[NCBI]
|
8.27064e-05
|
|
|
HBFQTL4
|
[NCBI]
|
8.27064e-05
|
|
|
AXPC1
|
[NCBI]
|
8.27064e-05
|
|
|
DSMA3
|
[NCBI]
|
8.27064e-05
|
|
|
autism, susceptibility to, 3
|
[NCBI]
|
8.27064e-05
|
|
|
microphthalmia with limb anomalies
|
[NCBI]
|
8.27064e-05
|
|
|
ARVD4
|
[NCBI]
|
8.27064e-05
|
|
|
CNA1
|
[NCBI]
|
8.27064e-05
|
|
|
restless legs syndrome, susceptibility to, 6
|
[NCBI]
|
8.27064e-05
|
|
|
spondyloenchondrodysplasia
|
[NCBI]
|
8.27064e-05
|
|
|
syndactyly, type i, with microcephaly and mental retardation
|
[NCBI]
|
8.27064e-05
|
|
|
antipyrine metabolism
|
[NCBI]
|
8.27064e-05
|
|
|
peyronie disease
|
[NCBI]
|
8.27064e-05
|
|
|
brachydactyly-mental retardation syndrome
|
[NCBI]
|
8.27064e-05
|
|
|
arrhythmogenic right ventricular dysplasia, familial, 6
|
[NCBI]
|
8.27064e-05
|
|
|
pulmonary function
|
[NCBI]
|
8.27064e-05
|
|
|
fibrochondrogenesis
|
[NCBI]
|
8.27064e-05
|
|
|
EA4
|
[NCBI]
|
8.27064e-05
|
|
|
FPLD1
|
[NCBI]
|
8.27064e-05
|
|
|
hypertension, essential, susceptibility to, 1
|
[NCBI]
|
8.27064e-05
|
|
|
GSM1
|
[NCBI]
|
8.27064e-05
|
|
|
SCA19
|
[NCBI]
|
8.27064e-05
|
|
|
CTAA2
|
[NCBI]
|
8.27064e-05
|
|
|
EVR3
|
[NCBI]
|
8.27064e-05
|
|
|
DFN4
|
[NCBI]
|
8.27064e-05
|
|
|
cenani syndactylism
|
[NCBI]
|
8.27064e-05
|
|
|
MYP1
|
[NCBI]
|
8.27064e-05
|
|
|
BRCA3
|
[NCBI]
|
8.27064e-05
|
|
|
kbg syndrome
|
[NCBI]
|
8.27064e-05
|
|
|
PMD
|
[NCBI]
|
8.26695e-05
|
|
|
FTD
|
[NCBI]
|
8.25283e-05
|
|
|
MAFD1
|
[NCBI]
|
8.2513e-05
|
|
|
CGL2
|
[NCBI]
|
8.2173e-05
|
|
|
SCA17
|
[NCBI]
|
8.2173e-05
|
|
|
PARK1
|
[NCBI]
|
8.14343e-05
|
|
|
LGMD2E
|
[NCBI]
|
8.14343e-05
|
|
|
CMT4C
|
[NCBI]
|
8.14343e-05
|
|
|
BBS
|
[NCBI]
|
8.05646e-05
|
|
|
VHL
|
[NCBI]
|
8.04969e-05
|
|
|
PEPA
|
[NCBI]
|
8.0488e-05
|
|
|
TSC1
|
[NCBI]
|
8.03865e-05
|
|
|
NF1
|
[NCBI]
|
7.95407e-05
|
|
|
CDPX2
|
[NCBI]
|
7.92956e-05
|
|
|
XLP1
|
[NCBI]
|
7.92956e-05
|
|
|
mitochondrial complex i deficiency
|
[NCBI]
|
7.92956e-05
|
|
|
MHS1
|
[NCBI]
|
7.88862e-05
|
|
|
HOS
|
[NCBI]
|
7.84939e-05
|
|
|
oca2 gene
|
[NCBI]
|
7.81177e-05
|
|
|
danubian endemic familial nephropathy
|
[NCBI]
|
7.80951e-05
|
|
|
fraser syndrome
|
[NCBI]
|
7.71927e-05
|
|
|
FED
|
[NCBI]
|
7.67716e-05
|
|
|
PFM
|
[NCBI]
|
7.67716e-05
|
|
|
AFD1
|
[NCBI]
|
7.67716e-05
|
|
|
CSID
|
[NCBI]
|
7.67716e-05
|
|
|
LIS2
|
[NCBI]
|
7.65104e-05
|
|
|
tibial hemimelia
|
[NCBI]
|
7.65104e-05
|
|
|
LGMD2F
|
[NCBI]
|
7.65104e-05
|
|
|
CGL1
|
[NCBI]
|
7.65104e-05
|
|
|
boomerang dysplasia
|
[NCBI]
|
7.65104e-05
|
|
|
severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-positive, nk cell-negative
|
[NCBI]
|
7.65104e-05
|
|
|
RCDP2
|
[NCBI]
|
7.65104e-05
|
|
|
HDL1
|
[NCBI]
|
7.65104e-05
|
|
|
serpentine fibula-polycystic kidney syndrome
|
[NCBI]
|
7.65104e-05
|
|
|
noonan-like/multiple giant cell lesion syndrome
|
[NCBI]
|
7.65104e-05
|
|
|
peters anomaly
|
[NCBI]
|
7.65104e-05
|
|
|
charcot-marie-tooth disease, axonal, type 2j
|
[NCBI]
|
7.65104e-05
|
|
|
menkes disease
|
[NCBI]
|
7.63025e-05
|
|
|
DHCR7
|
[NCBI]
|
7.60847e-05
|
|
|
CLS
|
[NCBI]
|
7.60413e-05
|
|
|
mucopolysaccharidosis type ii
|
[NCBI]
|
7.58467e-05
|
|
|
ATRX
|
[NCBI]
|
7.55306e-05
|
|
|
KCNQ1
|
[NCBI]
|
7.54994e-05
|
|
|
MAS
|
[NCBI]
|
7.54039e-05
|
|
|
ABCA4
|
[NCBI]
|
7.50263e-05
|
|
|
hashimoto thyroiditis
|
[NCBI]
|
7.39537e-05
|
|
|
APOA4
|
[NCBI]
|
7.34419e-05
|
|
|
platelet glycoprotein iv deficiency
|
[NCBI]
|
7.33913e-05
|
|
|
CMT2A2
|
[NCBI]
|
7.33913e-05
|
|
|
WS3
|
[NCBI]
|
7.33913e-05
|
|
|
RP11
|
[NCBI]
|
7.33913e-05
|
|
|
MCOPS3
|
[NCBI]
|
7.33913e-05
|
|
|
BDB1
|
[NCBI]
|
7.33913e-05
|
|
|
scheie syndrome
|
[NCBI]
|
7.33913e-05
|
|
|
DRRS
|
[NCBI]
|
7.33913e-05
|
|
|
PROP1
|
[NCBI]
|
7.33628e-05
|
|
|
ARPKD
|
[NCBI]
|
7.32923e-05
|
|
|
PCOS1
|
[NCBI]
|
7.30605e-05
|
|
|
GDXY
|
[NCBI]
|
7.28912e-05
|
|
|
lactase persistence
|
[NCBI]
|
7.23756e-05
|
|
|
FLNA
|
[NCBI]
|
7.23745e-05
|
|
|
STL1
|
[NCBI]
|
7.16799e-05
|
|
|
EEC3
|
[NCBI]
|
7.11127e-05
|
|
|
neuropathy, congenital hypomyelinating
|
[NCBI]
|
7.11127e-05
|
|
|
pituitary dwarfism iii
|
[NCBI]
|
7.11127e-05
|
|
|
C4A
|
[NCBI]
|
7.0768e-05
|
|
|
TFPI
|
[NCBI]
|
7.04253e-05
|
|
|
SLC26A2
|
[NCBI]
|
7.03835e-05
|
|
|
SLC26A4
|
[NCBI]
|
6.97122e-05
|
|
|
PSACH
|
[NCBI]
|
6.94533e-05
|
|
|
PLG
|
[NCBI]
|
6.93286e-05
|
|
|
PF4
|
[NCBI]
|
6.90388e-05
|
|
|
KRT17
|
[NCBI]
|
6.8988e-05
|
|
|
ORM2
|
[NCBI]
|
6.8988e-05
|
|
|
PLP1
|
[NCBI]
|
6.87955e-05
|
|
|
RMD
|
[NCBI]
|
6.8224e-05
|
|
|
RUNX2
|
[NCBI]
|
6.82033e-05
|
|
|
JAG1
|
[NCBI]
|
6.82033e-05
|
|
|
JBTS1
|
[NCBI]
|
6.81556e-05
|
|
|
thrombocytopenia-absent radius syndrome
|
[NCBI]
|
6.81556e-05
|
|
|
LWD
|
[NCBI]
|
6.81514e-05
|
|
|
FPLD2
|
[NCBI]
|
6.80326e-05
|
|
|
TGFBR2
|
[NCBI]
|
6.77982e-05
|
|
|
NPC1
|
[NCBI]
|
6.77982e-05
|
|
|
GAPDH
|
[NCBI]
|
6.71045e-05
|
|
|
HNF1B
|
[NCBI]
|
6.67835e-05
|
|
|
axenfeld-rieger anomaly with partially absent eye muscles, distinctive face, hydrocephaly, and skeletal abnormalities
|
[NCBI]
|
6.67172e-05
|
|
|
MADB
|
[NCBI]
|
6.67172e-05
|
|
|
brunner syndrome
|
[NCBI]
|
6.67172e-05
|
|
|
deafness, sensorineural, and male infertility
|
[NCBI]
|
6.67172e-05
|
|
|
cerebrofrontofacial syndrome
|
[NCBI]
|
6.67172e-05
|
|
|
stapes ankylosis with broad thumb and toes
|
[NCBI]
|
6.67172e-05
|
|
|
diabetes mellitus, permanent neonatal, with cerebellar agenesis
|
[NCBI]
|
6.67172e-05
|
|
|
FEB3
|
[NCBI]
|
6.67172e-05
|
|
|
basal cell carcinoma, multiple
|
[NCBI]
|
6.67172e-05
|
|
|
CDA
|
[NCBI]
|
6.63964e-05
|
|
|
SACS
|
[NCBI]
|
6.63964e-05
|
|
|
congenital cataracts, facial dysmorphism, and neuropathy
|
[NCBI]
|
6.63964e-05
|
|
|
LGMD2H
|
[NCBI]
|
6.63964e-05
|
|
|
PPARA
|
[NCBI]
|
6.63924e-05
|
|
|
weaver syndrome
|
[NCBI]
|
6.59462e-05
|
|
|
BGS
|
[NCBI]
|
6.59462e-05
|
|
|
camurati-engelmann disease
|
[NCBI]
|
6.59462e-05
|
|
|
IDUA
|
[NCBI]
|
6.58034e-05
|
|
|
CLN6
|
[NCBI]
|
6.56369e-05
|
|
|
twinning, monozygotic
|
[NCBI]
|
6.56369e-05
|
|
|
pneumothorax, primary spontaneous
|
[NCBI]
|
6.56369e-05
|
|
|
AOII
|
[NCBI]
|
6.56369e-05
|
|
|
floating-harbor syndrome
|
[NCBI]
|
6.56369e-05
|
|
|
CO
|
[NCBI]
|
6.56369e-05
|
|
|
drug metabolism, poor, cyp2c19-related
|
[NCBI]
|
6.56369e-05
|
|
|
ATP7B
|
[NCBI]
|
6.53315e-05
|
|
|
MB
|
[NCBI]
|
6.49871e-05
|
|
|
marden-walker syndrome
|
[NCBI]
|
6.49026e-05
|
|
|
FKRP
|
[NCBI]
|
6.47712e-05
|
|
|
OPMD
|
[NCBI]
|
6.44992e-05
|
|
|
dubowitz syndrome
|
[NCBI]
|
6.43207e-05
|
|
|
ADCYAP1
|
[NCBI]
|
6.43028e-05
|
|
|
MHA
|
[NCBI]
|
6.41722e-05
|
|
|
SEDC
|
[NCBI]
|
6.41722e-05
|
|
|
ehlers-danlos syndrome, type iv, autosomal dominant
|
[NCBI]
|
6.41722e-05
|
|
|
ODDD
|
[NCBI]
|
6.41722e-05
|
|
|
GAA
|
[NCBI]
|
6.39633e-05
|
|
|
MODY
|
[NCBI]
|
6.38101e-05
|
|
|
GIP
|
[NCBI]
|
6.32625e-05
|
|
|
TSC2
|
[NCBI]
|
6.30367e-05
|
|
|
PGP
|
[NCBI]
|
6.28607e-05
|
|
|
PCDH15
|
[NCBI]
|
6.25507e-05
|
|
|
RAI1
|
[NCBI]
|
6.20491e-05
|
|
|
LPA
|
[NCBI]
|
6.13505e-05
|
|
|
VWM
|
[NCBI]
|
6.12087e-05
|
|
|
JBS
|
[NCBI]
|
6.12087e-05
|
|
|
PPR
|
[NCBI]
|
6.09447e-05
|
|
|
SMAX1
|
[NCBI]
|
6.0844e-05
|
|
|
PAX6
|
[NCBI]
|
6.0347e-05
|
|
|
PGD
|
[NCBI]
|
6.02926e-05
|
|
|
CDSP
|
[NCBI]
|
6.02643e-05
|
|
|
amelogenesis imperfecta, hypoplastic/hypomaturation, x-linked 1
|
[NCBI]
|
6.02409e-05
|
|
|
chromosome 22q13.3 deletion syndrome
|
[NCBI]
|
6.02409e-05
|
|
|
HFM
|
[NCBI]
|
6.02396e-05
|
|
|
RB1
|
[NCBI]
|
5.94928e-05
|
|
|
G6PD
|
[NCBI]
|
5.93157e-05
|
|
|
TNNT2
|
[NCBI]
|
5.93105e-05
|
|
|
contractural arachnodactyly, congenital
|
[NCBI]
|
5.93105e-05
|
|
|
AHO
|
[NCBI]
|
5.92004e-05
|
|
|
FFI
|
[NCBI]
|
5.91699e-05
|
|
|
CMD1A
|
[NCBI]
|
5.8171e-05
|
|
|
PXE
|
[NCBI]
|
5.81512e-05
|
|
|
HD
|
[NCBI]
|
5.79439e-05
|
|
|
FCMD
|
[NCBI]
|
5.7806e-05
|
|
|
AN2
|
[NCBI]
|
5.7806e-05
|
|
|
ARSB
|
[NCBI]
|
5.76562e-05
|
|
|
GCNT2
|
[NCBI]
|
5.74885e-05
|
|
|
A4GALT
|
[NCBI]
|
5.74885e-05
|
|
|
BBS4
|
[NCBI]
|
5.74885e-05
|
|
|
FANCA
|
[NCBI]
|
5.71628e-05
|
|
|
char syndrome
|
[NCBI]
|
5.69537e-05
|
|
|
mal de meleda
|
[NCBI]
|
5.69537e-05
|
|
|
cryptorchidism, unilateral or bilateral
|
[NCBI]
|
5.69537e-05
|
|
|
DYT12
|
[NCBI]
|
5.69537e-05
|
|
|
SC
|
[NCBI]
|
5.69537e-05
|
|
|
MCOPS2
|
[NCBI]
|
5.69537e-05
|
|
|
TRS
|
[NCBI]
|
5.69537e-05
|
|
|
FANCB
|
[NCBI]
|
5.69537e-05
|
|
|
DFNB3
|
[NCBI]
|
5.69537e-05
|
|
|
desmoid disease, hereditary
|
[NCBI]
|
5.69537e-05
|
|
|
HEPOD
|
[NCBI]
|
5.68485e-05
|
|
|
ORW2
|
[NCBI]
|
5.68485e-05
|
|
|
PMC
|
[NCBI]
|
5.68485e-05
|
|
|
HBFQTL1
|
[NCBI]
|
5.68067e-05
|
|
|
CRB1
|
[NCBI]
|
5.64111e-05
|
|
|
ENAM
|
[NCBI]
|
5.64111e-05
|
|
|
COL1A1
|
[NCBI]
|
5.63072e-05
|
|
|
alport syndrome, autosomal dominant
|
[NCBI]
|
5.61492e-05
|
|
|
CDAN1
|
[NCBI]
|
5.58028e-05
|
|
|
SHBG
|
[NCBI]
|
5.55514e-05
|
|
|
SCA7
|
[NCBI]
|
5.54502e-05
|
|
|
ALAD
|
[NCBI]
|
5.54499e-05
|
|
|
COL7A1
|
[NCBI]
|
5.54499e-05
|
|
|
scleroderma, familial progressive
|
[NCBI]
|
5.51047e-05
|
|
|
LI1
|
[NCBI]
|
5.49489e-05
|
|
|
ABCD1
|
[NCBI]
|
5.49044e-05
|
|
|
OPD2
|
[NCBI]
|
5.47734e-05
|
|
|
PRODH
|
[NCBI]
|
5.45587e-05
|
|
|
DMD
|
[NCBI]
|
5.45401e-05
|
|
|
HGF
|
[NCBI]
|
5.41237e-05
|
|
|
AMY2A
|
[NCBI]
|
5.39487e-05
|
|
|
SGCA
|
[NCBI]
|
5.39487e-05
|
|
|
ZMPSTE24
|
[NCBI]
|
5.38635e-05
|
|
|
BOR1
|
[NCBI]
|
5.34519e-05
|
|
|
RP2
|
[NCBI]
|
5.33084e-05
|
|
|
PTPN11
|
[NCBI]
|
5.31054e-05
|
|
|
gm1-gangliosidosis, type i
|
[NCBI]
|
5.28228e-05
|
|
|
CJD
|
[NCBI]
|
5.27303e-05
|
|
|
SPG12
|
[NCBI]
|
5.26531e-05
|
|
|
ETM2
|
[NCBI]
|
5.26531e-05
|
|
|
AUTS5
|
[NCBI]
|
5.26531e-05
|
|
|
hennekam lymphangiectasia-lymphedema syndrome
|
[NCBI]
|
5.26531e-05
|
|
|
ehlers-danlos syndrome, type vib
|
[NCBI]
|
5.26531e-05
|
|
|
SCA4
|
[NCBI]
|
5.26531e-05
|
|
|
WT3
|
[NCBI]
|
5.26531e-05
|
|
|
chorioretinal atrophy, progressive bifocal
|
[NCBI]
|
5.26531e-05
|
|
|
BZX
|
[NCBI]
|
5.26531e-05
|
|
|
tongue, pigmented fungiform papillae of
|
[NCBI]
|
5.26531e-05
|
|
|
myopathy, tubular aggregate
|
[NCBI]
|
5.26531e-05
|
|
|
syndactyly, type i
|
[NCBI]
|
5.26531e-05
|
|
|
plasmodium falciparum blood infection level
|
[NCBI]
|
5.26531e-05
|
|
|
CTAA1
|
[NCBI]
|
5.26531e-05
|
|
|
migraine, familial typical, susceptibility to, 2
|
[NCBI]
|
5.26531e-05
|
|
|
CTPP1
|
[NCBI]
|
5.26531e-05
|
|
|
electroencephalogram, low-voltage
|
[NCBI]
|
5.26531e-05
|
|
|
cerebellar ataxia and hypogonadotropic hypogonadism
|
[NCBI]
|
5.26531e-05
|
|
|
anosmia, congenital
|
[NCBI]
|
5.26531e-05
|
|
|
CDH23
|
[NCBI]
|
5.25359e-05
|
|
|
IBD1
|
[NCBI]
|
5.1908e-05
|
|
|
GPI
|
[NCBI]
|
5.18475e-05
|
|
|
DFNB37
|
[NCBI]
|
5.16965e-05
|
|
|
premature aging syndrome, penttinen type
|
[NCBI]
|
5.16965e-05
|
|
|
patterson pseudoleprechaunism syndrome
|
[NCBI]
|
5.16965e-05
|
|
|
marfanoid mental retardation syndrome, autosomal
|
[NCBI]
|
5.16965e-05
|
|
|
CDLS3
|
[NCBI]
|
5.16965e-05
|
|
|
furlong syndrome: fs
|
[NCBI]
|
5.16965e-05
|
|
|
crumpled helices and small mouth
|
[NCBI]
|
5.16965e-05
|
|
|
HHF5
|
[NCBI]
|
5.16965e-05
|
|
|
chondrodysplasia, acromesomelic, with genital anomalies
|
[NCBI]
|
5.16965e-05
|
|
|
aminoadipic aciduria
|
[NCBI]
|
5.16965e-05
|
|
|
growth factors, combined defect of
|
[NCBI]
|
5.16965e-05
|
|
|
barber-say syndrome
|
[NCBI]
|
5.16965e-05
|
|
|
epilepsy, x-linked, with variable learning disabilities and behavior disorders
|
[NCBI]
|
5.16965e-05
|
|
|
PMSE
|
[NCBI]
|
5.16965e-05
|
|
|
hyaluronan metabolism, defect in
|
[NCBI]
|
5.16965e-05
|
|
|
COXPD3
|
[NCBI]
|
5.16965e-05
|
|
|
osteogenesis imperfecta, sillence type ii/iii, without abnormality of type i collagen
|
[NCBI]
|
5.16965e-05
|
|
|
ectodermal dysplasia with mental retardation and syndactyly
|
[NCBI]
|
5.16965e-05
|
|
|
TLPD
|
[NCBI]
|
5.16965e-05
|
|
|
nasal alar collapse, bilateral
|
[NCBI]
|
5.16965e-05
|
|
|
gastrocutaneous syndrome
|
[NCBI]
|
5.16965e-05
|
|
|
ermine phenotype
|
[NCBI]
|
5.16965e-05
|
|
|
MRX14
|
[NCBI]
|
5.16965e-05
|
|
|
OFD10
|
[NCBI]
|
5.16965e-05
|
|
|
ectrodactyly-cleft palate syndrome
|
[NCBI]
|
5.16965e-05
|
|
|
morquio syndrome, nonkeratosulfate-excreting type
|
[NCBI]
|
5.16965e-05
|
|
|
mucopolysaccharidoses, unclassified types
|
[NCBI]
|
5.16965e-05
|
|
|
sugarman brachydactyly
|
[NCBI]
|
5.16965e-05
|
|
|
hypomagnesemia, hypertension, and hypercholesterolemia, mitochondrial
|
[NCBI]
|
5.16965e-05
|
|
|
phosphatase, acid, of tissues
|
[NCBI]
|
5.16965e-05
|
|
|
cyprus facial neuromusculoskeletal syndrome
|
[NCBI]
|
5.16965e-05
|
|
|
arthrogryposis, distal, type 2e
|
[NCBI]
|
5.16965e-05
|
|
|
simosa craniofacial syndrome
|
[NCBI]
|
5.16965e-05
|
|
|
MLRD
|
[NCBI]
|
5.16965e-05
|
|
|
keratosis palmoplantaris striata iii
|
[NCBI]
|
5.16965e-05
|
|
|
tibia, absence or hypoplasia of, with polydactyly, retrocerebellar arachnoid cyst, and other anomalies
|
[NCBI]
|
5.16965e-05
|
|
|
caroli disease, isolated
|
[NCBI]
|
5.16965e-05
|
|
|
radioulnar synostosis, unilateral, with developmental retardation and hypotonia
|
[NCBI]
|
5.16965e-05
|
|
|
cree mental retardation syndrome
|
[NCBI]
|
5.16965e-05
|
|
|
ROCA
|
[NCBI]
|
5.16965e-05
|
|
|
spondyloepimetaphyseal dysplasia, x-linked, with mental deterioration
|
[NCBI]
|
5.16965e-05
|
|
|
peters anomaly with cataract
|
[NCBI]
|
5.16965e-05
|
|
|
myopathy, early-onset, with fatal cardiomyopathy
|
[NCBI]
|
5.16965e-05
|
|
|
macdermot-winter syndrome
|
[NCBI]
|
5.16965e-05
|
|
|
RHE
|
[NCBI]
|
5.16965e-05
|
|
|
ribbing disease
|
[NCBI]
|
5.16965e-05
|
|
|
liver fibrocystic disease and polydactyly
|
[NCBI]
|
5.16965e-05
|
|
|
thoracopelvic dysostosis
|
[NCBI]
|
5.16965e-05
|
|
|
cortical dysplasia-focal epilepsy syndrome
|
[NCBI]
|
5.16965e-05
|
|
|
THB
|
[NCBI]
|
5.16965e-05
|
|
|
metaphyseal chondrodysplasia, spahr type
|
[NCBI]
|
5.16965e-05
|
|
|
cleft soft palate
|
[NCBI]
|
5.16965e-05
|
|
|
contiguous abcd1/dxs1375e deletion syndrome
|
[NCBI]
|
5.16965e-05
|
|
|
infundibulopelvic dysgenesis
|
[NCBI]
|
5.16965e-05
|
|
|
prenatal bowing
|
[NCBI]
|
5.16965e-05
|
|
|
muscular hypoplasia, congenital universal, of krabbe
|
[NCBI]
|
5.16965e-05
|
|
|
syringomas, multiple
|
[NCBI]
|
5.16965e-05
|
|
|
cerebrofacioarticular syndrome
|
[NCBI]
|
5.16965e-05
|
|
|
brachydactyly, long-thumb type
|
[NCBI]
|
5.16965e-05
|
|
|
MCOPCB5
|
[NCBI]
|
5.16965e-05
|
|
|
NEM5
|
[NCBI]
|
5.16965e-05
|
|
|
gms syndrome
|
[NCBI]
|
5.16965e-05
|
|
|
gonadal dysgenesis, hypergonadotropic, xx type, short stature, and recurrent metabolic acidosis
|
[NCBI]
|
5.16965e-05
|
|
|
arthropathy, erosive
|
[NCBI]
|
5.16965e-05
|
|
|
cervical rib
|
[NCBI]
|
5.16965e-05
|
|
|
glutathione transferase activity toward trans-stilbene oxide
|
[NCBI]
|
5.16965e-05
|
|
|
hypotrichosis-lymphedema-telangiectasia syndrome
|
[NCBI]
|
5.16965e-05
|
|
|
minicore myopathy, antenatal onset, with arthrogryposis
|
[NCBI]
|
5.16965e-05
|
|
|
rombo syndrome
|
[NCBI]
|
5.16965e-05
|
|
|
peripheral dysostosis
|
[NCBI]
|
5.16965e-05
|
|
|
osteopenia and sparse hair
|
[NCBI]
|
5.16965e-05
|
|
|
NFLS
|
[NCBI]
|
5.16965e-05
|
|
|
PERRS
|
[NCBI]
|
5.16965e-05
|
|
|
patent ductus arteriosus and bicuspid aortic valve with hand anomalies
|
[NCBI]
|
5.16965e-05
|
|
|
metaphyseal chondrodysplasia with retinitis pigmentosa
|
[NCBI]
|
5.16965e-05
|
|
|
cataract-ataxia-deafness-retardation syndrome
|
[NCBI]
|
5.16965e-05
|
|
|
nasal hyperpigmentation, familial transverse
|
[NCBI]
|
5.16965e-05
|
|
|
lymphedema, congenital recessive
|
[NCBI]
|
5.16965e-05
|
|
|
GPHN
|
[NCBI]
|
5.16965e-05
|
|
|
cataract, sutural, with punctate and cerulean opacities
|
[NCBI]
|
5.16965e-05
|
|
|
HPE9
|
[NCBI]
|
5.16965e-05
|
|
|
SAPX
|
[NCBI]
|
5.16965e-05
|
|
|
DFNB53
|
[NCBI]
|
5.16965e-05
|
|
|
vascular hyalinosis
|
[NCBI]
|
5.16965e-05
|
|
|
kleine-levin hibernation syndrome
|
[NCBI]
|
5.16965e-05
|
|
|
mandibulofacial dysostosis with ptosis, autosomal dominant
|
[NCBI]
|
5.16965e-05
|
|
|
deafness, congenital, with inner ear agenesis, microtia, and microdontia
|
[NCBI]
|
5.16965e-05
|
|
|
low density lipoprotein, variation in molecular weight of
|
[NCBI]
|
5.16965e-05
|
|
|
taurodontism
|
[NCBI]
|
5.16965e-05
|
|
|
HBFQTL5
|
[NCBI]
|
5.16965e-05
|
|
|
spastic paraplegia, ataxia, and mental retardation
|
[NCBI]
|
5.16965e-05
|
|
|
SCDO2
|
[NCBI]
|
5.16965e-05
|
|
|
microcephaly-cardiomyopathy
|
[NCBI]
|
5.16965e-05
|
|
|
bladder diverticulum
|
[NCBI]
|
5.16965e-05
|
|
|
pa polymorphism of alpha-2-globulin
|
[NCBI]
|
5.16965e-05
|
|
|
thalassemias
|
[NCBI]
|
5.16965e-05
|
|
|
blood group--private systems
|
[NCBI]
|
5.16965e-05
|
|
|
loose anagen hair syndrome
|
[NCBI]
|
5.16965e-05
|
|
|
lutheran null
|
[NCBI]
|
5.16965e-05
|
|
|
pseudoxanthoma elasticum-like disorder with multiple coagulation factor deficiency
|
[NCBI]
|
5.16965e-05
|
|
|
low density lipoprotein cholesterol, mild elevation of
|
[NCBI]
|
5.16965e-05
|
|
|
fructose utilization
|
[NCBI]
|
5.16965e-05
|
|
|
spondyloepiphyseal dysplasia with atlantoaxial instability
|
[NCBI]
|
5.16965e-05
|
|
|
osteogenesis imperfecta congenita, microcephaly, and cataracts
|
[NCBI]
|
5.16965e-05
|
|
|
CDG1M
|
[NCBI]
|
5.16965e-05
|
|
|
EN1
|
[NCBI]
|
5.16778e-05
|
|
|
SCN5A
|
[NCBI]
|
5.12759e-05
|
|
|
LAH
|
[NCBI]
|
5.10041e-05
|
|
|
fragile site 17p12
|
[NCBI]
|
5.10041e-05
|
|
|
FANCI
|
[NCBI]
|
5.10041e-05
|
|
|
marshall-smith syndrome
|
[NCBI]
|
5.10041e-05
|
|
|
epidermolysis bullosa simplex, ogna type
|
[NCBI]
|
5.10041e-05
|
|
|
MRT2
|
[NCBI]
|
5.10041e-05
|
|
|
fecundity gene, booroola, of sheep, homolog of
|
[NCBI]
|
5.10041e-05
|
|
|
trigonocephaly, nonsyndromic
|
[NCBI]
|
5.10041e-05
|
|
|
cardiomyopathy, dilated, autosomal recessive
|
[NCBI]
|
5.10041e-05
|
|
|
cortisone reductase deficiency
|
[NCBI]
|
5.10041e-05
|
|
|
CFEOM2
|
[NCBI]
|
5.10041e-05
|
|
|
CDG1G
|
[NCBI]
|
5.10041e-05
|
|
|
SCA13
|
[NCBI]
|
5.10041e-05
|
|
|
kanzaki disease
|
[NCBI]
|
5.10041e-05
|
|
|
familial mediterranean fever, autosomal dominant
|
[NCBI]
|
5.10041e-05
|
|
|
lenz-majewski hyperostotic dwarfism
|
[NCBI]
|
5.10041e-05
|
|
|
LI3
|
[NCBI]
|
5.10041e-05
|
|
|
CLOCK
|
[NCBI]
|
5.08543e-05
|
|
|
ARSA
|
[NCBI]
|
5.0817e-05
|
|
|
SLC7A9
|
[NCBI]
|
5.06931e-05
|
|
|
TRMU
|
[NCBI]
|
5.03119e-05
|
|
|
WRN
|
[NCBI]
|
5.02236e-05
|
|
|
ADLTE
|
[NCBI]
|
4.98806e-05
|
|
|
potocki-shaffer syndrome
|
[NCBI]
|
4.98806e-05
|
|
|
mowat-wilson syndrome
|
[NCBI]
|
4.98806e-05
|
|
|
succinic semialdehyde dehydrogenase deficiency
|
[NCBI]
|
4.98806e-05
|
|
|
von willebrand disease
|
[NCBI]
|
4.98045e-05
|
|
|
CBBM
|
[NCBI]
|
4.98037e-05
|
|
|
SYM1
|
[NCBI]
|
4.97937e-05
|
|
|
epidermolysis bullosa dystrophica, pasini type
|
[NCBI]
|
4.97937e-05
|
|
|
SPG10
|
[NCBI]
|
4.97937e-05
|
|
|
currarino syndrome
|
[NCBI]
|
4.97937e-05
|
|
|
DFNA3
|
[NCBI]
|
4.97937e-05
|
|
|
mucolipidosis iii, complementation group c
|
[NCBI]
|
4.97937e-05
|
|
|
hydrops-ectopic calcification-moth-eaten skeletal dysplasia
|
[NCBI]
|
4.97937e-05
|
|
|
OCA1A
|
[NCBI]
|
4.96914e-05
|
|
|
FOXC1
|
[NCBI]
|
4.95725e-05
|
|
|
Ge
|
[NCBI]
|
4.95725e-05
|
|
|
ulcerative colitis, susceptibility to
|
[NCBI]
|
4.90958e-05
|
|
|
MTTK
|
[NCBI]
|
4.90767e-05
|
|
|
SPG4
|
[NCBI]
|
4.90767e-05
|
|
|
POLG
|
[NCBI]
|
4.88195e-05
|
|
|
TNFRSF11B
|
[NCBI]
|
4.83789e-05
|
|
|
FMR1
|
[NCBI]
|
4.79034e-05
|
|
|
SGCE
|
[NCBI]
|
4.7612e-05
|
|
|
LMX1B
|
[NCBI]
|
4.7612e-05
|
|
|
PGM3
|
[NCBI]
|
4.7612e-05
|
|
|
FUT2
|
[NCBI]
|
4.7612e-05
|
|
|
C3
|
[NCBI]
|
4.75039e-05
|
|
|
SMN1
|
[NCBI]
|
4.74742e-05
|
|
|
GLC1A
|
[NCBI]
|
4.71287e-05
|
|
|
NAT1
|
[NCBI]
|
4.66165e-05
|
|
|
PRKAR1A
|
[NCBI]
|
4.6288e-05
|
|
|
BMPR1B
|
[NCBI]
|
4.59897e-05
|
|
|
MYOC
|
[NCBI]
|
4.57028e-05
|
|
|
MVP
|
[NCBI]
|
4.56657e-05
|
|
|
MADA
|
[NCBI]
|
4.5637e-05
|
|
|
PKD1
|
[NCBI]
|
4.55283e-05
|
|
|
pseudoxanthoma elasticum, forme fruste
|
[NCBI]
|
4.54749e-05
|
|
|
GCE
|
[NCBI]
|
4.54749e-05
|
|
|
PARK6
|
[NCBI]
|
4.54749e-05
|
|
|
ATP7A
|
[NCBI]
|
4.54749e-05
|
|
|
FRAS1
|
[NCBI]
|
4.53959e-05
|
|
|
BCHE
|
[NCBI]
|
4.5137e-05
|
|
|
RECQL2
|
[NCBI]
|
4.43563e-05
|
|
|
wolman disease
|
[NCBI]
|
4.43563e-05
|
|
|
ALPP
|
[NCBI]
|
4.406e-05
|
|
|
DCX
|
[NCBI]
|
4.406e-05
|
|
|
MC4R
|
[NCBI]
|
4.40027e-05
|
|
|
COL3A1
|
[NCBI]
|
4.38465e-05
|
|
|
WAS
|
[NCBI]
|
4.38465e-05
|
|
|
spondyloepimetaphyseal dysplasia, strudwick type
|
[NCBI]
|
4.37578e-05
|
|
|
gaucher disease, perinatal lethal
|
[NCBI]
|
4.37578e-05
|
|
|
trifunctional protein deficiency
|
[NCBI]
|
4.37578e-05
|
|
|
LISX1
|
[NCBI]
|
4.37578e-05
|
|
|
WZS
|
[NCBI]
|
4.37578e-05
|
|
|
muenke syndrome
|
[NCBI]
|
4.37578e-05
|
|
|
CZP1
|
[NCBI]
|
4.37578e-05
|
|
|
MCPH5
|
[NCBI]
|
4.37578e-05
|
|
|
DA1
|
[NCBI]
|
4.37578e-05
|
|
|
FMD
|
[NCBI]
|
4.37578e-05
|
|
|
NOD2
|
[NCBI]
|
4.3275e-05
|
|
|
C4B
|
[NCBI]
|
4.3275e-05
|
|
|
RHO
|
[NCBI]
|
4.31155e-05
|
|
|
EFNB1
|
[NCBI]
|
4.30635e-05
|
|
|
PRH1
|
[NCBI]
|
4.30635e-05
|
|
|
TECTA
|
[NCBI]
|
4.30635e-05
|
|
|
NP
|
[NCBI]
|
4.29317e-05
|
|
|
CACNA1A
|
[NCBI]
|
4.29317e-05
|
|
|
IAPP
|
[NCBI]
|
4.26951e-05
|
|
|
NF2
|
[NCBI]
|
4.24738e-05
|
|
|
PEX13
|
[NCBI]
|
4.24251e-05
|
|
|
BSCL2
|
[NCBI]
|
4.24251e-05
|
|
|
CLCNKB
|
[NCBI]
|
4.24251e-05
|
|
|
MTTE
|
[NCBI]
|
4.24251e-05
|
|
|
SCDO1
|
[NCBI]
|
4.24205e-05
|
|
|
POAG
|
[NCBI]
|
4.23539e-05
|
|
|
CAV3
|
[NCBI]
|
4.23135e-05
|
|
|
TWIST1
|
[NCBI]
|
4.23135e-05
|
|
|
DJS
|
[NCBI]
|
4.18445e-05
|
|
|
PSORS1
|
[NCBI]
|
4.17216e-05
|
|
|
GJB2
|
[NCBI]
|
4.15949e-05
|
|
|
diabetes-deafness syndrome, maternally transmitted
|
[NCBI]
|
4.14878e-05
|
|
|
DYX2
|
[NCBI]
|
4.14878e-05
|
|
|
AHDS
|
[NCBI]
|
4.14878e-05
|
|
|
SPG2
|
[NCBI]
|
4.14878e-05
|
|
|
down syndrome
|
[NCBI]
|
4.14041e-05
|
|
|
PARK2
|
[NCBI]
|
4.11927e-05
|
|
|
GLI3
|
[NCBI]
|
4.10983e-05
|
|
|
MEFV
|
[NCBI]
|
4.10983e-05
|
|
|
MTRNR1
|
[NCBI]
|
4.10983e-05
|
|
|
PKHD1
|
[NCBI]
|
4.09732e-05
|
|
|
POMT1
|
[NCBI]
|
4.09732e-05
|
|
|
CA1
|
[NCBI]
|
4.09161e-05
|
|
|
SRY
|
[NCBI]
|
4.08072e-05
|
|
|
TYR
|
[NCBI]
|
4.08072e-05
|
|
|
DFNA10
|
[NCBI]
|
4.07119e-05
|
|
|
paroxysmal extreme pain disorder
|
[NCBI]
|
4.07119e-05
|
|
|
iris coloboma with ptosis, hypertelorism, and mental retardation
|
[NCBI]
|
4.07119e-05
|
|
|
macrocephaly/autism syndrome
|
[NCBI]
|
4.07119e-05
|
|
|
RCDP3
|
[NCBI]
|
4.07119e-05
|
|
|
JAE
|
[NCBI]
|
4.07119e-05
|
|
|
RP15
|
[NCBI]
|
4.07119e-05
|
|
|
shprintzen-goldberg craniosynostosis syndrome
|
[NCBI]
|
4.07119e-05
|
|
|
asthma-related traits, susceptibility to, 5
|
[NCBI]
|
4.07119e-05
|
|
|
AIHHT
|
[NCBI]
|
4.07119e-05
|
|
|
schindler disease, type i
|
[NCBI]
|
4.07119e-05
|
|
|
peters-plus syndrome
|
[NCBI]
|
4.07119e-05
|
|
|
subglottic bar
|
[NCBI]
|
4.07119e-05
|
|
|
PFM2
|
[NCBI]
|
4.07119e-05
|
|
|
severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-positive, nk cell-positive
|
[NCBI]
|
4.07119e-05
|
|
|
asthma-related traits, susceptibility to, 1
|
[NCBI]
|
4.07119e-05
|
|
|
DFNA13
|
[NCBI]
|
4.07119e-05
|
|
|
retinitis pigmentosa, x-linked, with recurrent respiratory infections
|
[NCBI]
|
4.07119e-05
|
|
|
LI2
|
[NCBI]
|
4.07119e-05
|
|
|
hypophosphatemic rickets, x-linked recessive
|
[NCBI]
|
4.07119e-05
|
|
|
weyers acrofacial dysostosis
|
[NCBI]
|
4.07119e-05
|
|
|
DFNA17
|
[NCBI]
|
4.07119e-05
|
|
|
GALT
|
[NCBI]
|
4.0327e-05
|
|
|
mucopolysaccharidosis type iva
|
[NCBI]
|
4.02348e-05
|
|
|
RSTS
|
[NCBI]
|
4.0129e-05
|
|
|
SERPINA6
|
[NCBI]
|
4.00151e-05
|
|
|
NOTCH1
|
[NCBI]
|
3.94741e-05
|
|
|
MFN2
|
[NCBI]
|
3.94726e-05
|
|
|
MRXHF1
|
[NCBI]
|
3.94239e-05
|
|
|
charge syndrome
|
[NCBI]
|
3.94239e-05
|
|
|
JUNB
|
[NCBI]
|
3.9396e-05
|
|
|
TTC10
|
[NCBI]
|
3.9396e-05
|
|
|
MLPH
|
[NCBI]
|
3.9396e-05
|
|
|
RPS4X
|
[NCBI]
|
3.9396e-05
|
|
|
CNGB3
|
[NCBI]
|
3.9396e-05
|
|
|
RAPSN
|
[NCBI]
|
3.90524e-05
|
|
|
PGA3
|
[NCBI]
|
3.90328e-05
|
|
|
BLOC1S3
|
[NCBI]
|
3.90328e-05
|
|
|
CSNK1E
|
[NCBI]
|
3.89861e-05
|
|
|
A1BG
|
[NCBI]
|
3.89861e-05
|
|
|
NPR2
|
[NCBI]
|
3.89861e-05
|
|
|
CATSPER2
|
[NCBI]
|
3.89861e-05
|
|
|
KIT
|
[NCBI]
|
3.86979e-05
|
|
|
corpus callosum, agenesis of
|
[NCBI]
|
3.8587e-05
|
|
|
BDC
|
[NCBI]
|
3.8587e-05
|
|
|
feingold syndrome
|
[NCBI]
|
3.8587e-05
|
|
|
GVM
|
[NCBI]
|
3.8587e-05
|
|
|
SCA14
|
[NCBI]
|
3.8587e-05
|
|
|
kniest dysplasia
|
[NCBI]
|
3.8587e-05
|
|
|
OCD1
|
[NCBI]
|
3.8587e-05
|
|
|
MBP
|
[NCBI]
|
3.84048e-05
|
|
|
MYH9
|
[NCBI]
|
3.81043e-05
|
|
|
LS
|
[NCBI]
|
3.80824e-05
|
|
|
AKR1B1
|
[NCBI]
|
3.79637e-05
|
|
|
glucose transport defect, blood-brain barrier
|
[NCBI]
|
3.78642e-05
|
|
|
GABEB
|
[NCBI]
|
3.78642e-05
|
|
|
FHM2
|
[NCBI]
|
3.78642e-05
|
|
|
homocystinuria
|
[NCBI]
|
3.76233e-05
|
|
|
C7
|
[NCBI]
|
3.72778e-05
|
|
|
CMPK1
|
[NCBI]
|
3.72778e-05
|
|
|
MAPT
|
[NCBI]
|
3.68359e-05
|
|
|
MTM1
|
[NCBI]
|
3.68047e-05
|
|
|
MDM1
|
[NCBI]
|
3.67672e-05
|
|
|
POMGNT1
|
[NCBI]
|
3.67672e-05
|
|
|
HESX1
|
[NCBI]
|
3.67672e-05
|
|
|
TYRP1
|
[NCBI]
|
3.66926e-05
|
|
|
DYX1
|
[NCBI]
|
3.66279e-05
|
|
|
LCA1
|
[NCBI]
|
3.66279e-05
|
|
|
RPGR
|
[NCBI]
|
3.63993e-05
|
|
|
TNFSF10
|
[NCBI]
|
3.6316e-05
|
|
|
TBP
|
[NCBI]
|
3.593e-05
|
|
|
L1CAM
|
[NCBI]
|
3.57519e-05
|
|
|
NDP
|
[NCBI]
|
3.56912e-05
|
|
|
ATXN8OS
|
[NCBI]
|
3.55681e-05
|
|
|
WAS
|
[NCBI]
|
3.54449e-05
|
|
|
giant platelet syndrome
|
[NCBI]
|
3.53862e-05
|
|
|
THRB
|
[NCBI]
|
3.47894e-05
|
|
|
EKD1
|
[NCBI]
|
3.47156e-05
|
|
|
TBS
|
[NCBI]
|
3.47043e-05
|
|
|
walker-warburg syndrome
|
[NCBI]
|
3.47043e-05
|
|
|
GEFS+
|
[NCBI]
|
3.45593e-05
|
|
|
EBN1
|
[NCBI]
|
3.45593e-05
|
|
|
ANK2
|
[NCBI]
|
3.44914e-05
|
|
|
MTTH
|
[NCBI]
|
3.44914e-05
|
|
|
PITX3
|
[NCBI]
|
3.44497e-05
|
|
|
TD1
|
[NCBI]
|
3.44114e-05
|
|
|
MUT
|
[NCBI]
|
3.43896e-05
|
|
|
GJA8
|
[NCBI]
|
3.43896e-05
|
|
|
WT1
|
[NCBI]
|
3.42585e-05
|
|
|
GSC
|
[NCBI]
|
3.42585e-05
|
|
|
MRXS13
|
[NCBI]
|
3.41033e-05
|
|
|
SMA4
|
[NCBI]
|
3.41033e-05
|
|
|
medulloblastoma
|
[NCBI]
|
3.41033e-05
|
|
|
LGMD2D
|
[NCBI]
|
3.41033e-05
|
|
|
DA2B
|
[NCBI]
|
3.41033e-05
|
|
|
PMDS
|
[NCBI]
|
3.41033e-05
|
|
|
acheiropody
|
[NCBI]
|
3.41033e-05
|
|
|
KCNJ2
|
[NCBI]
|
3.40955e-05
|
|
|
ADRB3
|
[NCBI]
|
3.40955e-05
|
|
|
GUCY2D
|
[NCBI]
|
3.40955e-05
|
|
|
spermatogenic failure, nonobstructive, y-linked
|
[NCBI]
|
3.4038e-05
|
|
|
mucopolysaccharidosis type vii
|
[NCBI]
|
3.40155e-05
|
|
|
OKS
|
[NCBI]
|
3.40155e-05
|
|
|
ABO
|
[NCBI]
|
3.37926e-05
|
|
|
FANCC
|
[NCBI]
|
3.37926e-05
|
|
|
DHFR
|
[NCBI]
|
3.34321e-05
|
|
|
ectopia lentis, isolated
|
[NCBI]
|
3.31934e-05
|
|
|
FPLD3
|
[NCBI]
|
3.31934e-05
|
|
|
PLSDT
|
[NCBI]
|
3.31934e-05
|
|
|
ceroid lipofuscinosis, neuronal, 8, northern epilepsy variant
|
[NCBI]
|
3.31934e-05
|
|
|
DFNA11
|
[NCBI]
|
3.31934e-05
|
|
|
hemoglobin--variants for which the chain carrying the mutation is unknown or uncertain
|
[NCBI]
|
3.31934e-05
|
|
|
keratoderma, palmoplantar, with deafness
|
[NCBI]
|
3.31934e-05
|
|
|
minicore myopathy with external ophthalmoplegia
|
[NCBI]
|
3.31934e-05
|
|
|
sarcosinemia
|
[NCBI]
|
3.31934e-05
|
|
|
gaucher disease, atypical, due to saposin c deficiency
|
[NCBI]
|
3.31934e-05
|
|
|
naxos disease
|
[NCBI]
|
3.31934e-05
|
|
|
HCA2
|
[NCBI]
|
3.31934e-05
|
|
|
EDNRB
|
[NCBI]
|
3.28916e-05
|
|
|
PPT1
|
[NCBI]
|
3.28916e-05
|
|
|
AHR
|
[NCBI]
|
3.28301e-05
|
|
|
CMM
|
[NCBI]
|
3.27772e-05
|
|
|
NEB
|
[NCBI]
|
3.26597e-05
|
|
|
SMA3
|
[NCBI]
|
3.2572e-05
|
|
|
CMTX1
|
[NCBI]
|
3.2572e-05
|
|
|
MDLS
|
[NCBI]
|
3.2572e-05
|
|
|
geleophysic dysplasia
|
[NCBI]
|
3.24199e-05
|
|
|
actinic prurigo
|
[NCBI]
|
3.24199e-05
|
|
|
peho syndrome
|
[NCBI]
|
3.24199e-05
|
|
|
HPC10
|
[NCBI]
|
3.24199e-05
|
|
|
vestibulopathy, familial
|
[NCBI]
|
3.24199e-05
|
|
|
CCA1
|
[NCBI]
|
3.24199e-05
|
|
|
ATOD6
|
[NCBI]
|
3.24199e-05
|
|
|
dysgnathia complex
|
[NCBI]
|
3.24199e-05
|
|
|
OFD4
|
[NCBI]
|
3.24199e-05
|
|
|
CLN4A
|
[NCBI]
|
3.24199e-05
|
|
|
NIDDM2
|
[NCBI]
|
3.24199e-05
|
|
|
corpus callosum, agenesis of, with facial anomalies and robin sequence
|
[NCBI]
|
3.24199e-05
|
|
|
pierre robin sequence with pectus excavatum and rib and scapular anomalies
|
[NCBI]
|
3.24199e-05
|
|
|
panbronchiolitis, diffuse
|
[NCBI]
|
3.24199e-05
|
|
|
CDAN3
|
[NCBI]
|
3.24199e-05
|
|
|
EOCA
|
[NCBI]
|
3.24199e-05
|
|
|
MCOPS6
|
[NCBI]
|
3.24199e-05
|
|
|
cataract and cardiomyopathy
|
[NCBI]
|
3.24199e-05
|
|
|
stature as a quantitative trait
|
[NCBI]
|
3.24199e-05
|
|
|
short rib-polydactyly syndrome, type i
|
[NCBI]
|
3.24199e-05
|
|
|
STHAG4
|
[NCBI]
|
3.24199e-05
|
|
|
NNO1
|
[NCBI]
|
3.24199e-05
|
|
|
CNC2
|
[NCBI]
|
3.24199e-05
|
|
|
IDH1
|
[NCBI]
|
3.23814e-05
|
|
|
SALL4
|
[NCBI]
|
3.23814e-05
|
|
|
SGCD
|
[NCBI]
|
3.23814e-05
|
|
|
ART4
|
[NCBI]
|
3.23814e-05
|
|
|
FKTN
|
[NCBI]
|
3.23814e-05
|
|
|
COL1A2
|
[NCBI]
|
3.2285e-05
|
|
|
ALGS1
|
[NCBI]
|
3.21861e-05
|
|
|
LPL
|
[NCBI]
|
3.21298e-05
|
|
|
STK11
|
[NCBI]
|
3.20205e-05
|
|
|
FY
|
[NCBI]
|
3.20205e-05
|
|
|
ATM
|
[NCBI]
|
3.19126e-05
|
|
|
CD
|
[NCBI]
|
3.17368e-05
|
|
|
autism
|
[NCBI]
|
3.17246e-05
|
|
|
stroke, ischemic
|
[NCBI]
|
3.1536e-05
|
|
|
autonomic control, congenital failure of
|
[NCBI]
|
3.1536e-05
|
|
|
ORM1
|
[NCBI]
|
3.13126e-05
|
|
|
protoporphyria, erythropoietic
|
[NCBI]
|
3.11777e-05
|
|
|
EDN3
|
[NCBI]
|
3.11599e-05
|
|
|
PG
|
[NCBI]
|
3.10408e-05
|
|
|
CHD7
|
[NCBI]
|
3.1022e-05
|
|
|
NHS
|
[NCBI]
|
3.1022e-05
|
|
|
B3GALNT1
|
[NCBI]
|
3.1022e-05
|
|
|
TBX22
|
[NCBI]
|
3.1022e-05
|
|
|
CDK2
|
[NCBI]
|
3.0891e-05
|
|
|
AMC
|
[NCBI]
|
3.08359e-05
|
|
|
WT1
|
[NCBI]
|
3.07211e-05
|
|
|
TPM1
|
[NCBI]
|
3.05175e-05
|
|
|
XG
|
[NCBI]
|
3.05175e-05
|
|
|
MED12
|
[NCBI]
|
3.05175e-05
|
|
|
NAGA
|
[NCBI]
|
3.05175e-05
|
|
|
FLNB
|
[NCBI]
|
3.05175e-05
|
|
|
SRA2
|
[NCBI]
|
3.05175e-05
|
|
|
ATD1
|
[NCBI]
|
3.04089e-05
|
|
|
MBS
|
[NCBI]
|
3.04089e-05
|
|
|
GPT
|
[NCBI]
|
3.03888e-05
|
|
|
ARH
|
[NCBI]
|
3.01788e-05
|
|
|
multiple pterygium syndrome, escobar variant
|
[NCBI]
|
3.01788e-05
|
|
|
denys-drash syndrome
|
[NCBI]
|
3.01788e-05
|
|
|
epidermolysis bullosa simplex and limb-girdle muscular dystrophy
|
[NCBI]
|
3.01788e-05
|
|
|
papillorenal syndrome
|
[NCBI]
|
3.01788e-05
|
|
|
thiopurine s-methyltransferase deficiency
|
[NCBI]
|
3.01788e-05
|
|
|
acyl-coa dehydrogenase, short-chain, deficiency of
|
[NCBI]
|
3.01788e-05
|
|
|
ED2
|
[NCBI]
|
3.01788e-05
|
|
|
KFSD
|
[NCBI]
|
3.01788e-05
|
|
|
CMD3B
|
[NCBI]
|
3.01788e-05
|
|
|
RENS1
|
[NCBI]
|
3.01788e-05
|
|
|
NCIE1
|
[NCBI]
|
3.01788e-05
|
|
|
AK1
|
[NCBI]
|
3.01735e-05
|
|
|
RP
|
[NCBI]
|
3.0106e-05
|
|
|
ASIP
|
[NCBI]
|
3.00451e-05
|
|
|
MYB
|
[NCBI]
|
3.00451e-05
|
|
|
complement component 8 deficiency, type i
|
[NCBI]
|
3.00451e-05
|
|
|
HOXD13
|
[NCBI]
|
3.00451e-05
|
|
|
ATP2A2
|
[NCBI]
|
3.00451e-05
|
|
|
FOXC2
|
[NCBI]
|
3.00451e-05
|
|
|
SMA1
|
[NCBI]
|
2.95401e-05
|
|
|
FMF
|
[NCBI]
|
2.92853e-05
|
|
|
alzheimer disease 3
|
[NCBI]
|
2.92842e-05
|
|
|
STGD1
|
[NCBI]
|
2.92842e-05
|
|
|
leiomyomatosis and renal cell cancer, hereditary
|
[NCBI]
|
2.92842e-05
|
|
|
RECQL3
|
[NCBI]
|
2.92272e-05
|
|
|
IL2
|
[NCBI]
|
2.89531e-05
|
|
|
PCSK9
|
[NCBI]
|
2.88241e-05
|
|
|
DCTN1
|
[NCBI]
|
2.88241e-05
|
|
|
SALL1
|
[NCBI]
|
2.88241e-05
|
|
|
PLA2G7
|
[NCBI]
|
2.88241e-05
|
|
|
pfeiffer syndrome
|
[NCBI]
|
2.87637e-05
|
|
|
CCAL2
|
[NCBI]
|
2.87637e-05
|
|
|
ETM1
|
[NCBI]
|
2.87637e-05
|
|
|
osteogenesis imperfecta, type iii
|
[NCBI]
|
2.87637e-05
|
|
|
CSA
|
[NCBI]
|
2.87246e-05
|
|
|
CMT1B
|
[NCBI]
|
2.87246e-05
|
|
|
glioma of brain, familial
|
[NCBI]
|
2.85041e-05
|
|
|
SOX10
|
[NCBI]
|
2.83185e-05
|
|
|
PAFAH1B1
|
[NCBI]
|
2.83185e-05
|
|
|
NNT
|
[NCBI]
|
2.82031e-05
|
|
|
ACP2
|
[NCBI]
|
2.82031e-05
|
|
|
NIPBL
|
[NCBI]
|
2.82031e-05
|
|
|
DVL2
|
[NCBI]
|
2.82031e-05
|
|
|
HLXB9
|
[NCBI]
|
2.82031e-05
|
|
|
LGR8
|
[NCBI]
|
2.82031e-05
|
|
|
ATP10A
|
[NCBI]
|
2.82031e-05
|
|
|
d-2-@hydroxyglutarate dehydrogenase
|
[NCBI]
|
2.79002e-05
|
|
|
SMARCAL1
|
[NCBI]
|
2.79002e-05
|
|
|
DNAJA2
|
[NCBI]
|
2.79002e-05
|
|
|
ETFDH
|
[NCBI]
|
2.79002e-05
|
|
|
FREM2
|
[NCBI]
|
2.79002e-05
|
|
|
SPBC25
|
[NCBI]
|
2.79002e-05
|
|
|
MESDC2
|
[NCBI]
|
2.79002e-05
|
|
|
KRT6B
|
[NCBI]
|
2.79002e-05
|
|
|
CRBN
|
[NCBI]
|
2.79002e-05
|
|
|
LETM1
|
[NCBI]
|
2.79002e-05
|
|
|
SACP
|
[NCBI]
|
2.79002e-05
|
|
|
FOXH1
|
[NCBI]
|
2.79002e-05
|
|
|
TGFBI
|
[NCBI]
|
2.77194e-05
|
|
|
GRP
|
[NCBI]
|
2.76681e-05
|
|
|
SST
|
[NCBI]
|
2.74696e-05
|
|
|
PEPD
|
[NCBI]
|
2.74449e-05
|
|
|
asthma, nasal polyps, and aspirin intolerance
|
[NCBI]
|
2.73824e-05
|
|
|
STHAG3
|
[NCBI]
|
2.73824e-05
|
|
|
TD2
|
[NCBI]
|
2.73824e-05
|
|
|
palmoplantar hyperkeratosis with squamous cell carcinoma of skin and sex reversal
|
[NCBI]
|
2.73824e-05
|
|
|
LGMD2J
|
[NCBI]
|
2.73824e-05
|
|
|
LGMD1C
|
[NCBI]
|
2.73824e-05
|
|
|
fragile site 2q11
|
[NCBI]
|
2.73824e-05
|
|
|
frontonasal dysplasia
|
[NCBI]
|
2.73824e-05
|
|
|
EJM1
|
[NCBI]
|
2.73824e-05
|
|
|
short stature, idiopathic, autosomal
|
[NCBI]
|
2.73824e-05
|
|
|
cataract-microcornea syndrome
|
[NCBI]
|
2.73824e-05
|
|
|
DSS
|
[NCBI]
|
2.73824e-05
|
|
|
cardiomyopathy, dilated, with woolly hair and keratoderma
|
[NCBI]
|
2.73824e-05
|
|
|
CCM3
|
[NCBI]
|
2.73824e-05
|
|
|
lujan-fryns syndrome
|
[NCBI]
|
2.73824e-05
|
|
|
STL2
|
[NCBI]
|
2.73824e-05
|
|
|
atrial septal defect with atrioventricular conduction defects
|
[NCBI]
|
2.73824e-05
|
|
|
deafness, congenital, with keratopachydermia and constrictions of fingers and toes
|
[NCBI]
|
2.73824e-05
|
|
|
neuroblastoma
|
[NCBI]
|
2.73513e-05
|
|
|
NAGLU
|
[NCBI]
|
2.72754e-05
|
|
|
TNFRSF11A
|
[NCBI]
|
2.72754e-05
|
|
|
ME2
|
[NCBI]
|
2.72754e-05
|
|
|
PAND1
|
[NCBI]
|
2.72685e-05
|
|
|
glycogen storage disease ii
|
[NCBI]
|
2.72335e-05
|
|
|
GDNF
|
[NCBI]
|
2.71951e-05
|
|
|
GHRH
|
[NCBI]
|
2.7195e-05
|
|
|
MCOPS7
|
[NCBI]
|
2.71404e-05
|
|
|
galactosemia
|
[NCBI]
|
2.71076e-05
|
|
|
BRCA1
|
[NCBI]
|
2.69157e-05
|
|
|
AVSD
|
[NCBI]
|
2.68014e-05
|
|
|
WGN1
|
[NCBI]
|
2.67184e-05
|
|
|
progressive external ophthalmoplegia with mitochondrial dna deletions, autosomal recessive
|
[NCBI]
|
2.67184e-05
|
|
|
HFTC
|
[NCBI]
|
2.67184e-05
|
|
|
tetralogy of fallot
|
[NCBI]
|
2.67184e-05
|
|
|
COFS1
|
[NCBI]
|
2.67184e-05
|
|
|
USH1C
|
[NCBI]
|
2.67184e-05
|
|
|
LGMD1B
|
[NCBI]
|
2.67184e-05
|
|
|
mucolipidosis iiia
|
[NCBI]
|
2.67184e-05
|
|
|
AGS1
|
[NCBI]
|
2.67184e-05
|
|
|
HLA-DRB1
|
[NCBI]
|
2.66487e-05
|
|
|
NKX2E
|
[NCBI]
|
2.66487e-05
|
|
|
SLC3A1
|
[NCBI]
|
2.66487e-05
|
|
|
BMP4
|
[NCBI]
|
2.63628e-05
|
|
|
PSEN1
|
[NCBI]
|
2.62824e-05
|
|
|
sialuria, finnish type
|
[NCBI]
|
2.62161e-05
|
|
|
mannosidosis, alpha b, lysosomal
|
[NCBI]
|
2.62161e-05
|
|
|
thyroid carcinoma, papillary
|
[NCBI]
|
2.62079e-05
|
|
|
PKD2
|
[NCBI]
|
2.60248e-05
|
|
|
JARID2
|
[NCBI]
|
2.58511e-05
|
|
|
PANK2
|
[NCBI]
|
2.58511e-05
|
|
|
SCN9A
|
[NCBI]
|
2.58511e-05
|
|
|
ATP1A2
|
[NCBI]
|
2.58511e-05
|
|
|
SACS
|
[NCBI]
|
2.58365e-05
|
|
|
RPS6KB1
|
[NCBI]
|
2.58365e-05
|
|
|
TOP3A
|
[NCBI]
|
2.58365e-05
|
|
|
DDB2
|
[NCBI]
|
2.58365e-05
|
|
|
PTF1A
|
[NCBI]
|
2.58365e-05
|
|
|
complement component c1r deficiency
|
[NCBI]
|
2.58365e-05
|
|
|
ABCC6
|
[NCBI]
|
2.5795e-05
|
|
|
MYO7A
|
[NCBI]
|
2.5795e-05
|
|
|
PHEX
|
[NCBI]
|
2.5795e-05
|
|
|
PRPH2
|
[NCBI]
|
2.5795e-05
|
|
|
GNAS
|
[NCBI]
|
2.57519e-05
|
|
|
PJS
|
[NCBI]
|
2.56675e-05
|
|
|
SCN1A
|
[NCBI]
|
2.56326e-05
|
|
|
GALC
|
[NCBI]
|
2.56326e-05
|
|
|
CDKN1C
|
[NCBI]
|
2.56326e-05
|
|
|
APOB
|
[NCBI]
|
2.5562e-05
|
|
|
HHT
|
[NCBI]
|
2.55619e-05
|
|
|
GRA
|
[NCBI]
|
2.55619e-05
|
|
|
WFS2
|
[NCBI]
|
2.55006e-05
|
|
|
filaminopathy, autosomal dominant
|
[NCBI]
|
2.55006e-05
|
|
|
eem syndrome
|
[NCBI]
|
2.55006e-05
|
|
|
pallister w syndrome
|
[NCBI]
|
2.55006e-05
|
|
|
aarskog syndrome
|
[NCBI]
|
2.55006e-05
|
|
|
oroacral syndrome, verloes-koulischer type
|
[NCBI]
|
2.55006e-05
|
|
|
telecanthus
|
[NCBI]
|
2.55006e-05
|
|
|
cardiomyopathy, dilated, with quadriceps myopathy
|
[NCBI]
|
2.55006e-05
|
|
|
b-cell immunodeficiency, distal limb anomalies, and urogenital malformations
|
[NCBI]
|
2.55006e-05
|
|
|
VUR2
|
[NCBI]
|
2.55006e-05
|
|
|
abcd syndrome
|
[NCBI]
|
2.55006e-05
|
|
|
radial aplasia, x-linked
|
[NCBI]
|
2.55006e-05
|
|
|
t-cell immunodeficiency, congenital alopecia, and nail dystrophy
|
[NCBI]
|
2.55006e-05
|
|
|
cholesteatoma, congenital
|
[NCBI]
|
2.55006e-05
|
|
|
chondrodysplasia punctata, brachytelephalangic, autosomal
|
[NCBI]
|
2.55006e-05
|
|
|
epiphyseal dysplasia, multiple, with myopia and conductive deafness
|
[NCBI]
|
2.55006e-05
|
|
|
gigantiform cementoma, familial
|
[NCBI]
|
2.55006e-05
|
|
|
ARMD3
|
[NCBI]
|
2.55006e-05
|
|
|
caspase 8 deficiency
|
[NCBI]
|
2.55006e-05
|
|
|
AGS4
|
[NCBI]
|
2.55006e-05
|
|
|
fucosidase regulator
|
[NCBI]
|
2.55006e-05
|
|
|
ectrodactyly and ectodermal dysplasia without cleft lip/palate
|
[NCBI]
|
2.55006e-05
|
|
|
nevus, keratinocytic, nonepidermolytic
|
[NCBI]
|
2.55006e-05
|
|
|
brachymorphism-onychodysplasia-dysphalangism syndrome
|
[NCBI]
|
2.55006e-05
|
|
|
immune deficiency, familial variable
|
[NCBI]
|
2.55006e-05
|
|
|
colchicine resistance
|
[NCBI]
|
2.55006e-05
|
|
|
ivic syndrome
|
[NCBI]
|
2.55006e-05
|
|
|
CMH10
|
[NCBI]
|
2.55006e-05
|
|
|
williams-beuren region duplication syndrome
|
[NCBI]
|
2.55006e-05
|
|
|
SCA16
|
[NCBI]
|
2.55006e-05
|
|
|
MCOPS5
|
[NCBI]
|
2.55006e-05
|
|
|
holzgreve syndrome
|
[NCBI]
|
2.55006e-05
|
|
|
DMAT
|
[NCBI]
|
2.55006e-05
|
|
|
PROA
|
[NCBI]
|
2.55006e-05
|
|
|
hypomyelination and congenital cataract
|
[NCBI]
|
2.55006e-05
|
|
|
mental retardation, x-linked, with brachydactyly and macroglossia
|
[NCBI]
|
2.55006e-05
|
|
|
intrauterine growth retardation with increased mitomycin c sensitivity
|
[NCBI]
|
2.55006e-05
|
|
|
larsen-like syndrome, lethal type
|
[NCBI]
|
2.55006e-05
|
|
|
epidermolysis bullosa simplex with migratory circinate erythema
|
[NCBI]
|
2.55006e-05
|
|
|
PPCD3
|
[NCBI]
|
2.55006e-05
|
|
|
pyridoxamine 5-prime-phosphate oxidase deficiency
|
[NCBI]
|
2.55006e-05
|
|
|
atrial standstill
|
[NCBI]
|
2.55006e-05
|
|
|
metaphyseal dysplasia without hypotrichosis
|
[NCBI]
|
2.55006e-05
|
|
|
BOR2
|
[NCBI]
|
2.55006e-05
|
|
|
STQTL9
|
[NCBI]
|
2.55006e-05
|
|
|
SHEP9
|
[NCBI]
|
2.55006e-05
|
|
|
MCOPCB4
|
[NCBI]
|
2.55006e-05
|
|
|
devriendt syndrome
|
[NCBI]
|
2.55006e-05
|
|
|
SAL-I
|
[NCBI]
|
2.55006e-05
|
|
|
dermal ridges, nelson syndrome
|
[NCBI]
|
2.55006e-05
|
|
|
cerebellotrigeminal dermal dysplasia
|
[NCBI]
|
2.55006e-05
|
|
|
favism, susceptibility to
|
[NCBI]
|
2.55006e-05
|
|
|
corpus callosum, agenesis of, with abnormal genitalia
|
[NCBI]
|
2.55006e-05
|
|
|
rapadilino syndrome
|
[NCBI]
|
2.55006e-05
|
|
|
ear pits, posterior helical
|
[NCBI]
|
2.55006e-05
|
|
|
MRD1
|
[NCBI]
|
2.55006e-05
|
|
|
cataract, nonnuclear polymorphic congenital, autosomal dominant
|
[NCBI]
|
2.55006e-05
|
|
|
bothnia retinal dystrophy
|
[NCBI]
|
2.55006e-05
|
|
|
SHEP4
|
[NCBI]
|
2.55006e-05
|
|
|
factor viii deficiency
|
[NCBI]
|
2.55006e-05
|
|
|
myoclonic epilepsy, progressive
|
[NCBI]
|
2.55006e-05
|
|
|
spondylometaphyseal dysplasia with dentinogenesis imperfecta
|
[NCBI]
|
2.55006e-05
|
|
|
spondyloepimetaphyseal dysplasia, x-linked
|
[NCBI]
|
2.55006e-05
|
|
|
NFRCD
|
[NCBI]
|
2.55006e-05
|
|
|
MCOP3
|
[NCBI]
|
2.55006e-05
|
|
|
osteogenesis imperfecta with opalescent teeth
|
[NCBI]
|
2.55006e-05
|
|
|
epidermolysis bullosa, late-onset localized junctional, with mental retardation
|
[NCBI]
|
2.55006e-05
|
|
|
MCOPS8
|
[NCBI]
|
2.55006e-05
|
|
|
PLGL
|
[NCBI]
|
2.55006e-05
|
|
|
human herpesvirus type 6, integrated
|
[NCBI]
|
2.55006e-05
|
|
|
fibromatosis, gingival, with hypertrichosis
|
[NCBI]
|
2.55006e-05
|
|
|
FIM1
|
[NCBI]
|
2.55006e-05
|
|
|
dystonia, juvenile-onset
|
[NCBI]
|
2.55006e-05
|
|
|
syndactyly, type iv
|
[NCBI]
|
2.55006e-05
|
|
|
sjogren-larsson-like ichthyosis without cns or eye involvement
|
[NCBI]
|
2.55006e-05
|
|
|
body length, mouse, human homolog
|
[NCBI]
|
2.55006e-05
|
|
|
TCC
|
[NCBI]
|
2.55006e-05
|
|
|
deafness, autosomal recessive
|
[NCBI]
|
2.55006e-05
|
|
|
PPCD2
|
[NCBI]
|
2.55006e-05
|
|
|
SCDO3
|
[NCBI]
|
2.55006e-05
|
|
|
c-like syndrome
|
[NCBI]
|
2.55006e-05
|
|
|
lissencephaly type iii and bone dysplasia
|
[NCBI]
|
2.55006e-05
|
|
|
OPTB6
|
[NCBI]
|
2.55006e-05
|
|
|
magnesium, elevated red cell
|
[NCBI]
|
2.55006e-05
|
|
|
HMN7B
|
[NCBI]
|
2.55006e-05
|
|
|
knuckle pads, leukonychia, and sensorineural deafness
|
[NCBI]
|
2.55006e-05
|
|
|
mental and growth retardation with amblyopia
|
[NCBI]
|
2.55006e-05
|
|
|
exostoses, multiple, type i
|
[NCBI]
|
2.51303e-05
|
|
|
GFAP
|
[NCBI]
|
2.51249e-05
|
|
|
GK
|
[NCBI]
|
2.5015e-05
|
|
|
ALDH2
|
[NCBI]
|
2.5015e-05
|
|
|
ADA
|
[NCBI]
|
2.49432e-05
|
|
|
TCOF
|
[NCBI]
|
2.49419e-05
|
|
|
ADH2
|
[NCBI]
|
2.46665e-05
|
|
|
SLC22A5
|
[NCBI]
|
2.46665e-05
|
|
|
GSTM1
|
[NCBI]
|
2.46665e-05
|
|
|
CD4
|
[NCBI]
|
2.46665e-05
|
|
|
ALDH1A1
|
[NCBI]
|
2.46665e-05
|
|
|
AHSG
|
[NCBI]
|
2.46665e-05
|
|
|
FRAP1
|
[NCBI]
|
2.45674e-05
|
|
|
CRX
|
[NCBI]
|
2.45346e-05
|
|
|
KEL
|
[NCBI]
|
2.45346e-05
|
|
|
DLL3
|
[NCBI]
|
2.45346e-05
|
|
|
JMJD6
|
[NCBI]
|
2.45346e-05
|
|
|
FGF8
|
[NCBI]
|
2.4453e-05
|
|
|
RS1
|
[NCBI]
|
2.42628e-05
|
|
|
GCK
|
[NCBI]
|
2.39464e-05
|
|
|
MADD
|
[NCBI]
|
2.38712e-05
|
|
|
ELN
|
[NCBI]
|
2.38101e-05
|
|
|
LMBR1
|
[NCBI]
|
2.38037e-05
|
|
|
MORF4
|
[NCBI]
|
2.38037e-05
|
|
|
EMT
|
[NCBI]
|
2.38037e-05
|
|
|
ELOVL4
|
[NCBI]
|
2.38037e-05
|
|
|
SCN1B
|
[NCBI]
|
2.38037e-05
|
|
|
PEX12
|
[NCBI]
|
2.38037e-05
|
|
|
LEP
|
[NCBI]
|
2.37879e-05
|
|
|
DYT1
|
[NCBI]
|
2.37468e-05
|
|
|
tibial muscular dystrophy, tardive
|
[NCBI]
|
2.36497e-05
|
|
|
leprosy, susceptibility to
|
[NCBI]
|
2.36497e-05
|
|
|
MCPH1
|
[NCBI]
|
2.36497e-05
|
|
|
HPE3
|
[NCBI]
|
2.36497e-05
|
|
|
JH
|
[NCBI]
|
2.36497e-05
|
|
|
LRP1
|
[NCBI]
|
2.36314e-05
|
|
|
ACH
|
[NCBI]
|
2.36212e-05
|
|
|
transcobalamin ii deficiency
|
[NCBI]
|
2.35368e-05
|
|
|
CFB
|
[NCBI]
|
2.34331e-05
|
|
|
GPS
|
[NCBI]
|
2.33498e-05
|
|
|
PTS
|
[NCBI]
|
2.33128e-05
|
|
|
C5
|
[NCBI]
|
2.33128e-05
|
|
|
SGBS1
|
[NCBI]
|
2.32445e-05
|
|
|
periodic fever, familial, autosomal dominant
|
[NCBI]
|
2.32445e-05
|
|
|
HCCS
|
[NCBI]
|
2.29937e-05
|
|
|
PPT2
|
[NCBI]
|
2.29937e-05
|
|
|
SOX18
|
[NCBI]
|
2.29937e-05
|
|
|
TIE1
|
[NCBI]
|
2.29937e-05
|
|
|
MTTY
|
[NCBI]
|
2.29937e-05
|
|
|
RNASEH2A
|
[NCBI]
|
2.29937e-05
|
|
|
MAP3K3
|
[NCBI]
|
2.29937e-05
|
|
|
EFHC1
|
[NCBI]
|
2.29937e-05
|
|
|
ALOXE3
|
[NCBI]
|
2.29937e-05
|
|
|
EIF4EBP1
|
[NCBI]
|
2.29937e-05
|
|
|
SNX3
|
[NCBI]
|
2.29937e-05
|
|
|
CSNK1D
|
[NCBI]
|
2.29937e-05
|
|
|
MAGEL2
|
[NCBI]
|
2.29937e-05
|
|
|
PGL4
|
[NCBI]
|
2.27336e-05
|
|
|
pseudo-von willebrand disease
|
[NCBI]
|
2.27336e-05
|
|
|
ehlers-danlos syndrome, type vii, autosomal recessive
|
[NCBI]
|
2.27336e-05
|
|
|
EPPK
|
[NCBI]
|
2.27336e-05
|
|
|
hyperprolinemia, type i
|
[NCBI]
|
2.27336e-05
|
|
|
HPS2
|
[NCBI]
|
2.27336e-05
|
|
|
de sanctis-cacchione syndrome
|
[NCBI]
|
2.27336e-05
|
|
|
AOI
|
[NCBI]
|
2.27336e-05
|
|
|
kuru, susceptibility to
|
[NCBI]
|
2.27336e-05
|
|
|
IDD
|
[NCBI]
|
2.27336e-05
|
|
|
ACHM3
|
[NCBI]
|
2.27336e-05
|
|
|
hermaphroditism, true
|
[NCBI]
|
2.27336e-05
|
|
|
EBS-MP
|
[NCBI]
|
2.27336e-05
|
|
|
colorectal adenomatous polyposis, autosomal recessive
|
[NCBI]
|
2.27336e-05
|
|
|
AIH2
|
[NCBI]
|
2.27336e-05
|
|
|
MDC1C
|
[NCBI]
|
2.27336e-05
|
|
|
short syndrome
|
[NCBI]
|
2.27336e-05
|
|
|
omphalocele
|
[NCBI]
|
2.27336e-05
|
|
|
PARK4
|
[NCBI]
|
2.27336e-05
|
|
|
wilson disease
|
[NCBI]
|
2.25002e-05
|
|
|
PON1
|
[NCBI]
|
2.22445e-05
|
|
|
FOXL2
|
[NCBI]
|
2.21746e-05
|
|
|
XRCC9
|
[NCBI]
|
2.21746e-05
|
|
|
FRAXE
|
[NCBI]
|
2.21746e-05
|
|
|
PRKCG
|
[NCBI]
|
2.21746e-05
|
|
|
MUTYH
|
[NCBI]
|
2.21746e-05
|
|
|
PER2
|
[NCBI]
|
2.21746e-05
|
|
|
PEPC
|
[NCBI]
|
2.20277e-05
|
|
|
SLC17A5
|
[NCBI]
|
2.20277e-05
|
|
|
SGCG
|
[NCBI]
|
2.20277e-05
|
|
|
PRB1
|
[NCBI]
|
2.20277e-05
|
|
|
PPP2R4
|
[NCBI]
|
2.20277e-05
|
|
|
GSS
|
[NCBI]
|
2.20277e-05
|
|
|
AOS
|
[NCBI]
|
2.19927e-05
|
|
|
HOKPP
|
[NCBI]
|
2.17099e-05
|
|
|
mitochondrial complex iv deficiency
|
[NCBI]
|
2.14749e-05
|
|
|
SPG3A
|
[NCBI]
|
2.14749e-05
|
|
|
complement component 6 deficiency
|
[NCBI]
|
2.1232e-05
|
|
|
ATXN1
|
[NCBI]
|
2.1232e-05
|
|
|
GCDH
|
[NCBI]
|
2.1232e-05
|
|
|
lynch syndrome i
|
[NCBI]
|
2.12198e-05
|
|
|
LCP1
|
[NCBI]
|
2.11109e-05
|
|
|
robinow syndrome, autosomal recessive
|
[NCBI]
|
2.09159e-05
|
|
|
pyruvate carboxylase deficiency
|
[NCBI]
|
2.09159e-05
|
|
|
NBIA1
|
[NCBI]
|
2.09159e-05
|
|
|
severe combined immunodeficiency with sensitivity to ionizing radiation
|
[NCBI]
|
2.09159e-05
|
|
|
PPAC
|
[NCBI]
|
2.09159e-05
|
|
|
IPEX
|
[NCBI]
|
2.09159e-05
|
|
|
GLA
|
[NCBI]
|
2.08694e-05
|
|
|
IHH
|
[NCBI]
|
2.04756e-05
|
|
|
IGF1R
|
[NCBI]
|
2.04661e-05
|
|
|
neuraminidase deficiency with beta-galactosidase deficiency
|
[NCBI]
|
2.04661e-05
|
|
|
ALPL
|
[NCBI]
|
2.04661e-05
|
|
|
ZIC3
|
[NCBI]
|
2.04558e-05
|
|
|
MCM6
|
[NCBI]
|
2.04558e-05
|
|
|
PAX9
|
[NCBI]
|
2.04558e-05
|
|
|
EIF2AK3
|
[NCBI]
|
2.04558e-05
|
|
|
FLCN
|
[NCBI]
|
2.04558e-05
|
|
|
CCND2
|
[NCBI]
|
2.04558e-05
|
|
|
TFAP2B
|
[NCBI]
|
2.04558e-05
|
|
|
SCN8A
|
[NCBI]
|
2.04558e-05
|
|
|
AMBP
|
[NCBI]
|
2.04558e-05
|
|
|
FUT3
|
[NCBI]
|
2.04558e-05
|
|
|
KCNQ4
|
[NCBI]
|
2.04558e-05
|
|
|
MS4A2
|
[NCBI]
|
2.04558e-05
|
|
|
C10ORF2
|
[NCBI]
|
2.04558e-05
|
|
|
VMD
|
[NCBI]
|
2.04357e-05
|
|
|
JPS
|
[NCBI]
|
2.04357e-05
|
|
|
SOX9
|
[NCBI]
|
2.02561e-05
|
|
|
HSPCA
|
[NCBI]
|
2.0114e-05
|
|
|
PEX7
|
[NCBI]
|
2.0114e-05
|
|
|
MAFD2
|
[NCBI]
|
2.01116e-05
|
|
|
PLK1
|
[NCBI]
|
1.98613e-05
|
|
|
immunodeficiency-centromeric instability-facial anomalies syndrome
|
[NCBI]
|
1.98137e-05
|
|
|
KRT5
|
[NCBI]
|
1.97323e-05
|
|
|
MN
|
[NCBI]
|
1.97323e-05
|
|
|
BANF1
|
[NCBI]
|
1.97323e-05
|
|
|
MELAS
|
[NCBI]
|
1.97158e-05
|
|
|
gaucher disease, type iii
|
[NCBI]
|
1.97158e-05
|
|
|
central core disease of muscle
|
[NCBI]
|
1.97158e-05
|
|
|
CPX
|
[NCBI]
|
1.97158e-05
|
|
|
STRC
|
[NCBI]
|
1.96969e-05
|
|
|
ADAM33
|
[NCBI]
|
1.96969e-05
|
|
|
ALG12
|
[NCBI]
|
1.96969e-05
|
|
|
MMP20
|
[NCBI]
|
1.96969e-05
|
|
|
VPS33B
|
[NCBI]
|
1.96969e-05
|
|
|
ZW10
|
[NCBI]
|
1.96969e-05
|
|
|
frank-ter haar syndrome
|
[NCBI]
|
1.96969e-05
|
|
|
EDARADD
|
[NCBI]
|
1.96969e-05
|
|
|
CUL7
|
[NCBI]
|
1.96969e-05
|
|
|
DNAJB1
|
[NCBI]
|
1.96969e-05
|
|
|
RNF128
|
[NCBI]
|
1.96969e-05
|
|
|
IKZF3
|
[NCBI]
|
1.96969e-05
|
|
|
RNF28
|
[NCBI]
|
1.96969e-05
|
|
|
VAX2
|
[NCBI]
|
1.96969e-05
|
|
|
KCNC3
|
[NCBI]
|
1.96969e-05
|
|
|
PEX3
|
[NCBI]
|
1.96969e-05
|
|
|
SH3TC2
|
[NCBI]
|
1.96969e-05
|
|
|
PYCS
|
[NCBI]
|
1.96969e-05
|
|
|
CRKL
|
[NCBI]
|
1.96969e-05
|
|
|
IL6
|
[NCBI]
|
1.96702e-05
|
|
|
KAL1
|
[NCBI]
|
1.96622e-05
|
|
|
FAAH
|
[NCBI]
|
1.96168e-05
|
|
|
MTTM
|
[NCBI]
|
1.95161e-05
|
|
|
SLC9A9
|
[NCBI]
|
1.95161e-05
|
|
|
SLC37A1
|
[NCBI]
|
1.95161e-05
|
|
|
nanos, drosophila, homolog of, 3
|
[NCBI]
|
1.95161e-05
|
|
|
DCTN2
|
[NCBI]
|
1.95161e-05
|
|
|
HSPA14
|
[NCBI]
|
1.95161e-05
|
|
|
hom-tes-103 gene
|
[NCBI]
|
1.95161e-05
|
|
|
GTPBP3
|
[NCBI]
|
1.95161e-05
|
|
|
UTP14A
|
[NCBI]
|
1.95161e-05
|
|
|
DISP2
|
[NCBI]
|
1.95161e-05
|
|
|
lymphocyte cytosol polypeptide, 100-kd
|
[NCBI]
|
1.95161e-05
|
|
|
BLOC1S2
|
[NCBI]
|
1.95161e-05
|
|
|
ESB3
|
[NCBI]
|
1.95161e-05
|
|
|
XGR
|
[NCBI]
|
1.95161e-05
|
|
|
DISP1
|
[NCBI]
|
1.95161e-05
|
|
|
FUZ
|
[NCBI]
|
1.95161e-05
|
|
|
KCNJ15
|
[NCBI]
|
1.95161e-05
|
|
|
NHEDC2
|
[NCBI]
|
1.95161e-05
|
|
|
fras1-related extracellular matrix protein 3
|
[NCBI]
|
1.95161e-05
|
|
|
BCDO2
|
[NCBI]
|
1.95161e-05
|
|
|
ZWILCH
|
[NCBI]
|
1.95161e-05
|
|
|
CCNK
|
[NCBI]
|
1.95161e-05
|
|
|
LYPD1
|
[NCBI]
|
1.95161e-05
|
|
|
utp14, s. cerevisiae, homolog of, b
|
[NCBI]
|
1.95161e-05
|
|
|
nanos, drosophila, homolog of, 2
|
[NCBI]
|
1.95161e-05
|
|
|
ZFP276
|
[NCBI]
|
1.95161e-05
|
|
|
serum protein polymorphism m-158
|
[NCBI]
|
1.95161e-05
|
|
|
lymphocyte cytosol polypeptide, 40-kd
|
[NCBI]
|
1.95161e-05
|
|
|
LUZP4
|
[NCBI]
|
1.95161e-05
|
|
|
COL1AR
|
[NCBI]
|
1.95161e-05
|
|
|
DBR1
|
[NCBI]
|
1.95161e-05
|
|
|
lymphocyte cytosol polypeptide, 49-kd
|
[NCBI]
|
1.95161e-05
|
|
|
MACROD2
|
[NCBI]
|
1.95161e-05
|
|
|
NOTUM
|
[NCBI]
|
1.95161e-05
|
|
|
MPZL3
|
[NCBI]
|
1.95161e-05
|
|
|
SMEK1
|
[NCBI]
|
1.95161e-05
|
|
|
tissue-specific extinguisher 3
|
[NCBI]
|
1.95161e-05
|
|
|
PIGX
|
[NCBI]
|
1.95161e-05
|
|
|
LUZP2
|
[NCBI]
|
1.95161e-05
|
|
|
RBMS2
|
[NCBI]
|
1.95161e-05
|
|
|
g8 protein
|
[NCBI]
|
1.95161e-05
|
|
|
C2ORF34
|
[NCBI]
|
1.95161e-05
|
|
|
phosphatidylinositol 3,4,5-trisphosphate-dependent rac exchanger 1
|
[NCBI]
|
1.95161e-05
|
|
|
SUGT1
|
[NCBI]
|
1.95161e-05
|
|
|
ZNF74
|
[NCBI]
|
1.95161e-05
|
|
|
SCNM1
|
[NCBI]
|
1.95161e-05
|
|
|
ribonuclease 1, serum
|
[NCBI]
|
1.95161e-05
|
|
|
NCAM2
|
[NCBI]
|
1.95161e-05
|
|
|
TSE2
|
[NCBI]
|
1.95161e-05
|
|
|
salivary esterase
|
[NCBI]
|
1.95161e-05
|
|
|
NAT5
|
[NCBI]
|
1.95161e-05
|
|
|
prostate cancer
|
[NCBI]
|
1.92639e-05
|
|
|
GHRHR
|
[NCBI]
|
1.91772e-05
|
|
|
EBP
|
[NCBI]
|
1.91772e-05
|
|
|
MRX1
|
[NCBI]
|
1.91141e-05
|
|
|
RELN
|
[NCBI]
|
1.90867e-05
|
|
|
F13B
|
[NCBI]
|
1.905e-05
|
|
|
NPC2
|
[NCBI]
|
1.905e-05
|
|
|
RMRP
|
[NCBI]
|
1.905e-05
|
|
|
PRKAG2
|
[NCBI]
|
1.905e-05
|
|
|
MEF2C
|
[NCBI]
|
1.905e-05
|
|
|
DYRK1A
|
[NCBI]
|
1.905e-05
|
|
|
fundus albipunctatus
|
[NCBI]
|
1.89286e-05
|
|
|
por deficiency
|
[NCBI]
|
1.89286e-05
|
|
|
gitelman syndrome
|
[NCBI]
|
1.89286e-05
|
|
|
CMT4B2
|
[NCBI]
|
1.89286e-05
|
|
|
hyperlipidemia, combined, 1
|
[NCBI]
|
1.89286e-05
|
|
|
LRS1
|
[NCBI]
|
1.89286e-05
|
|
|
hypoalphalipoproteinemia, primary
|
[NCBI]
|
1.89286e-05
|
|
|
EDM4
|
[NCBI]
|
1.89286e-05
|
|
|
tobacco addiction, susceptibility to
|
[NCBI]
|
1.89286e-05
|
|
|
alpha-methylacetoacetic aciduria
|
[NCBI]
|
1.89286e-05
|
|
|
carnitine palmitoyltransferase ii deficiency, lethal neonatal
|
[NCBI]
|
1.89286e-05
|
|
|
ACG2
|
[NCBI]
|
1.89286e-05
|
|
|
3-@methylglutaconic aciduria, type i
|
[NCBI]
|
1.89286e-05
|
|
|
APRT
|
[NCBI]
|
1.89033e-05
|
|
|
ND
|
[NCBI]
|
1.88596e-05
|
|
|
thrombasthenia of glanzmann and naegeli
|
[NCBI]
|
1.87131e-05
|
|
|
APS2
|
[NCBI]
|
1.86763e-05
|
|
|
diarrhea 2, with microvillous atrophy
|
[NCBI]
|
1.86763e-05
|
|
|
schistosoma mansoni infection, susceptibility/resistance to
|
[NCBI]
|
1.86763e-05
|
|
|
spiegler-brooke syndrome
|
[NCBI]
|
1.86763e-05
|
|
|
MEAX
|
[NCBI]
|
1.86763e-05
|
|
|
HMN1
|
[NCBI]
|
1.86763e-05
|
|
|
thyroid carcinoma, nonmedullary, with or without cell oxyphilia
|
[NCBI]
|
1.86763e-05
|
|
|
MNG1
|
[NCBI]
|
1.86763e-05
|
|
|
ECA1
|
[NCBI]
|
1.86763e-05
|
|
|
progeroid syndrome, neonatal
|
[NCBI]
|
1.86763e-05
|
|
|
AUTS4
|
[NCBI]
|
1.86763e-05
|
|
|
acrodysostosis
|
[NCBI]
|
1.86763e-05
|
|
|
PHP
|
[NCBI]
|
1.86763e-05
|
|
|
neuropathy, hereditary motor and sensory, russe type
|
[NCBI]
|
1.86763e-05
|
|
|
mental health wellness 1
|
[NCBI]
|
1.86763e-05
|
|
|
PSORS4
|
[NCBI]
|
1.86763e-05
|
|
|
gonadal dysgenesis, xx type, with deafness
|
[NCBI]
|
1.86763e-05
|
|
|
MTND4
|
[NCBI]
|
1.86456e-05
|
|
|
MKKS
|
[NCBI]
|
1.84717e-05
|
|
|
SPCH1
|
[NCBI]
|
1.84717e-05
|
|
|
RSMD1
|
[NCBI]
|
1.84717e-05
|
|
|
PHA
|
[NCBI]
|
1.84717e-05
|
|
|
periodontitis, aggressive, 1
|
[NCBI]
|
1.84717e-05
|
|
|
CORD2
|
[NCBI]
|
1.84717e-05
|
|
|
GLB1
|
[NCBI]
|
1.83536e-05
|
|
|
FMO3
|
[NCBI]
|
1.83536e-05
|
|
|
CBD
|
[NCBI]
|
1.83536e-05
|
|
|
GATA3
|
[NCBI]
|
1.8295e-05
|
|
|
CYP1B1
|
[NCBI]
|
1.8295e-05
|
|
|
WFS1
|
[NCBI]
|
1.8295e-05
|
|
|
RPE65
|
[NCBI]
|
1.8295e-05
|
|
|
LAMB3
|
[NCBI]
|
1.8295e-05
|
|
|
DLD
|
[NCBI]
|
1.8295e-05
|
|
|
GJB3
|
[NCBI]
|
1.8295e-05
|
|
|
PCTT
|
[NCBI]
|
1.82541e-05
|
|
|
SJS1
|
[NCBI]
|
1.82541e-05
|
|
|
CADASIL
|
[NCBI]
|
1.82541e-05
|
|
|
cortisol 11-beta-ketoreductase deficiency
|
[NCBI]
|
1.81787e-05
|
|
|
PTHLH
|
[NCBI]
|
1.80071e-05
|
|
|
dyschromatosis symmetrica hereditaria 1
|
[NCBI]
|
1.78745e-05
|
|
|
TRAPPC2
|
[NCBI]
|
1.7782e-05
|
|
|
EIF2B5
|
[NCBI]
|
1.7782e-05
|
|
|
EN2
|
[NCBI]
|
1.7782e-05
|
|
|
FANCD2
|
[NCBI]
|
1.7782e-05
|
|
|
PXMP3
|
[NCBI]
|
1.7782e-05
|
|
|
MSX2
|
[NCBI]
|
1.7782e-05
|
|
|
alsin
|
[NCBI]
|
1.7782e-05
|
|
|
HLCS
|
[NCBI]
|
1.7782e-05
|
|
|
CYP3A5
|
[NCBI]
|
1.7782e-05
|
|
|
STAT1
|
[NCBI]
|
1.7773e-05
|
|
|
SDC2
|
[NCBI]
|
1.7758e-05
|
|
|
aortic valve disease
|
[NCBI]
|
1.77152e-05
|
|
|
DYT1
|
[NCBI]
|
1.77152e-05
|
|
|
OA1
|
[NCBI]
|
1.77051e-05
|
|
|
CYP2A6
|
[NCBI]
|
1.77051e-05
|
|
|
SOD1
|
[NCBI]
|
1.7519e-05
|
|
|
EMD
|
[NCBI]
|
1.74624e-05
|
|
|
EDA
|
[NCBI]
|
1.74624e-05
|
|
|
UROS
|
[NCBI]
|
1.74624e-05
|
|
|
PMM2
|
[NCBI]
|
1.74624e-05
|
|
|
LDHA
|
[NCBI]
|
1.74624e-05
|
|
|
MAP2
|
[NCBI]
|
1.74587e-05
|
|
|
PEDF
|
[NCBI]
|
1.7406e-05
|
|
|
HSN2
|
[NCBI]
|
1.72238e-05
|
|
|
DHCR24
|
[NCBI]
|
1.72238e-05
|
|
|
STK3
|
[NCBI]
|
1.72238e-05
|
|
|
DIA3
|
[NCBI]
|
1.72238e-05
|
|
|
NPHP3
|
[NCBI]
|
1.72238e-05
|
|
|
IGHA2
|
[NCBI]
|
1.72238e-05
|
|
|
COH1
|
[NCBI]
|
1.72238e-05
|
|
|
NLGN4
|
[NCBI]
|
1.72238e-05
|
|
|
SLC35C1
|
[NCBI]
|
1.72238e-05
|
|
|
ALOX12B
|
[NCBI]
|
1.72238e-05
|
|
|
BLOC1S1
|
[NCBI]
|
1.72238e-05
|
|
|
PRB3
|
[NCBI]
|
1.72238e-05
|
|
|
DEAF1
|
[NCBI]
|
1.72238e-05
|
|
|
MTTN
|
[NCBI]
|
1.72238e-05
|
|
|
ENO3
|
[NCBI]
|
1.72238e-05
|
|
|
STAT3
|
[NCBI]
|
1.70923e-05
|
|
|
IGAD1
|
[NCBI]
|
1.69979e-05
|
|
|
TBG
|
[NCBI]
|
1.69548e-05
|
|
|
HBA2
|
[NCBI]
|
1.6742e-05
|
|
|
RPS19
|
[NCBI]
|
1.66751e-05
|
|
|
EGR2
|
[NCBI]
|
1.66751e-05
|
|
|
LRP5
|
[NCBI]
|
1.66751e-05
|
|
|
SRD5A2
|
[NCBI]
|
1.66751e-05
|
|
|
PRX
|
[NCBI]
|
1.66303e-05
|
|
|
ARMD1
|
[NCBI]
|
1.66182e-05
|
|
|
ALPS2A
|
[NCBI]
|
1.65955e-05
|
|
|
steatocystoma multiplex
|
[NCBI]
|
1.65955e-05
|
|
|
CIDX
|
[NCBI]
|
1.65955e-05
|
|
|
SCA11
|
[NCBI]
|
1.65955e-05
|
|
|
pulmonary hypertension, familial persistent, of the newborn
|
[NCBI]
|
1.65955e-05
|
|
|
epilepsy, nocturnal frontal lobe, type 3
|
[NCBI]
|
1.65955e-05
|
|
|
slowed nerve conduction velocity, autosomal dominant
|
[NCBI]
|
1.65955e-05
|
|
|
progeroid short stature with pigmented nevi
|
[NCBI]
|
1.65955e-05
|
|
|
aglossia-adactylia
|
[NCBI]
|
1.65955e-05
|
|
|
DFNB31
|
[NCBI]
|
1.65955e-05
|
|
|
fetal akinesia syndrome, x-linked
|
[NCBI]
|
1.65955e-05
|
|
|
NSIAD
|
[NCBI]
|
1.65955e-05
|
|
|
CLN10
|
[NCBI]
|
1.65955e-05
|
|
|
PEOA4
|
[NCBI]
|
1.65955e-05
|
|
|
chromosome xp11.3 deletion syndrome
|
[NCBI]
|
1.65955e-05
|
|
|
dystonia, familial, with visual failure and striatal lucencies
|
[NCBI]
|
1.65955e-05
|
|
|
craniofacial dysostosis with diaphyseal hyperplasia
|
[NCBI]
|
1.65955e-05
|
|
|
retinohepatoendocrinologic syndrome
|
[NCBI]
|
1.65955e-05
|
|
|
glycogen storage disease 0, liver
|
[NCBI]
|
1.65955e-05
|
|
|
blood group--froese
|
[NCBI]
|
1.65955e-05
|
|
|
satoyoshi syndrome
|
[NCBI]
|
1.65955e-05
|
|
|
OODD
|
[NCBI]
|
1.65955e-05
|
|
|
CMD1J
|
[NCBI]
|
1.65955e-05
|
|
|
carcinoid tumors, intestinal
|
[NCBI]
|
1.65955e-05
|
|
|
CMD1L
|
[NCBI]
|
1.65955e-05
|
|
|
MRX46
|
[NCBI]
|
1.65955e-05
|
|
|
DFNA15
|
[NCBI]
|
1.65955e-05
|
|
|
abdominal body fat distribution
|
[NCBI]
|
1.65955e-05
|
|
|
microduplication 22q11.2
|
[NCBI]
|
1.65955e-05
|
|
|
isovaleric acid, inability to smell
|
[NCBI]
|
1.65955e-05
|
|
|
lathosterolosis
|
[NCBI]
|
1.65955e-05
|
|
|
methylmalonic aciduria, cblb type
|
[NCBI]
|
1.65955e-05
|
|
|
otofaciocervical syndrome
|
[NCBI]
|
1.65955e-05
|
|
|
charcot-marie-tooth disease, axonal, type 2f
|
[NCBI]
|
1.65955e-05
|
|
|
OGD
|
[NCBI]
|
1.65955e-05
|
|
|
YT
|
[NCBI]
|
1.65955e-05
|
|
|
thyroid hormonogenesis, genetic defect in, 6
|
[NCBI]
|
1.65955e-05
|
|
|
siderius x-linked mental retardation syndrome
|
[NCBI]
|
1.65955e-05
|
|
|
HMERF
|
[NCBI]
|
1.65955e-05
|
|
|
amelogenesis imperfecta, hypoplastic, and openbite malocclusion, autosomal recessive
|
[NCBI]
|
1.65955e-05
|
|
|
SMC
|
[NCBI]
|
1.65955e-05
|
|
|
HHS
|
[NCBI]
|
1.65955e-05
|
|
|
agonadism with multiple internal malformations
|
[NCBI]
|
1.65955e-05
|
|
|
parotid proline-rich salivary protein pc
|
[NCBI]
|
1.65955e-05
|
|
|
DDU
|
[NCBI]
|
1.65955e-05
|
|
|
crisponi syndrome
|
[NCBI]
|
1.65955e-05
|
|
|
TYRL
|
[NCBI]
|
1.65955e-05
|
|
|
ATMDS
|
[NCBI]
|
1.65955e-05
|
|
|
encephalopathy, ethylmalonic
|
[NCBI]
|
1.65955e-05
|
|
|
dyskeratosis congenita, autosomal recessive
|
[NCBI]
|
1.65955e-05
|
|
|
mixed lymphocyte culture locus ii
|
[NCBI]
|
1.65955e-05
|
|
|
charcot-marie-tooth disease, axonal, type 2i
|
[NCBI]
|
1.65955e-05
|
|
|
spondyloepiphyseal dysplasia, kimberley type
|
[NCBI]
|
1.65955e-05
|
|
|
steatocystoma multiplex with natal teeth
|
[NCBI]
|
1.65955e-05
|
|
|
glomerulocystic kidney disease with hyperuricemia and isosthenuria
|
[NCBI]
|
1.65955e-05
|
|
|
genitopalatocardiac syndrome
|
[NCBI]
|
1.65955e-05
|
|
|
ARMD10
|
[NCBI]
|
1.65955e-05
|
|
|
epidermolysis bullosa, pretibial
|
[NCBI]
|
1.65955e-05
|
|
|
keloids
|
[NCBI]
|
1.65955e-05
|
|
|
split-foot deformity with mandibulofacial dysostosis
|
[NCBI]
|
1.65955e-05
|
|
|
JPHT
|
[NCBI]
|
1.65955e-05
|
|
|
polydactyly
|
[NCBI]
|
1.65955e-05
|
|
|
ABSD
|
[NCBI]
|
1.65955e-05
|
|
|
FECD1
|
[NCBI]
|
1.65955e-05
|
|
|
moved to 310600
|
[NCBI]
|
1.65955e-05
|
|
|
fibular hypoplasia and complex brachydactyly
|
[NCBI]
|
1.65955e-05
|
|
|
DDSH
|
[NCBI]
|
1.65955e-05
|
|
|
macular dystrophy, concentric annular
|
[NCBI]
|
1.65955e-05
|
|
|
catel-manzke syndrome
|
[NCBI]
|
1.65955e-05
|
|
|
tuberous sclerosis 4
|
[NCBI]
|
1.65955e-05
|
|
|
SPS
|
[NCBI]
|
1.65955e-05
|
|
|
myocardial infarction, susceptibility to, 2
|
[NCBI]
|
1.65955e-05
|
|
|
coloboma of optic nerve
|
[NCBI]
|
1.65955e-05
|
|
|
micromelic bone dysplasia with cloverleaf skull
|
[NCBI]
|
1.65955e-05
|
|
|
CMTX5
|
[NCBI]
|
1.65955e-05
|
|
|
HANAC
|
[NCBI]
|
1.65955e-05
|
|
|
LORD
|
[NCBI]
|
1.65955e-05
|
|
|
roifman syndrome
|
[NCBI]
|
1.65955e-05
|
|
|
majeed syndrome
|
[NCBI]
|
1.65955e-05
|
|
|
pterygia, mental retardation, and distinctive craniofacial features
|
[NCBI]
|
1.65955e-05
|
|
|
CMD3A
|
[NCBI]
|
1.65955e-05
|
|
|
hypotonia-cystinuria syndrome
|
[NCBI]
|
1.65955e-05
|
|
|
SHEP5
|
[NCBI]
|
1.65955e-05
|
|
|
advanced sleep-phase syndrome, familial
|
[NCBI]
|
1.65955e-05
|
|
|
autism, x-linked, susceptibility to, 1
|
[NCBI]
|
1.65955e-05
|
|
|
zunich neuroectodermal syndrome
|
[NCBI]
|
1.65955e-05
|
|
|
TPO
|
[NCBI]
|
1.65745e-05
|
|
|
OXT
|
[NCBI]
|
1.65691e-05
|
|
|
BPES
|
[NCBI]
|
1.65e-05
|
|
|
ASPA
|
[NCBI]
|
1.6482e-05
|
|
|
DSG3
|
[NCBI]
|
1.64608e-05
|
|
|
myeloproliferative syndrome, transient
|
[NCBI]
|
1.63276e-05
|
|
|
restless legs syndrome, susceptibility to, 1
|
[NCBI]
|
1.63276e-05
|
|
|
leopard syndrome 1
|
[NCBI]
|
1.62807e-05
|
|
|
ABS
|
[NCBI]
|
1.62807e-05
|
|
|
SHEP2
|
[NCBI]
|
1.62807e-05
|
|
|
EAOH
|
[NCBI]
|
1.62807e-05
|
|
|
OFC1
|
[NCBI]
|
1.61648e-05
|
|
|
KDR
|
[NCBI]
|
1.60883e-05
|
|
|
F13A1
|
[NCBI]
|
1.59811e-05
|
|
|
GLO1
|
[NCBI]
|
1.59295e-05
|
|
|
PMS2
|
[NCBI]
|
1.59295e-05
|
|
|
SHOX
|
[NCBI]
|
1.59048e-05
|
|
|
PTPRC
|
[NCBI]
|
1.59048e-05
|
|
|
hematopoietic stem cell kinetics, control of
|
[NCBI]
|
1.57649e-05
|
|
|
CDB1
|
[NCBI]
|
1.57649e-05
|
|
|
lymphedema, hereditary, i
|
[NCBI]
|
1.57649e-05
|
|
|
alport syndrome, autosomal recessive
|
[NCBI]
|
1.57649e-05
|
|
|
ankyloblepharon-ectodermal defects-cleft lip/palate
|
[NCBI]
|
1.57649e-05
|
|
|
SMMCI
|
[NCBI]
|
1.57649e-05
|
|
|
DFNA2
|
[NCBI]
|
1.57649e-05
|
|
|
keratitis-ichthyosis-deafness syndrome, autosomal dominant
|
[NCBI]
|
1.57649e-05
|
|
|
GBD1
|
[NCBI]
|
1.57649e-05
|
|
|
17-@beta hydroxysteroid dehydrogenase iii deficiency
|
[NCBI]
|
1.57649e-05
|
|
|
HFE4
|
[NCBI]
|
1.57649e-05
|
|
|
CLN8
|
[NCBI]
|
1.57649e-05
|
|
|
aryl hydrocarbon hydroxylase inducibility
|
[NCBI]
|
1.57649e-05
|
|
|
PKD3
|
[NCBI]
|
1.57649e-05
|
|
|
stuve-wiedemann syndrome
|
[NCBI]
|
1.57649e-05
|
|
|
VDR
|
[NCBI]
|
1.57276e-05
|
|
|
LIG4
|
[NCBI]
|
1.5578e-05
|
|
|
KCNQ2
|
[NCBI]
|
1.5578e-05
|
|
|
OTOF
|
[NCBI]
|
1.5578e-05
|
|
|
LOR
|
[NCBI]
|
1.5578e-05
|
|
|
behcet syndrome
|
[NCBI]
|
1.55205e-05
|
|
|
FXN
|
[NCBI]
|
1.55152e-05
|
|
|
INSR
|
[NCBI]
|
1.5363e-05
|
|
|
NR0B1
|
[NCBI]
|
1.53488e-05
|
|
|
FBXW4
|
[NCBI]
|
1.52577e-05
|
|
|
TUBA1A
|
[NCBI]
|
1.52577e-05
|
|
|
NFIA
|
[NCBI]
|
1.52577e-05
|
|
|
LHX1
|
[NCBI]
|
1.52577e-05
|
|
|
SLC6A9
|
[NCBI]
|
1.52577e-05
|
|
|
RNF2
|
[NCBI]
|
1.52577e-05
|
|
|
CDKN2C
|
[NCBI]
|
1.52577e-05
|
|
|
SIL
|
[NCBI]
|
1.52577e-05
|
|
|
KRT6A
|
[NCBI]
|
1.52577e-05
|
|
|
NHLRC1
|
[NCBI]
|
1.52577e-05
|
|
|
SOX6
|
[NCBI]
|
1.52577e-05
|
|
|
ATP2C1
|
[NCBI]
|
1.52577e-05
|
|
|
NFKB2
|
[NCBI]
|
1.52577e-05
|
|
|
SLURP1
|
[NCBI]
|
1.52577e-05
|
|
|
ALDH5A1
|
[NCBI]
|
1.52577e-05
|
|
|
FANCB
|
[NCBI]
|
1.52577e-05
|
|
|
ASS
|
[NCBI]
|
1.5234e-05
|
|
|
EYA1
|
[NCBI]
|
1.52223e-05
|
|
|
MVK
|
[NCBI]
|
1.52223e-05
|
|
|
LRP8
|
[NCBI]
|
1.52223e-05
|
|
|
COL4A3
|
[NCBI]
|
1.52223e-05
|
|
|
COMP
|
[NCBI]
|
1.51201e-05
|
|
|
SLS
|
[NCBI]
|
1.49177e-05
|
|
|
bare lymphocyte syndrome, type ii
|
[NCBI]
|
1.49177e-05
|
|
|
SMN2
|
[NCBI]
|
1.4813e-05
|
|
|
UMOD
|
[NCBI]
|
1.4813e-05
|
|
|
DES
|
[NCBI]
|
1.4813e-05
|
|
|
hypertension, essential
|
[NCBI]
|
1.48105e-05
|
|
|
CFH
|
[NCBI]
|
1.46314e-05
|
|
|
MYH7
|
[NCBI]
|
1.46226e-05
|
|
|
LHX3
|
[NCBI]
|
1.46117e-05
|
|
|
LAMA2
|
[NCBI]
|
1.46117e-05
|
|
|
PLA2G2A
|
[NCBI]
|
1.46117e-05
|
|
|
usher syndrome, type i
|
[NCBI]
|
1.46015e-05
|
|
|
PPSH
|
[NCBI]
|
1.46015e-05
|
|
|
musical perfect pitch
|
[NCBI]
|
1.46015e-05
|
|
|
myoclonic epilepsy of lafora
|
[NCBI]
|
1.46015e-05
|
|
|
CHRNE
|
[NCBI]
|
1.45505e-05
|
|
|
HIGM1
|
[NCBI]
|
1.43852e-05
|
|
|
CLL
|
[NCBI]
|
1.43852e-05
|
|
|
acyl-coa dehydrogenase, very long-chain, deficiency of
|
[NCBI]
|
1.43127e-05
|
|
|
BFLS
|
[NCBI]
|
1.43127e-05
|
|
|
brugada syndrome 1
|
[NCBI]
|
1.43127e-05
|
|
|
IGFALS
|
[NCBI]
|
1.42453e-05
|
|
|
CDK5
|
[NCBI]
|
1.42034e-05
|
|
|
BCNS
|
[NCBI]
|
1.42004e-05
|
|
|
H6PD
|
[NCBI]
|
1.40821e-05
|
|
|
CYP1A1
|
[NCBI]
|
1.39218e-05
|
|
|
PITX2
|
[NCBI]
|
1.39116e-05
|
|
|
ARX
|
[NCBI]
|
1.39116e-05
|
|
|
NOG
|
[NCBI]
|
1.39116e-05
|
|
|
CAST
|
[NCBI]
|
1.37206e-05
|
|
|
SOX2
|
[NCBI]
|
1.37206e-05
|
|
|
DLL1
|
[NCBI]
|
1.37206e-05
|
|
|
SLC16A2
|
[NCBI]
|
1.37206e-05
|
|
|
BTRC
|
[NCBI]
|
1.37206e-05
|
|
|
NSD1
|
[NCBI]
|
1.37206e-05
|
|
|
PMCH
|
[NCBI]
|
1.36871e-05
|
|
|
GAL
|
[NCBI]
|
1.36865e-05
|
|
|
dystrophia myotonica 1
|
[NCBI]
|
1.368e-05
|
|
|
DMRT1
|
[NCBI]
|
1.36367e-05
|
|
|
RBX1
|
[NCBI]
|
1.36367e-05
|
|
|
ALX4
|
[NCBI]
|
1.36367e-05
|
|
|
SPRY1
|
[NCBI]
|
1.36367e-05
|
|
|
ME1
|
[NCBI]
|
1.36367e-05
|
|
|
FANCE
|
[NCBI]
|
1.36367e-05
|
|
|
CNGA3
|
[NCBI]
|
1.36367e-05
|
|
|
GNAT2
|
[NCBI]
|
1.36367e-05
|
|
|
TRIM32
|
[NCBI]
|
1.36367e-05
|
|
|
LPIN2
|
[NCBI]
|
1.36367e-05
|
|
|
PEX6
|
[NCBI]
|
1.36367e-05
|
|
|
USH3A
|
[NCBI]
|
1.36367e-05
|
|
|
SAT1
|
[NCBI]
|
1.36367e-05
|
|
|
COLQ
|
[NCBI]
|
1.36367e-05
|
|
|
TARDBP
|
[NCBI]
|
1.36367e-05
|
|
|
PRPF31
|
[NCBI]
|
1.36367e-05
|
|
|
TCF21
|
[NCBI]
|
1.36367e-05
|
|
|
HLA-A
|
[NCBI]
|
1.35879e-05
|
|
|
SPINK1
|
[NCBI]
|
1.35177e-05
|
|
|
CML
|
[NCBI]
|
1.33957e-05
|
|
|
GP1BA
|
[NCBI]
|
1.33031e-05
|
|
|
TP73L
|
[NCBI]
|
1.33031e-05
|
|
|
RCC1
|
[NCBI]
|
1.32724e-05
|
|
|
ACPP
|
[NCBI]
|
1.32475e-05
|
|
|
apert syndrome
|
[NCBI]
|
1.3149e-05
|
|
|
IRID1
|
[NCBI]
|
1.31054e-05
|
|
|
BDA1
|
[NCBI]
|
1.31054e-05
|
|
|
BOS1
|
[NCBI]
|
1.31054e-05
|
|
|
MODY3
|
[NCBI]
|
1.31054e-05
|
|
|
HSS
|
[NCBI]
|
1.31054e-05
|
|
|
SCAR1
|
[NCBI]
|
1.31054e-05
|
|
|
GINGF
|
[NCBI]
|
1.31054e-05
|
|
|
coloboma, ocular
|
[NCBI]
|
1.31054e-05
|
|
|
ichthyosis vulgaris
|
[NCBI]
|
1.31054e-05
|
|
|
obesity
|
[NCBI]
|
1.30727e-05
|
|
|
PTK2
|
[NCBI]
|
1.30086e-05
|
|
|
BTHS
|
[NCBI]
|
1.29166e-05
|
|
|
CBP
|
[NCBI]
|
1.28957e-05
|
|
|
JK
|
[NCBI]
|
1.28957e-05
|
|
|
GJA3
|
[NCBI]
|
1.28957e-05
|
|
|
NPM1
|
[NCBI]
|
1.2796e-05
|
|
|
LPO
|
[NCBI]
|
1.2796e-05
|
|
|
CYP11B2
|
[NCBI]
|
1.27232e-05
|
|
|
COL4A5
|
[NCBI]
|
1.27232e-05
|
|
|
KCNJ11
|
[NCBI]
|
1.27232e-05
|
|
|
CTGF
|
[NCBI]
|
1.27203e-05
|
|
|
ACE
|
[NCBI]
|
1.27003e-05
|
|
|
MLH1
|
[NCBI]
|
1.26941e-05
|
|
|
UCN
|
[NCBI]
|
1.26165e-05
|
|
|
AAA
|
[NCBI]
|
1.25427e-05
|
|
|
masa syndrome
|
[NCBI]
|
1.25427e-05
|
|
|
SRS
|
[NCBI]
|
1.24915e-05
|
|
|
glycogen storage disease vii
|
[NCBI]
|
1.24242e-05
|
|
|
IL2RA
|
[NCBI]
|
1.24035e-05
|
|
|
PEPB
|
[NCBI]
|
1.22664e-05
|
|
|
POR
|
[NCBI]
|
1.22664e-05
|
|
|
CHRND
|
[NCBI]
|
1.22664e-05
|
|
|
PRH2
|
[NCBI]
|
1.22664e-05
|
|
|
hemojuvelin
|
[NCBI]
|
1.22664e-05
|
|
|
F2RL3
|
[NCBI]
|
1.22664e-05
|
|
|
BCAT1
|
[NCBI]
|
1.22664e-05
|
|
|
DNASE1
|
[NCBI]
|
1.22664e-05
|
|
|
FGF14
|
[NCBI]
|
1.22664e-05
|
|
|
RBL1
|
[NCBI]
|
1.22664e-05
|
|
|
DYNC1H1
|
[NCBI]
|
1.22664e-05
|
|
|
SIP1
|
[NCBI]
|
1.22664e-05
|
|
|
ARSE
|
[NCBI]
|
1.22664e-05
|
|
|
POU2AF1
|
[NCBI]
|
1.22664e-05
|
|
|
RFNG
|
[NCBI]
|
1.22664e-05
|
|
|
IRF2
|
[NCBI]
|
1.22664e-05
|
|
|
TXK
|
[NCBI]
|
1.22664e-05
|
|
|
MAF
|
[NCBI]
|
1.22664e-05
|
|
|
HEY2
|
[NCBI]
|
1.22664e-05
|
|
|
NFE2L2
|
[NCBI]
|
1.22664e-05
|
|
|
CCL3L1
|
[NCBI]
|
1.22664e-05
|
|
|
ERCC2
|
[NCBI]
|
1.21698e-05
|
|
|
CAPN3
|
[NCBI]
|
1.21698e-05
|
|
|
CDKN1B
|
[NCBI]
|
1.21698e-05
|
|
|
SLC40A1
|
[NCBI]
|
1.21698e-05
|
|
|
DCN
|
[NCBI]
|
1.21698e-05
|
|
|
ACTC1
|
[NCBI]
|
1.21297e-05
|
|
|
COL11A2
|
[NCBI]
|
1.21297e-05
|
|
|
PQBP1
|
[NCBI]
|
1.21297e-05
|
|
|
MTATP6
|
[NCBI]
|
1.19698e-05
|
|
|
POMC
|
[NCBI]
|
1.18956e-05
|
|
|
hypophosphatasia, infantile
|
[NCBI]
|
1.18071e-05
|
|
|
RP3
|
[NCBI]
|
1.18071e-05
|
|
|
ENPP1
|
[NCBI]
|
1.16413e-05
|
|
|
NIDDM
|
[NCBI]
|
1.1612e-05
|
|
|
DMPK
|
[NCBI]
|
1.15505e-05
|
|
|
ww domain-containing protein, 45-kd
|
[NCBI]
|
1.14965e-05
|
|
|
ENTPD2
|
[NCBI]
|
1.14965e-05
|
|
|
IQWD1
|
[NCBI]
|
1.14965e-05
|
|
|
ZIC4
|
[NCBI]
|
1.14965e-05
|
|
|
NCAPH2
|
[NCBI]
|
1.14965e-05
|
|
|
KRTHA7
|
[NCBI]
|
1.14965e-05
|
|
|
CKLFSF4
|
[NCBI]
|
1.14965e-05
|
|
|
CHMP5
|
[NCBI]
|
1.14965e-05
|
|
|
MIS12
|
[NCBI]
|
1.14965e-05
|
|
|
flavoprotein oxidoreductase mical2
|
[NCBI]
|
1.14965e-05
|
|
|
CCPG1
|
[NCBI]
|
1.14965e-05
|
|
|
GAB3
|
[NCBI]
|
1.14965e-05
|
|
|
PDCL3
|
[NCBI]
|
1.14965e-05
|
|
|
u5 snrnp-specific protein, 116-kd
|
[NCBI]
|
1.14965e-05
|
|
|
TELO2
|
[NCBI]
|
1.14965e-05
|
|
|
C5ORF13
|
[NCBI]
|
1.14965e-05
|
|
|
KIF21A
|
[NCBI]
|
1.14965e-05
|
|
|
PEX11G
|
[NCBI]
|
1.14965e-05
|
|
|
mesoderm posterior 1
|
[NCBI]
|
1.14965e-05
|
|
|
ATP6V1D
|
[NCBI]
|
1.14965e-05
|
|
|
MASTL
|
[NCBI]
|
1.14965e-05
|
|
|
TMEM142C
|
[NCBI]
|
1.14965e-05
|
|
|
ARVCF
|
[NCBI]
|
1.14965e-05
|
|
|
ABCB8
|
[NCBI]
|
1.14965e-05
|
|
|
KRTHA8
|
[NCBI]
|
1.14965e-05
|
|
|
CENTA2
|
[NCBI]
|
1.14965e-05
|
|
|
MEPE
|
[NCBI]
|
1.14965e-05
|
|
|
PRKAG3
|
[NCBI]
|
1.14965e-05
|
|
|
small membrane protein 1
|
[NCBI]
|
1.14965e-05
|
|
|
GABRG1
|
[NCBI]
|
1.14965e-05
|
|
|
TMEM142B
|
[NCBI]
|
1.14965e-05
|
|
|
NICAL
|
[NCBI]
|
1.14965e-05
|
|
|
MTTP
|
[NCBI]
|
1.14965e-05
|
|
|
UBIAD1
|
[NCBI]
|
1.14965e-05
|
|
|
ORAOV1
|
[NCBI]
|
1.14965e-05
|
|
|
KDELR2
|
[NCBI]
|
1.14965e-05
|
|
|
RASAL1
|
[NCBI]
|
1.14965e-05
|
|
|
RBKS
|
[NCBI]
|
1.14965e-05
|
|
|
KCNG2
|
[NCBI]
|
1.14965e-05
|
|
|
MORF4L1
|
[NCBI]
|
1.14965e-05
|
|
|
HLA-DMB
|
[NCBI]
|
1.14965e-05
|
|
|
DDX8
|
[NCBI]
|
1.14965e-05
|
|
|
ataxin 2-binding protein 1
|
[NCBI]
|
1.14965e-05
|
|
|
FGF11
|
[NCBI]
|
1.14965e-05
|
|
|
FBXL16
|
[NCBI]
|
1.14965e-05
|
|
|
SOLH
|
[NCBI]
|
1.14965e-05
|
|
|
USP29
|
[NCBI]
|
1.14965e-05
|
|
|
TBRG4
|
[NCBI]
|
1.14965e-05
|
|
|
HOXC13
|
[NCBI]
|
1.14965e-05
|
|
|
TRIP13
|
[NCBI]
|
1.14965e-05
|
|
|
NANOS1
|
[NCBI]
|
1.14965e-05
|
|
|
FREM1
|
[NCBI]
|
1.14965e-05
|
|
|
RALA
|
[NCBI]
|
1.14965e-05
|
|
|
RRM2
|
[NCBI]
|
1.14965e-05
|
|
|
KCNS2
|
[NCBI]
|
1.14965e-05
|
|
|
XYLT2
|
[NCBI]
|
1.14965e-05
|
|
|
SF3A3
|
[NCBI]
|
1.14965e-05
|
|
|
SPBC24
|
[NCBI]
|
1.14965e-05
|
|
|
DISC2
|
[NCBI]
|
1.14965e-05
|
|
|
CCDC28B
|
[NCBI]
|
1.14965e-05
|
|
|
RNASEH2C
|
[NCBI]
|
1.14965e-05
|
|
|
RAB11FIP1
|
[NCBI]
|
1.14965e-05
|
|
|
SNRPB
|
[NCBI]
|
1.14965e-05
|
|
|
g-substrate
|
[NCBI]
|
1.14965e-05
|
|
|
UVRAG
|
[NCBI]
|
1.14965e-05
|
|
|
CNKSR1
|
[NCBI]
|
1.14965e-05
|
|
|
CCT7
|
[NCBI]
|
1.14965e-05
|
|
|
DIA2
|
[NCBI]
|
1.14965e-05
|
|
|
GPR177
|
[NCBI]
|
1.14965e-05
|
|
|
SMPD2
|
[NCBI]
|
1.14965e-05
|
|
|
ORC6L
|
[NCBI]
|
1.14965e-05
|
|
|
ZDHHC9
|
[NCBI]
|
1.14965e-05
|
|
|
SNAPAP
|
[NCBI]
|
1.14965e-05
|
|
|
bone morphogenetic protein-binding endothelial cell precursor-derived regulator
|
[NCBI]
|
1.14965e-05
|
|
|
NEURL
|
[NCBI]
|
1.14965e-05
|
|
|
DVL1L1
|
[NCBI]
|
1.14965e-05
|
|
|
lipin 3
|
[NCBI]
|
1.14965e-05
|
|
|
MORF4L2
|
[NCBI]
|
1.14965e-05
|
|
|
DNAJA1
|
[NCBI]
|
1.14965e-05
|
|
|
COG4
|
[NCBI]
|
1.14965e-05
|
|
|
flavoprotein oxidoreductase mical3
|
[NCBI]
|
1.14965e-05
|
|
|
CARKL
|
[NCBI]
|
1.14965e-05
|
|
|
FBXL20
|
[NCBI]
|
1.14965e-05
|
|
|
SPRY3
|
[NCBI]
|
1.14965e-05
|
|
|
CRTAC1
|
[NCBI]
|
1.14965e-05
|
|
|
ste20-related adaptor protein
|
[NCBI]
|
1.14965e-05
|
|
|
PRCD
|
[NCBI]
|
1.14965e-05
|
|
|
ELP4
|
[NCBI]
|
1.14965e-05
|
|
|
ichthyin
|
[NCBI]
|
1.14965e-05
|
|
|
CIDEA
|
[NCBI]
|
1.14965e-05
|
|
|
TAS2R38
|
[NCBI]
|
1.14965e-05
|
|
|
TMEM113
|
[NCBI]
|
1.14965e-05
|
|
|
CDX4
|
[NCBI]
|
1.14965e-05
|
|
|
PHF16
|
[NCBI]
|
1.14965e-05
|
|
|
NID2
|
[NCBI]
|
1.14965e-05
|
|
|
SP8
|
[NCBI]
|
1.14965e-05
|
|
|
SMEK2
|
[NCBI]
|
1.14965e-05
|
|
|
KCNH3
|
[NCBI]
|
1.14965e-05
|
|
|
INTU
|
[NCBI]
|
1.14965e-05
|
|
|
RNASEH2B
|
[NCBI]
|
1.14965e-05
|
|
|
GNG3
|
[NCBI]
|
1.14965e-05
|
|
|
DOCK3
|
[NCBI]
|
1.14965e-05
|
|
|
BAT2
|
[NCBI]
|
1.14965e-05
|
|
|
PHACTR4
|
[NCBI]
|
1.14965e-05
|
|
|
CEMP1
|
[NCBI]
|
1.14965e-05
|
|
|
KRTHA3B
|
[NCBI]
|
1.14965e-05
|
|
|
SHOC2
|
[NCBI]
|
1.14965e-05
|
|
|
MBD5
|
[NCBI]
|
1.14965e-05
|
|
|
human immunodeficiency virus type 1, susceptibility to
|
[NCBI]
|
1.14717e-05
|
|
|
twinning, dizygotic
|
[NCBI]
|
1.14474e-05
|
|
|
glaucoma-related pigment dispersion syndrome
|
[NCBI]
|
1.14474e-05
|
|
|
CACNA1S
|
[NCBI]
|
1.14162e-05
|
|
|
AMY1A
|
[NCBI]
|
1.14162e-05
|
|
|
phenylketonuria ii
|
[NCBI]
|
1.14162e-05
|
|
|
FRDA
|
[NCBI]
|
1.1412e-05
|
|
|
carbimazole sensitivity
|
[NCBI]
|
1.13658e-05
|
|
|
melanoma-astrocytoma syndrome
|
[NCBI]
|
1.13658e-05
|
|
|
ARMD2
|
[NCBI]
|
1.13658e-05
|
|
|
leprosy, susceptibility to, 2
|
[NCBI]
|
1.13658e-05
|
|
|
MLASA
|
[NCBI]
|
1.13658e-05
|
|
|
gonadal agenesis
|
[NCBI]
|
1.13658e-05
|
|
|
myxoma, intracardiac
|
[NCBI]
|
1.13658e-05
|
|
|
papilloma of choroid plexus
|
[NCBI]
|
1.13658e-05
|
|
|
CHBL
|
[NCBI]
|
1.13658e-05
|
|
|
USH1G
|
[NCBI]
|
1.13658e-05
|
|
|
TS
|
[NCBI]
|
1.13658e-05
|
|
|
roussy-levy hereditary areflexic dystasia
|
[NCBI]
|
1.13658e-05
|
|
|
heterotaxy, visceral, 2, autosomal
|
[NCBI]
|
1.13658e-05
|
|
|
LCA5
|
[NCBI]
|
1.13658e-05
|
|
|
SCA27
|
[NCBI]
|
1.13658e-05
|
|
|
SPG7
|
[NCBI]
|
1.13658e-05
|
|
|
platelet disorder, familial, with associated myeloid malignancy
|
[NCBI]
|
1.13658e-05
|
|
|
larynx, congenital partial atresia of
|
[NCBI]
|
1.13658e-05
|
|
|
HPE5
|
[NCBI]
|
1.13658e-05
|
|
|
vitamin k-dependent clotting factors, combined deficiency of, 2
|
[NCBI]
|
1.13658e-05
|
|
|
cleft larynx, posterior
|
[NCBI]
|
1.13658e-05
|
|
|
weyers ulnar ray/oligodactyly syndrome
|
[NCBI]
|
1.13658e-05
|
|
|
corpus callosum, partial agenesis of, x-linked
|
[NCBI]
|
1.13658e-05
|
|
|
RD
|
[NCBI]
|
1.13658e-05
|
|
|
resting heart rate
|
[NCBI]
|
1.13658e-05
|
|
|
ruvalcaba syndrome
|
[NCBI]
|
1.13658e-05
|
|
|
varicose veins
|
[NCBI]
|
1.13658e-05
|
|
|
anal atresia, hypospadias, and penoscrotal inversion
|
[NCBI]
|
1.13658e-05
|
|
|
pulmonic stenosis
|
[NCBI]
|
1.13658e-05
|
|
|
simpson-golabi-behmel syndrome, type 2
|
[NCBI]
|
1.13658e-05
|
|
|
MCOP2
|
[NCBI]
|
1.13658e-05
|
|
|
polydactyly, preaxial i
|
[NCBI]
|
1.13658e-05
|
|
|
PURE&apos
|
[NCBI]
|
1.13658e-05
|
|
|
CLN7
|
[NCBI]
|
1.13658e-05
|
|
|
CSB
|
[NCBI]
|
1.13658e-05
|
|
|
proprotein convertase 1 deficiency
|
[NCBI]
|
1.13658e-05
|
|
|
amyloidosis, familial visceral
|
[NCBI]
|
1.13658e-05
|
|
|
PRTS
|
[NCBI]
|
1.13658e-05
|
|
|
CDG1D
|
[NCBI]
|
1.13658e-05
|
|
|
charcot-marie-tooth disease, recessive intermediate a
|
[NCBI]
|
1.13658e-05
|
|
|
CMD1G
|
[NCBI]
|
1.13658e-05
|
|
|
carotid intimal medial thickness 1
|
[NCBI]
|
1.13658e-05
|
|
|
leigh syndrome, x-linked
|
[NCBI]
|
1.13658e-05
|
|
|
SCA15
|
[NCBI]
|
1.13658e-05
|
|
|
nephrotic syndrome, early-onset, with diffuse mesangial sclerosis
|
[NCBI]
|
1.13658e-05
|
|
|
CMD1C
|
[NCBI]
|
1.13658e-05
|
|
|
fanconi anemia, complementation group j
|
[NCBI]
|
1.13658e-05
|
|
|
neuropathy, ataxia, and retinitis pigmentosa
|
[NCBI]
|
1.13658e-05
|
|
|
cryohydrocytosis, stomatin-deficient, with mental retardation, seizures, cataracts, and massive hepatosplenomegaly
|
[NCBI]
|
1.13658e-05
|
|
|
acth deficiency
|
[NCBI]
|
1.13658e-05
|
|
|
PTLS
|
[NCBI]
|
1.13658e-05
|
|
|
RP19
|
[NCBI]
|
1.13658e-05
|
|
|
bilirubin, elevated concentrations of, in serum
|
[NCBI]
|
1.13658e-05
|
|
|
segawa syndrome, autosomal recessive
|
[NCBI]
|
1.13658e-05
|
|
|
lig4 syndrome
|
[NCBI]
|
1.13658e-05
|
|
|
IGAD2
|
[NCBI]
|
1.13658e-05
|
|
|
immunodeficiency with hyper-igm, type 3
|
[NCBI]
|
1.13658e-05
|
|
|
laurence-moon syndrome
|
[NCBI]
|
1.13658e-05
|
|
|
rheumatic fever-related antigen
|
[NCBI]
|
1.13658e-05
|
|
|
carnitine palmitoyltransferase ii deficiency, infantile
|
[NCBI]
|
1.13658e-05
|
|
|
ARVD9
|
[NCBI]
|
1.13658e-05
|
|
|
dermographism, familial
|
[NCBI]
|
1.13658e-05
|
|
|
FHL4
|
[NCBI]
|
1.13658e-05
|
|
|
tietz syndrome
|
[NCBI]
|
1.13658e-05
|
|
|
tongue curling, folding, or rolling
|
[NCBI]
|
1.13658e-05
|
|
|
FHCA
|
[NCBI]
|
1.13658e-05
|
|
|
HHF3
|
[NCBI]
|
1.13658e-05
|
|
|
EBN2
|
[NCBI]
|
1.13658e-05
|
|
|
chondrodysplasia punctata, tibia-metacarpal type
|
[NCBI]
|
1.13658e-05
|
|
|
PCI
|
[NCBI]
|
1.11961e-05
|
|
|
BRCA2
|
[NCBI]
|
1.11494e-05
|
|
|
HBG2
|
[NCBI]
|
1.1145e-05
|
|
|
POU1F1
|
[NCBI]
|
1.11361e-05
|
|
|
leber optic atrophy
|
[NCBI]
|
1.10963e-05
|
|
|
GSTT1
|
[NCBI]
|
1.10864e-05
|
|
|
SHANK3
|
[NCBI]
|
1.10864e-05
|
|
|
KRTHB6
|
[NCBI]
|
1.10864e-05
|
|
|
HTN3
|
[NCBI]
|
1.10864e-05
|
|
|
EDAR
|
[NCBI]
|
1.10864e-05
|
|
|
HBE1
|
[NCBI]
|
1.10864e-05
|
|
|
FGF5
|
[NCBI]
|
1.10864e-05
|
|
|
FOXN1
|
[NCBI]
|
1.10864e-05
|
|
|
SIAH1
|
[NCBI]
|
1.10864e-05
|
|
|
FKHL16
|
[NCBI]
|
1.10864e-05
|
|
|
EYA4
|
[NCBI]
|
1.10864e-05
|
|
|
SYN1
|
[NCBI]
|
1.10864e-05
|
|
|
GUCA1A
|
[NCBI]
|
1.10864e-05
|
|
|
CLDN16
|
[NCBI]
|
1.10864e-05
|
|
|
DSG4
|
[NCBI]
|
1.10864e-05
|
|
|
farber lipogranulomatosis
|
[NCBI]
|
1.10864e-05
|
|
|
TRPS1
|
[NCBI]
|
1.10864e-05
|
|
|
ANXA7
|
[NCBI]
|
1.10864e-05
|
|
|
LEFTY2
|
[NCBI]
|
1.10864e-05
|
|
|
MYOCD
|
[NCBI]
|
1.10864e-05
|
|
|
ATP8B1
|
[NCBI]
|
1.10864e-05
|
|
|
ITIH1
|
[NCBI]
|
1.10864e-05
|
|
|
ALMS1
|
[NCBI]
|
1.10864e-05
|
|
|
ANKH
|
[NCBI]
|
1.10864e-05
|
|
|
EPOR
|
[NCBI]
|
1.09614e-05
|
|
|
MNGIE
|
[NCBI]
|
1.09498e-05
|
|
|
histidinemia
|
[NCBI]
|
1.09498e-05
|
|
|
CDPX1
|
[NCBI]
|
1.09498e-05
|
|
|
TRPS1
|
[NCBI]
|
1.09498e-05
|
|
|
mismatch repair cancer syndrome
|
[NCBI]
|
1.09498e-05
|
|
|
GLC3A
|
[NCBI]
|
1.09498e-05
|
|
|
EBR1
|
[NCBI]
|
1.09498e-05
|
|
|
RASA1
|
[NCBI]
|
1.0939e-05
|
|
|
PTEN
|
[NCBI]
|
1.09206e-05
|
|
|
OCP
|
[NCBI]
|
1.09172e-05
|
|
|
THC1
|
[NCBI]
|
1.08526e-05
|
|
|
CMT4A
|
[NCBI]
|
1.08526e-05
|
|
|
sertoli cell-only syndrome, y-linked
|
[NCBI]
|
1.08526e-05
|
|
|
CLN5
|
[NCBI]
|
1.08526e-05
|
|
|
DFNA6
|
[NCBI]
|
1.08526e-05
|
|
|
SMDP1
|
[NCBI]
|
1.08526e-05
|
|
|
SEDT
|
[NCBI]
|
1.08526e-05
|
|
|
CMT2B
|
[NCBI]
|
1.08526e-05
|
|
|
lipoid proteinosis of urbach and wiethe
|
[NCBI]
|
1.08526e-05
|
|
|
CALCRL
|
[NCBI]
|
1.08455e-05
|
|
|
BIRC1
|
[NCBI]
|
1.08327e-05
|
|
|
FOXP3
|
[NCBI]
|
1.08327e-05
|
|
|
PPARG
|
[NCBI]
|
1.07904e-05
|
|
|
SVAS
|
[NCBI]
|
1.07685e-05
|
|
|
MSTN
|
[NCBI]
|
1.07527e-05
|
|
|
TNXB
|
[NCBI]
|
1.075e-05
|
|
|
HAMP
|
[NCBI]
|
1.075e-05
|
|
|
GJB6
|
[NCBI]
|
1.075e-05
|
|
|
AIRE
|
[NCBI]
|
1.07421e-05
|
|
|
complement component 2 deficiency
|
[NCBI]
|
1.06529e-05
|
|
|
anemia, sideroblastic, x-linked
|
[NCBI]
|
1.06529e-05
|
|
|
BCPM
|
[NCBI]
|
1.05394e-05
|
|
|
TGFB1
|
[NCBI]
|
1.05069e-05
|
|
|
VASP
|
[NCBI]
|
1.05051e-05
|
|
|
HDC
|
[NCBI]
|
1.02622e-05
|
|
|
FGF7
|
[NCBI]
|
1.02469e-05
|
|
|
GDF5
|
[NCBI]
|
1.01903e-05
|
|
|
IL13
|
[NCBI]
|
1.01903e-05
|
|
|
PGR
|
[NCBI]
|
1.01809e-05
|
|
|
sickle cell anemia
|
[NCBI]
|
1.01648e-05
|
|
|
ADHD
|
[NCBI]
|
1.01574e-05
|
|
|
HLA-DQB1
|
[NCBI]
|
1.01265e-05
|
|
|
SYP
|
[NCBI]
|
1.01265e-05
|
|
|
KRT1
|
[NCBI]
|
1.01265e-05
|
|
|
SLC1A5
|
[NCBI]
|
1.00561e-05
|
|
|
HOXA1
|
[NCBI]
|
1.00561e-05
|
|
|
FGD1
|
[NCBI]
|
1.00561e-05
|
|
|
PLEC1
|
[NCBI]
|
1.00561e-05
|
|
|
KRT16
|
[NCBI]
|
1.00561e-05
|
|
|
MDH1
|
[NCBI]
|
1.00561e-05
|
|
|
NEUROD1
|
[NCBI]
|
1.00561e-05
|
|
|
CD3G
|
[NCBI]
|
1.00561e-05
|
|
|
T
|
[NCBI]
|
1.00561e-05
|
|
|
NPPB
|
[NCBI]
|
1.00561e-05
|
|
|
ALPI
|
[NCBI]
|
1.00561e-05
|
|
|
LAMA3
|
[NCBI]
|
1.00561e-05
|
|
|
PTPRO
|
[NCBI]
|
1.00561e-05
|
|
|
NR2E3
|
[NCBI]
|
1.00561e-05
|
|
|
MTTI
|
[NCBI]
|
1.00561e-05
|
|
|
ornithine transcarbamylase deficiency, hyperammonemia due to
|
[NCBI]
|
9.96626e-06
|
|
|
FGF10
|
[NCBI]
|
9.74726e-06
|
|
|
RPS6KA3
|
[NCBI]
|
9.74726e-06
|
|
|
PSAP
|
[NCBI]
|
9.64997e-06
|
|
|
SCD
|
[NCBI]
|
9.63384e-06
|
|
|
homocysteinemia
|
[NCBI]
|
9.62873e-06
|
|
|
graves disease
|
[NCBI]
|
9.62873e-06
|
|
|
DKC
|
[NCBI]
|
9.62873e-06
|
|
|
TLR2
|
[NCBI]
|
9.61304e-06
|
|
|
BGLAP
|
[NCBI]
|
9.60558e-06
|
|
|
KCNH2
|
[NCBI]
|
9.5699e-06
|
|
|
MTACR1
|
[NCBI]
|
9.54585e-06
|
|
|
CGF
|
[NCBI]
|
9.54585e-06
|
|
|
AUTS9
|
[NCBI]
|
9.54585e-06
|
|
|
pulmonary disease, chronic obstructive
|
[NCBI]
|
9.54585e-06
|
|
|
myoclonic epilepsy, juvenile, 3
|
[NCBI]
|
9.54585e-06
|
|
|
RCD1
|
[NCBI]
|
9.54585e-06
|
|
|
CAPN10
|
[NCBI]
|
9.54188e-06
|
|
|
UBE3A
|
[NCBI]
|
9.54188e-06
|
|
|
APTX
|
[NCBI]
|
9.54188e-06
|
|
|
MDC1A
|
[NCBI]
|
9.5162e-06
|
|
|
CNC1
|
[NCBI]
|
9.5162e-06
|
|
|
deafness, conductive, with stapes fixation
|
[NCBI]
|
9.5162e-06
|
|
|
MTM1
|
[NCBI]
|
9.34687e-06
|
|
|
ED1
|
[NCBI]
|
9.34687e-06
|
|
|
CYP3A4
|
[NCBI]
|
9.32263e-06
|
|
|
XPA
|
[NCBI]
|
9.32263e-06
|
|
|
ACADS
|
[NCBI]
|
9.32263e-06
|
|
|
ESR2
|
[NCBI]
|
9.32263e-06
|
|
|
BGN
|
[NCBI]
|
9.32263e-06
|
|
|
AGT
|
[NCBI]
|
9.30549e-06
|
|
|
GNPAT
|
[NCBI]
|
9.14668e-06
|
|
|
PFN1
|
[NCBI]
|
9.14668e-06
|
|
|
ADH3
|
[NCBI]
|
9.14668e-06
|
|
|
JARID1C
|
[NCBI]
|
9.14668e-06
|
|
|
ECGF1
|
[NCBI]
|
9.14668e-06
|
|
|
MEIS1
|
[NCBI]
|
9.14668e-06
|
|
|
PON2
|
[NCBI]
|
9.14668e-06
|
|
|
MYO15A
|
[NCBI]
|
9.14668e-06
|
|
|
COL4A4
|
[NCBI]
|
9.14668e-06
|
|
|
TBX3
|
[NCBI]
|
9.14668e-06
|
|
|
POU3F4
|
[NCBI]
|
9.14668e-06
|
|
|
ZNF9
|
[NCBI]
|
9.14668e-06
|
|
|
MERTK
|
[NCBI]
|
9.14668e-06
|
|
|
JMML
|
[NCBI]
|
9.11843e-06
|
|
|
CHAT
|
[NCBI]
|
9.09574e-06
|
|
|
IL10
|
[NCBI]
|
8.99996e-06
|
|
|
SLC25A20
|
[NCBI]
|
8.99271e-06
|
|
|
HSR
|
[NCBI]
|
8.99271e-06
|
|
|
MSX1
|
[NCBI]
|
8.99271e-06
|
|
|
PINK1
|
[NCBI]
|
8.99271e-06
|
|
|
TK1
|
[NCBI]
|
8.99271e-06
|
|
|
alzheimer disease 2
|
[NCBI]
|
8.9352e-06
|
|
|
EDM1
|
[NCBI]
|
8.9352e-06
|
|
|
monilethrix
|
[NCBI]
|
8.9352e-06
|
|
|
mulibrey nanism
|
[NCBI]
|
8.9352e-06
|
|
|
cutis laxa, autosomal recessive, type i
|
[NCBI]
|
8.9352e-06
|
|
|
bartter syndrome, antenatal, type 2
|
[NCBI]
|
8.9352e-06
|
|
|
SHEP1
|
[NCBI]
|
8.9352e-06
|
|
|
wolff-parkinson-white syndrome
|
[NCBI]
|
8.9352e-06
|
|
|
GRTH
|
[NCBI]
|
8.9352e-06
|
|
|
cutis laxa, autosomal recessive, type ii
|
[NCBI]
|
8.9352e-06
|
|
|
pearson marrow-pancreas syndrome
|
[NCBI]
|
8.9352e-06
|
|
|
septooptic dysplasia
|
[NCBI]
|
8.9352e-06
|
|
|
chromosome 18q deletion syndrome
|
[NCBI]
|
8.9352e-06
|
|
|
ACCPN
|
[NCBI]
|
8.9352e-06
|
|
|
BMND1
|
[NCBI]
|
8.9352e-06
|
|
|
MCDS
|
[NCBI]
|
8.9352e-06
|
|
|
crouzon syndrome
|
[NCBI]
|
8.9352e-06
|
|
|
OPTN
|
[NCBI]
|
8.91544e-06
|
|
|
TTR
|
[NCBI]
|
8.9106e-06
|
|
|
ILK
|
[NCBI]
|
8.87829e-06
|
|
|
XPA
|
[NCBI]
|
8.79566e-06
|
|
|
pyruvate decarboxylase deficiency
|
[NCBI]
|
8.74109e-06
|
|
|
testicular tumors
|
[NCBI]
|
8.74109e-06
|
|
|
MAP3K5
|
[NCBI]
|
8.7254e-06
|
|
|
OTC
|
[NCBI]
|
8.6486e-06
|
|
|
DACT1
|
[NCBI]
|
8.61162e-06
|
|
|
PEX11A
|
[NCBI]
|
8.61162e-06
|
|
|
MYOZ2
|
[NCBI]
|
8.61162e-06
|
|
|
MYH14
|
[NCBI]
|
8.61162e-06
|
|
|
UNC93B1
|
[NCBI]
|
8.61162e-06
|
|
|
CDC27
|
[NCBI]
|
8.61162e-06
|
|
|
UBQLN2
|
[NCBI]
|
8.61162e-06
|
|
|
TM4SF5
|
[NCBI]
|
8.61162e-06
|
|
|
ST3GAL6
|
[NCBI]
|
8.61162e-06
|
|
|
ATOH7
|
[NCBI]
|
8.61162e-06
|
|
|
OSTN
|
[NCBI]
|
8.61162e-06
|
|
|
leucine-rich repeat-containing g protein-coupled receptor 7
|
[NCBI]
|
8.61162e-06
|
|
|
ATP2B4
|
[NCBI]
|
8.61162e-06
|
|
|
WNT9B
|
[NCBI]
|
8.61162e-06
|
|
|
CD96
|
[NCBI]
|
8.61162e-06
|
|
|
CBY
|
[NCBI]
|
8.61162e-06
|
|
|
lymphocyte cytosol polypeptide, 20-kd
|
[NCBI]
|
8.61162e-06
|
|
|
nebulette
|
[NCBI]
|
8.61162e-06
|
|
|
HOXD1
|
[NCBI]
|
8.61162e-06
|
|
|
GNPTG
|
[NCBI]
|
8.61162e-06
|
|
|
NAB2
|
[NCBI]
|
8.61162e-06
|
|
|
FANCI
|
[NCBI]
|
8.61162e-06
|
|
|
E2F5
|
[NCBI]
|
8.61162e-06
|
|
|
ITGA8
|
[NCBI]
|
8.61162e-06
|
|
|
COL21A1
|
[NCBI]
|
8.61162e-06
|
|
|
STK25
|
[NCBI]
|
8.61162e-06
|
|
|
NCAPD3
|
[NCBI]
|
8.61162e-06
|
|
|
RBM17
|
[NCBI]
|
8.61162e-06
|
|
|
SNRPA1
|
[NCBI]
|
8.61162e-06
|
|
|
MYO1D
|
[NCBI]
|
8.61162e-06
|
|
|
EIF3H
|
[NCBI]
|
8.61162e-06
|
|
|
EIF2B1
|
[NCBI]
|
8.61162e-06
|
|
|
keratin 6, hair follicle
|
[NCBI]
|
8.61162e-06
|
|
|
acidic cluster protein, 33-kd
|
[NCBI]
|
8.61162e-06
|
|
|
DMBX1
|
[NCBI]
|
8.61162e-06
|
|
|
PEX10
|
[NCBI]
|
8.61162e-06
|
|
|
PLEKHB1
|
[NCBI]
|
8.61162e-06
|
|
|
CNTN1
|
[NCBI]
|
8.61162e-06
|
|
|
UPP1
|
[NCBI]
|
8.61162e-06
|
|
|
ZWINT
|
[NCBI]
|
8.61162e-06
|
|
|
CHL1
|
[NCBI]
|
8.61162e-06
|
|
|
PCSK4
|
[NCBI]
|
8.61162e-06
|
|
|
DIRAS3
|
[NCBI]
|
8.61162e-06
|
|
|
SIRT6
|
[NCBI]
|
8.61162e-06
|
|
|
TCBA1
|
[NCBI]
|
8.61162e-06
|
|
|
ABHD5
|
[NCBI]
|
8.61162e-06
|
|
|
EPHB4
|
[NCBI]
|
8.61162e-06
|
|
|
RSU1
|
[NCBI]
|
8.61162e-06
|
|
|
SLC24A5
|
[NCBI]
|
8.61162e-06
|
|
|
C6ORF55
|
[NCBI]
|
8.61162e-06
|
|
|
CDC16
|
[NCBI]
|
8.61162e-06
|
|
|
CHK
|
[NCBI]
|
8.61162e-06
|
|
|
LSM6
|
[NCBI]
|
8.61162e-06
|
|
|
KNTC1
|
[NCBI]
|
8.61162e-06
|
|
|
u2 small nuclear ribonucleoprotein auxiliary factor, small subunit 1
|
[NCBI]
|
8.61162e-06
|
|
|
POMT2
|
[NCBI]
|
8.61162e-06
|
|
|
LCA5
|
[NCBI]
|
8.61162e-06
|
|
|
MIRN92-1
|
[NCBI]
|
8.61162e-06
|
|
|
CYLN2
|
[NCBI]
|
8.61162e-06
|
|
|
PVRL3
|
[NCBI]
|
8.61162e-06
|
|
|
CHSY1
|
[NCBI]
|
8.61162e-06
|
|
|
pre-t-cell receptor, alpha-chain precursor
|
[NCBI]
|
8.61162e-06
|
|
|
UCN2
|
[NCBI]
|
8.61162e-06
|
|
|
KRTHA4
|
[NCBI]
|
8.61162e-06
|
|
|
UFD1L
|
[NCBI]
|
8.61162e-06
|
|
|
ZRF1
|
[NCBI]
|
8.61162e-06
|
|
|
CNO
|
[NCBI]
|
8.61162e-06
|
|
|
PARL
|
[NCBI]
|
8.61162e-06
|
|
|
PIGQ
|
[NCBI]
|
8.61162e-06
|
|
|
C1ORF36
|
[NCBI]
|
8.61162e-06
|
|
|
GABRG3
|
[NCBI]
|
8.61162e-06
|
|
|
EPB41L4B
|
[NCBI]
|
8.61162e-06
|
|
|
TSFM
|
[NCBI]
|
8.61162e-06
|
|
|
ATP13A2
|
[NCBI]
|
8.61162e-06
|
|
|
VAX1
|
[NCBI]
|
8.61162e-06
|
|
|
SCO1
|
[NCBI]
|
8.61162e-06
|
|
|
PPP6C
|
[NCBI]
|
8.61162e-06
|
|
|
CYP7B1
|
[NCBI]
|
8.61162e-06
|
|
|
TPST2
|
[NCBI]
|
8.61162e-06
|
|
|
ARHGAP4
|
[NCBI]
|
8.61162e-06
|
|
|
PHYHIP
|
[NCBI]
|
8.61162e-06
|
|
|
TTBK2
|
[NCBI]
|
8.61162e-06
|
|
|
DMGDH
|
[NCBI]
|
8.61162e-06
|
|
|
GARNL1
|
[NCBI]
|
8.61162e-06
|
|
|
MTTV
|
[NCBI]
|
8.61162e-06
|
|
|
CSNK1A1
|
[NCBI]
|
8.61162e-06
|
|
|
HOXA11
|
[NCBI]
|
8.61162e-06
|
|
|
CLASP1
|
[NCBI]
|
8.61162e-06
|
|
|
TBCA
|
[NCBI]
|
8.61162e-06
|
|
|
PPM1B
|
[NCBI]
|
8.61162e-06
|
|
|
selective lim-binding factor, rat, homolog of
|
[NCBI]
|
8.61162e-06
|
|
|
NME3
|
[NCBI]
|
8.61162e-06
|
|
|
DDAH2
|
[NCBI]
|
8.61162e-06
|
|
|
basic helix-loop-helix protein mist1
|
[NCBI]
|
8.61162e-06
|
|
|
AGTPBP1
|
[NCBI]
|
8.61162e-06
|
|
|
INA
|
[NCBI]
|
8.61162e-06
|
|
|
UCK2
|
[NCBI]
|
8.61162e-06
|
|
|
locus control region, alpha
|
[NCBI]
|
8.61162e-06
|
|
|
UBL5
|
[NCBI]
|
8.61162e-06
|
|
|
COG6
|
[NCBI]
|
8.61162e-06
|
|
|
KRTHA5
|
[NCBI]
|
8.61162e-06
|
|
|
MARK1
|
[NCBI]
|
8.61162e-06
|
|
|
NCAPG2
|
[NCBI]
|
8.61162e-06
|
|
|
GDF2
|
[NCBI]
|
8.61162e-06
|
|
|
USP14
|
[NCBI]
|
8.61162e-06
|
|
|
DYM
|
[NCBI]
|
8.61162e-06
|
|
|
CELSR2
|
[NCBI]
|
8.61162e-06
|
|
|
ATP5J
|
[NCBI]
|
8.61162e-06
|
|
|
RPS6KB2
|
[NCBI]
|
8.61162e-06
|
|
|
EHMT1
|
[NCBI]
|
8.61162e-06
|
|
|
SEMA6A
|
[NCBI]
|
8.61162e-06
|
|
|
PRRX2
|
[NCBI]
|
8.61162e-06
|
|
|
IGLP1
|
[NCBI]
|
8.61162e-06
|
|
|
REXO2
|
[NCBI]
|
8.61162e-06
|
|
|
SETD1A
|
[NCBI]
|
8.61162e-06
|
|
|
PHF15
|
[NCBI]
|
8.61162e-06
|
|
|
TULP3
|
[NCBI]
|
8.61162e-06
|
|
|
STK36
|
[NCBI]
|
8.61162e-06
|
|
|
KRTHA3A
|
[NCBI]
|
8.61162e-06
|
|
|
NXPH3
|
[NCBI]
|
8.61162e-06
|
|
|
TNFRSF19
|
[NCBI]
|
8.61162e-06
|
|
|
IGHG4
|
[NCBI]
|
8.61162e-06
|
|
|
ANKS1A
|
[NCBI]
|
8.61162e-06
|
|
|
IDH3G
|
[NCBI]
|
8.61162e-06
|
|
|
ITGB8
|
[NCBI]
|
8.61162e-06
|
|
|
KRTHA6
|
[NCBI]
|
8.61162e-06
|
|
|
CACNA2D4
|
[NCBI]
|
8.61162e-06
|
|
|
NKX2C
|
[NCBI]
|
8.61162e-06
|
|
|
ESA4
|
[NCBI]
|
8.61162e-06
|
|
|
BRWD3
|
[NCBI]
|
8.61162e-06
|
|
|
associated molecule with the sh3 domain of stam
|
[NCBI]
|
8.61162e-06
|
|
|
UBASH3A
|
[NCBI]
|
8.61162e-06
|
|
|
FBN3
|
[NCBI]
|
8.61162e-06
|
|
|
SLC25A16
|
[NCBI]
|
8.61162e-06
|
|
|
FLRT3
|
[NCBI]
|
8.61162e-06
|
|
|
COX17
|
[NCBI]
|
8.61162e-06
|
|
|
AGTR1
|
[NCBI]
|
8.52479e-06
|
|
|
metachromatic leukodystrophy
|
[NCBI]
|
8.47975e-06
|
|
|
HEXA
|
[NCBI]
|
8.47027e-06
|
|
|
OPRM1
|
[NCBI]
|
8.44901e-06
|
|
|
STAR
|
[NCBI]
|
8.43222e-06
|
|
|
PARK2
|
[NCBI]
|
8.37114e-06
|
|
|
MATN3
|
[NCBI]
|
8.33679e-06
|
|
|
COL6A2
|
[NCBI]
|
8.33679e-06
|
|
|
OTX2
|
[NCBI]
|
8.33679e-06
|
|
|
SPINK5
|
[NCBI]
|
8.33679e-06
|
|
|
CRYGC
|
[NCBI]
|
8.33679e-06
|
|
|
NDRG1
|
[NCBI]
|
8.33679e-06
|
|
|
CLCN7
|
[NCBI]
|
8.33679e-06
|
|
|
GALNT3
|
[NCBI]
|
8.33679e-06
|
|
|
G22P1
|
[NCBI]
|
8.33679e-06
|
|
|
OCRL
|
[NCBI]
|
8.33679e-06
|
|
|
diphosphoglycerate mutase deficiency of erythrocyte
|
[NCBI]
|
8.33679e-06
|
|
|
MEG3
|
[NCBI]
|
8.33679e-06
|
|
|
SIX1
|
[NCBI]
|
8.33679e-06
|
|
|
RNF7
|
[NCBI]
|
8.33679e-06
|
|
|
APOBEC1
|
[NCBI]
|
8.33679e-06
|
|
|
PTPN6
|
[NCBI]
|
8.33679e-06
|
|
|
SIX3
|
[NCBI]
|
8.33679e-06
|
|
|
TSD
|
[NCBI]
|
8.28123e-06
|
|
|
glycogen storage disease iii
|
[NCBI]
|
8.22655e-06
|
|
|
PSNP1
|
[NCBI]
|
8.22655e-06
|
|
|
EKV
|
[NCBI]
|
8.22655e-06
|
|
|
diastrophic dysplasia
|
[NCBI]
|
8.22655e-06
|
|
|
methylmalonic aciduria due to methylmalonyl-coa mutase deficiency
|
[NCBI]
|
8.22655e-06
|
|
|
LDLR
|
[NCBI]
|
8.15827e-06
|
|
|
EDN1
|
[NCBI]
|
8.14982e-06
|
|
|
SNRPN
|
[NCBI]
|
8.14982e-06
|
|
|
MYH11
|
[NCBI]
|
8.14982e-06
|
|
|
antithrombin iii deficiency
|
[NCBI]
|
8.11594e-06
|
|
|
GHR
|
[NCBI]
|
8.11289e-06
|
|
|
TS
|
[NCBI]
|
8.09872e-06
|
|
|
GNRHR
|
[NCBI]
|
8.03189e-06
|
|
|
PNMT
|
[NCBI]
|
8.02532e-06
|
|
|
PAX2
|
[NCBI]
|
7.98921e-06
|
|
|
IL2RG
|
[NCBI]
|
7.98921e-06
|
|
|
EDMD
|
[NCBI]
|
7.92699e-06
|
|
|
DM2
|
[NCBI]
|
7.92699e-06
|
|
|
RCD3A
|
[NCBI]
|
7.88171e-06
|
|
|
CCZS
|
[NCBI]
|
7.88171e-06
|
|
|
EDM2
|
[NCBI]
|
7.88171e-06
|
|
|
IDDM10
|
[NCBI]
|
7.88171e-06
|
|
|
PFIC2
|
[NCBI]
|
7.88171e-06
|
|
|
h-y antigen receptor
|
[NCBI]
|
7.88171e-06
|
|
|
witkop syndrome
|
[NCBI]
|
7.88171e-06
|
|
|
epidermolysis bullosa of hands and feet
|
[NCBI]
|
7.88171e-06
|
|
|
MKS3
|
[NCBI]
|
7.88171e-06
|
|
|
young syndrome
|
[NCBI]
|
7.88171e-06
|
|
|
sea-blue histiocyte disease
|
[NCBI]
|
7.88171e-06
|
|
|
DFNB2
|
[NCBI]
|
7.88171e-06
|
|
|
STL3
|
[NCBI]
|
7.88171e-06
|
|
|
myopathy, centronuclear, autosomal recessive
|
[NCBI]
|
7.88171e-06
|
|
|
AH
|
[NCBI]
|
7.88171e-06
|
|
|
IN
|
[NCBI]
|
7.88171e-06
|
|
|
mitochondrial complex ii deficiency
|
[NCBI]
|
7.88171e-06
|
|
|
schneckenbecken dysplasia
|
[NCBI]
|
7.88171e-06
|
|
|
PPCRA
|
[NCBI]
|
7.88171e-06
|
|
|
chorioretinal dysplasia-microcephaly-mental retardation syndrome
|
[NCBI]
|
7.88171e-06
|
|
|
isoproterenol-mediated vasodilatation
|
[NCBI]
|
7.88171e-06
|
|
|
NN
|
[NCBI]
|
7.88171e-06
|
|
|
ED3
|
[NCBI]
|
7.88171e-06
|
|
|
premature chromosome condensation with microcephaly and mental retardation
|
[NCBI]
|
7.88171e-06
|
|
|
hunter-mcalpine craniosynostosis syndrome
|
[NCBI]
|
7.88171e-06
|
|
|
CMH3
|
[NCBI]
|
7.88171e-06
|
|
|
tropical calcific pancreatitis
|
[NCBI]
|
7.88171e-06
|
|
|
dentin dysplasia, type ii
|
[NCBI]
|
7.88171e-06
|
|
|
melanoma-pancreatic cancer syndrome
|
[NCBI]
|
7.88171e-06
|
|
|
PDB1
|
[NCBI]
|
7.88171e-06
|
|
|
ichthyosis, lamellar, autosomal dominant
|
[NCBI]
|
7.88171e-06
|
|
|
hyperprolinemia, type ii
|
[NCBI]
|
7.88171e-06
|
|
|
fragile site 10q25
|
[NCBI]
|
7.88171e-06
|
|
|
peroxisomal acyl-coa oxidase deficiency
|
[NCBI]
|
7.88171e-06
|
|
|
follicle-stimulating hormone deficiency, isolated
|
[NCBI]
|
7.88171e-06
|
|
|
OUBR
|
[NCBI]
|
7.88171e-06
|
|
|
hydroxyacyl-coa dehydrogenase ii deficiency
|
[NCBI]
|
7.88171e-06
|
|
|
recombinant chromosome 8 syndrome
|
[NCBI]
|
7.88171e-06
|
|
|
CTPP3
|
[NCBI]
|
7.88171e-06
|
|
|
thyroid hormonogenesis, genetic defect in, 1
|
[NCBI]
|
7.88171e-06
|
|
|
3-@methylcrotonyl-coa carboxylase 2 deficiency
|
[NCBI]
|
7.88171e-06
|
|
|
cystinosis, late-onset juvenile or adolescent nephropathic type
|
[NCBI]
|
7.88171e-06
|
|
|
hairy ears
|
[NCBI]
|
7.88171e-06
|
|
|
TTDN1
|
[NCBI]
|
7.88171e-06
|
|
|
macrocephaly, benign familial
|
[NCBI]
|
7.88171e-06
|
|
|
mental retardation, x-linked, with cerebellar hypoplasia and distinctive facial appearance
|
[NCBI]
|
7.88171e-06
|
|
|
KRS
|
[NCBI]
|
7.88171e-06
|
|
|
EBDSC
|
[NCBI]
|
7.88171e-06
|
|
|
EDM3
|
[NCBI]
|
7.88171e-06
|
|
|
keratosis palmoplantaris striata i
|
[NCBI]
|
7.88171e-06
|
|
|
spondylocarpotarsal synostosis syndrome
|
[NCBI]
|
7.88171e-06
|
|
|
ramon syndrome
|
[NCBI]
|
7.88171e-06
|
|
|
eunuchoidism, familial hypogonadotropic
|
[NCBI]
|
7.88171e-06
|
|
|
AVSD2
|
[NCBI]
|
7.88171e-06
|
|
|
CDHS
|
[NCBI]
|
7.88171e-06
|
|
|
osteogenesis imperfecta, type viii
|
[NCBI]
|
7.88171e-06
|
|
|
TRPS3
|
[NCBI]
|
7.88171e-06
|
|
|
renal tubular acidosis, distal, with hemolytic anemia
|
[NCBI]
|
7.88171e-06
|
|
|
SPDA1
|
[NCBI]
|
7.87816e-06
|
|
|
HSAS
|
[NCBI]
|
7.87816e-06
|
|
|
AIMAH
|
[NCBI]
|
7.87816e-06
|
|
|
TNC
|
[NCBI]
|
7.86621e-06
|
|
|
H19
|
[NCBI]
|
7.78978e-06
|
|
|
HBB
|
[NCBI]
|
7.77166e-06
|
|
|
IGAN1
|
[NCBI]
|
7.74054e-06
|
|
|
abdominal obesity-metabolic syndrome
|
[NCBI]
|
7.74054e-06
|
|
|
CDAN2
|
[NCBI]
|
7.74054e-06
|
|
|
IGF2
|
[NCBI]
|
7.73771e-06
|
|
|
XIST
|
[NCBI]
|
7.67594e-06
|
|
|
ichthyosis, x-linked
|
[NCBI]
|
7.62128e-06
|
|
|
C5R1
|
[NCBI]
|
7.61042e-06
|
|
|
HCRTR2
|
[NCBI]
|
7.61042e-06
|
|
|
LIMK1
|
[NCBI]
|
7.61042e-06
|
|
|
TCF4
|
[NCBI]
|
7.61042e-06
|
|
|
PLAG1
|
[NCBI]
|
7.61042e-06
|
|
|
DAZL
|
[NCBI]
|
7.61042e-06
|
|
|
ITGA2
|
[NCBI]
|
7.61042e-06
|
|
|
SKI
|
[NCBI]
|
7.61042e-06
|
|
|
MAT1A
|
[NCBI]
|
7.61042e-06
|
|
|
ADH1
|
[NCBI]
|
7.61042e-06
|
|
|
CEP290
|
[NCBI]
|
7.61042e-06
|
|
|
CALCR
|
[NCBI]
|
7.61042e-06
|
|
|
UBB
|
[NCBI]
|
7.61042e-06
|
|
|
tyrosine transaminase deficiency
|
[NCBI]
|
7.61042e-06
|
|
|
porphyria variegata
|
[NCBI]
|
7.55547e-06
|
|
|
GJA5
|
[NCBI]
|
7.52996e-06
|
|
|
PTPN1
|
[NCBI]
|
7.52996e-06
|
|
|
MUC1
|
[NCBI]
|
7.46041e-06
|
|
|
TFR2
|
[NCBI]
|
7.44393e-06
|
|
|
MAG
|
[NCBI]
|
7.39637e-06
|
|
|
coenzyme q10 deficiency
|
[NCBI]
|
7.29902e-06
|
|
|
LQT3
|
[NCBI]
|
7.29902e-06
|
|
|
ARMD4
|
[NCBI]
|
7.29902e-06
|
|
|
JLNS1
|
[NCBI]
|
7.29902e-06
|
|
|
trichodentoosseous syndrome
|
[NCBI]
|
7.29902e-06
|
|
|
ACHM2
|
[NCBI]
|
7.29902e-06
|
|
|
STGD3
|
[NCBI]
|
7.29902e-06
|
|
|
disorganization, mouse, homolog of
|
[NCBI]
|
7.29902e-06
|
|
|
SPD1
|
[NCBI]
|
7.29902e-06
|
|
|
anemia, dyserythropoietic congenital, type i
|
[NCBI]
|
7.29902e-06
|
|
|
gm1-gangliosidosis, type iii
|
[NCBI]
|
7.29902e-06
|
|
|
PPS
|
[NCBI]
|
7.29902e-06
|
|
|
ABCG2
|
[NCBI]
|
7.20999e-06
|
|
|
BMP2
|
[NCBI]
|
7.19211e-06
|
|
|
HEXB
|
[NCBI]
|
7.1116e-06
|
|
|
BRAF
|
[NCBI]
|
7.1116e-06
|
|
|
MTCYB
|
[NCBI]
|
7.1116e-06
|
|
|
PRG4
|
[NCBI]
|
7.09623e-06
|
|
|
KL
|
[NCBI]
|
7.09623e-06
|
|
|
IFNGR1
|
[NCBI]
|
7.09623e-06
|
|
|
adenylyl cyclase, soluble
|
[NCBI]
|
7.09623e-06
|
|
|
GPX1
|
[NCBI]
|
7.09623e-06
|
|
|
hyperglycerolemia
|
[NCBI]
|
7.06772e-06
|
|
|
acyl-coa dehydrogenase, medium-chain, deficiency of
|
[NCBI]
|
7.06772e-06
|
|
|
alcohol dependence
|
[NCBI]
|
7.06772e-06
|
|
|
AT
|
[NCBI]
|
7.01143e-06
|
|
|
3-@hydroxy-3-methylglutaryl-coa lyase deficiency
|
[NCBI]
|
6.95508e-06
|
|
|
APOC3
|
[NCBI]
|
6.95508e-06
|
|
|
DSG2
|
[NCBI]
|
6.95508e-06
|
|
|
DSCR1
|
[NCBI]
|
6.95508e-06
|
|
|
PCCA
|
[NCBI]
|
6.95508e-06
|
|
|
OGG1
|
[NCBI]
|
6.95508e-06
|
|
|
CRYGD
|
[NCBI]
|
6.95508e-06
|
|
|
FSHB
|
[NCBI]
|
6.95508e-06
|
|
|
BCKDHA
|
[NCBI]
|
6.95508e-06
|
|
|
ADAR
|
[NCBI]
|
6.95508e-06
|
|
|
RHAG
|
[NCBI]
|
6.95508e-06
|
|
|
LU
|
[NCBI]
|
6.95508e-06
|
|
|
KRT10
|
[NCBI]
|
6.95508e-06
|
|
|
HSPG2
|
[NCBI]
|
6.95508e-06
|
|
|
fabry disease
|
[NCBI]
|
6.93878e-06
|
|
|
HRAS
|
[NCBI]
|
6.90807e-06
|
|
|
hla-d histocompatibility type
|
[NCBI]
|
6.89489e-06
|
|
|
DCK
|
[NCBI]
|
6.89443e-06
|
|
|
CNTNAP2
|
[NCBI]
|
6.81813e-06
|
|
|
SYNGR1
|
[NCBI]
|
6.81813e-06
|
|
|
scribble, drosophila, homolog of
|
[NCBI]
|
6.81813e-06
|
|
|
ALG3
|
[NCBI]
|
6.81813e-06
|
|
|
homeodomain-only protein
|
[NCBI]
|
6.81813e-06
|
|
|
AOC2
|
[NCBI]
|
6.81813e-06
|
|
|
FDFT1
|
[NCBI]
|
6.81813e-06
|
|
|
SOCS7
|
[NCBI]
|
6.81813e-06
|
|
|
RGS5
|
[NCBI]
|
6.81813e-06
|
|
|
PCSK5
|
[NCBI]
|
6.81813e-06
|
|
|
NAP1L2
|
[NCBI]
|
6.81813e-06
|
|
|
ITGA9
|
[NCBI]
|
6.81813e-06
|
|
|
CTNND2
|
[NCBI]
|
6.81813e-06
|
|
|
IGHG3
|
[NCBI]
|
6.81813e-06
|
|
|
NUDC
|
[NCBI]
|
6.81813e-06
|
|
|
NADK
|
[NCBI]
|
6.81813e-06
|
|
|
RAB3D
|
[NCBI]
|
6.81813e-06
|
|
|
GUCY2F
|
[NCBI]
|
6.81813e-06
|
|
|
BBS2
|
[NCBI]
|
6.81813e-06
|
|
|
BTBD9
|
[NCBI]
|
6.81813e-06
|
|
|
FEM1C
|
[NCBI]
|
6.81813e-06
|
|
|
LEMD3
|
[NCBI]
|
6.81813e-06
|
|
|
CNOT7
|
[NCBI]
|
6.81813e-06
|
|
|
UBR1
|
[NCBI]
|
6.81813e-06
|
|
|
PNPO
|
[NCBI]
|
6.81813e-06
|
|
|
MIRN34A
|
[NCBI]
|
6.81813e-06
|
|
|
CXORF6
|
[NCBI]
|
6.81813e-06
|
|
|
protein z-dependent protease inhibitor precursor
|
[NCBI]
|
6.81813e-06
|
|
|
DNAJC7
|
[NCBI]
|
6.81813e-06
|
|
|
SMPD3
|
[NCBI]
|
6.81813e-06
|
|
|
HOXB8
|
[NCBI]
|
6.81813e-06
|
|
|
GPC1
|
[NCBI]
|
6.81813e-06
|
|
|
FBXW8
|
[NCBI]
|
6.81813e-06
|
|
|
DHPS
|
[NCBI]
|
6.81813e-06
|
|
|
ERAS
|
[NCBI]
|
6.81813e-06
|
|
|
SLC12A1
|
[NCBI]
|
6.81813e-06
|
|
|
PTP4A1
|
[NCBI]
|
6.81813e-06
|
|
|
LRP1B
|
[NCBI]
|
6.81813e-06
|
|
|
MINPP1
|
[NCBI]
|
6.81813e-06
|
|
|
RBMS1
|
[NCBI]
|
6.81813e-06
|
|
|
CTNNA3
|
[NCBI]
|
6.81813e-06
|
|
|
LTBP4
|
[NCBI]
|
6.81813e-06
|
|
|
AGPS
|
[NCBI]
|
6.81813e-06
|
|
|
NDE1
|
[NCBI]
|
6.81813e-06
|
|
|
TLR6
|
[NCBI]
|
6.81813e-06
|
|
|
DDX48
|
[NCBI]
|
6.81813e-06
|
|
|
ADHFE1
|
[NCBI]
|
6.81813e-06
|
|
|
ROR1
|
[NCBI]
|
6.81813e-06
|
|
|
C1QTNF5
|
[NCBI]
|
6.81813e-06
|
|
|
RDH10
|
[NCBI]
|
6.81813e-06
|
|
|
WIF1
|
[NCBI]
|
6.81813e-06
|
|
|
FAT
|
[NCBI]
|
6.81813e-06
|
|
|
XYLT1
|
[NCBI]
|
6.81813e-06
|
|
|
SHROOM3
|
[NCBI]
|
6.81813e-06
|
|
|
DOCK10
|
[NCBI]
|
6.81813e-06
|
|
|
OAZ3
|
[NCBI]
|
6.81813e-06
|
|
|
C3ORF10
|
[NCBI]
|
6.81813e-06
|
|
|
NDUFS2
|
[NCBI]
|
6.81813e-06
|
|
|
ZIC1
|
[NCBI]
|
6.81813e-06
|
|
|
ST5
|
[NCBI]
|
6.81813e-06
|
|
|
MKRN1
|
[NCBI]
|
6.81813e-06
|
|
|
SLC12A6
|
[NCBI]
|
6.81813e-06
|
|
|
CD5
|
[NCBI]
|
6.81813e-06
|
|
|
HPS3
|
[NCBI]
|
6.81813e-06
|
|
|
GYS2
|
[NCBI]
|
6.81813e-06
|
|
|
POU4F2
|
[NCBI]
|
6.81813e-06
|
|
|
PTP4A2
|
[NCBI]
|
6.81813e-06
|
|
|
CANX
|
[NCBI]
|
6.81813e-06
|
|
|
PCM1
|
[NCBI]
|
6.81813e-06
|
|
|
PAXIP1
|
[NCBI]
|
6.81813e-06
|
|
|
ETFB
|
[NCBI]
|
6.81813e-06
|
|
|
FUT8
|
[NCBI]
|
6.81813e-06
|
|
|
CH25H
|
[NCBI]
|
6.81813e-06
|
|
|
LATS1
|
[NCBI]
|
6.81813e-06
|
|
|
GPR34
|
[NCBI]
|
6.81813e-06
|
|
|
B4GALNT1
|
[NCBI]
|
6.81813e-06
|
|
|
ARHGEF9
|
[NCBI]
|
6.81813e-06
|
|
|
LRP4
|
[NCBI]
|
6.81813e-06
|
|
|
PREPL
|
[NCBI]
|
6.81813e-06
|
|
|
STRBP
|
[NCBI]
|
6.81813e-06
|
|
|
CYP26A1
|
[NCBI]
|
6.81813e-06
|
|
|
DVL3
|
[NCBI]
|
6.81813e-06
|
|
|
EIF2B3
|
[NCBI]
|
6.81813e-06
|
|
|
DYRK3
|
[NCBI]
|
6.81813e-06
|
|
|
DGCR8
|
[NCBI]
|
6.81813e-06
|
|
|
neutrophil-specific antigen 1
|
[NCBI]
|
6.81813e-06
|
|
|
PIAS2
|
[NCBI]
|
6.81813e-06
|
|
|
ACTG2
|
[NCBI]
|
6.81813e-06
|
|
|
RASGRF2
|
[NCBI]
|
6.81813e-06
|
|
|
CDC37
|
[NCBI]
|
6.81813e-06
|
|
|
RGS9BP
|
[NCBI]
|
6.81813e-06
|
|
|
LDB1
|
[NCBI]
|
6.81813e-06
|
|
|
SLC5A3
|
[NCBI]
|
6.81813e-06
|
|
|
TMEM15
|
[NCBI]
|
6.81813e-06
|
|
|
TBX18
|
[NCBI]
|
6.81813e-06
|
|
|
double parked, drosophila, homolog of
|
[NCBI]
|
6.81813e-06
|
|
|
COL8A2
|
[NCBI]
|
6.81813e-06
|
|
|
TSNAX
|
[NCBI]
|
6.81813e-06
|
|
|
SCARB2
|
[NCBI]
|
6.81813e-06
|
|
|
NELF
|
[NCBI]
|
6.81813e-06
|
|
|
RAD9A
|
[NCBI]
|
6.81813e-06
|
|
|
NT5E
|
[NCBI]
|
6.81813e-06
|
|
|
EVX2
|
[NCBI]
|
6.81813e-06
|
|
|
CLN5
|
[NCBI]
|
6.81813e-06
|
|
|
solute carrier family 26 (anion transporter), member 6: slc26a6
|
[NCBI]
|
6.81813e-06
|
|
|
POLM
|
[NCBI]
|
6.81813e-06
|
|
|
COG8
|
[NCBI]
|
6.81813e-06
|
|
|
MFAP1
|
[NCBI]
|
6.81813e-06
|
|
|
PEX26
|
[NCBI]
|
6.81813e-06
|
|
|
NR2F6
|
[NCBI]
|
6.81813e-06
|
|
|
BAAT
|
[NCBI]
|
6.81813e-06
|
|
|
RMI1
|
[NCBI]
|
6.81813e-06
|
|
|
SH2D2A
|
[NCBI]
|
6.81813e-06
|
|
|
hemoglobin--alpha locus 3
|
[NCBI]
|
6.81813e-06
|
|
|
SETDB1
|
[NCBI]
|
6.81813e-06
|
|
|
ANGPTL6
|
[NCBI]
|
6.81813e-06
|
|
|
CDX1
|
[NCBI]
|
6.81813e-06
|
|
|
RAE1
|
[NCBI]
|
6.81813e-06
|
|
|
CDH12
|
[NCBI]
|
6.81813e-06
|
|
|
CACNA2D2
|
[NCBI]
|
6.81813e-06
|
|
|
WDR5
|
[NCBI]
|
6.81813e-06
|
|
|
SEPT7
|
[NCBI]
|
6.81813e-06
|
|
|
NEF3
|
[NCBI]
|
6.81813e-06
|
|
|
TAF10
|
[NCBI]
|
6.81813e-06
|
|
|
CACNG4
|
[NCBI]
|
6.81813e-06
|
|
|
RARRES3
|
[NCBI]
|
6.81813e-06
|
|
|
MAGEB2
|
[NCBI]
|
6.81813e-06
|
|
|
INM7
|
[NCBI]
|
6.81813e-06
|
|
|
SC5DL
|
[NCBI]
|
6.81813e-06
|
|
|
PLN
|
[NCBI]
|
6.81099e-06
|
|
|
AR
|
[NCBI]
|
6.79333e-06
|
|
|
LFNG
|
[NCBI]
|
6.68619e-06
|
|
|
KRT14
|
[NCBI]
|
6.68619e-06
|
|
|
IPF1
|
[NCBI]
|
6.68619e-06
|
|
|
ABL
|
[NCBI]
|
6.67958e-06
|
|
|
PTK2B
|
[NCBI]
|
6.6512e-06
|
|
|
PDCD8
|
[NCBI]
|
6.52492e-06
|
|
|
sandhoff disease
|
[NCBI]
|
6.50995e-06
|
|
|
tyrosinemia, type i
|
[NCBI]
|
6.48508e-06
|
|
|
CASR
|
[NCBI]
|
6.37666e-06
|
|
|
AP3B1
|
[NCBI]
|
6.36092e-06
|
|
|
GDAP1
|
[NCBI]
|
6.36092e-06
|
|
|
GGCX
|
[NCBI]
|
6.36092e-06
|
|
|
ATRN
|
[NCBI]
|
6.36092e-06
|
|
|
INVS
|
[NCBI]
|
6.36092e-06
|
|
|
PIK3R1
|
[NCBI]
|
6.36092e-06
|
|
|
CCKAR
|
[NCBI]
|
6.36092e-06
|
|
|
SGSH
|
[NCBI]
|
6.36092e-06
|
|
|
TBX21
|
[NCBI]
|
6.36092e-06
|
|
|
APOA2
|
[NCBI]
|
6.36092e-06
|
|
|
CTNS
|
[NCBI]
|
6.36092e-06
|
|
|
MYBPC3
|
[NCBI]
|
6.36092e-06
|
|
|
SIX5
|
[NCBI]
|
6.36092e-06
|
|
|
LDHC
|
[NCBI]
|
6.36092e-06
|
|
|
HEPH
|
[NCBI]
|
6.36092e-06
|
|
|
ALDH1A2
|
[NCBI]
|
6.29819e-06
|
|
|
CAV1
|
[NCBI]
|
6.29819e-06
|
|
|
DISC1
|
[NCBI]
|
6.29819e-06
|
|
|
DDOST
|
[NCBI]
|
6.29819e-06
|
|
|
CVID
|
[NCBI]
|
6.27295e-06
|
|
|
porphyria, acute intermittent
|
[NCBI]
|
6.04395e-06
|
|
|
INS
|
[NCBI]
|
6.03718e-06
|
|
|
citrullinemia, classic
|
[NCBI]
|
6.02828e-06
|
|
|
PDB
|
[NCBI]
|
6.02828e-06
|
|
|
thiourea tasting
|
[NCBI]
|
6.02828e-06
|
|
|
ARNT
|
[NCBI]
|
6.02018e-06
|
|
|
TRPV1
|
[NCBI]
|
6.02018e-06
|
|
|
UCP2
|
[NCBI]
|
5.95417e-06
|
|
|
IRS2
|
[NCBI]
|
5.93077e-06
|
|
|
GPC3
|
[NCBI]
|
5.93077e-06
|
|
|
EIF4E
|
[NCBI]
|
5.91481e-06
|
|
|
JAK3
|
[NCBI]
|
5.91481e-06
|
|
|
CREBBP
|
[NCBI]
|
5.90571e-06
|
|
|
factor x deficiency
|
[NCBI]
|
5.90571e-06
|
|
|
DCT
|
[NCBI]
|
5.90571e-06
|
|
|
hypophosphatasia, adult type
|
[NCBI]
|
5.90209e-06
|
|
|
CDG2C
|
[NCBI]
|
5.90209e-06
|
|
|
CRS1
|
[NCBI]
|
5.90209e-06
|
|
|
UMS
|
[NCBI]
|
5.90209e-06
|
|
|
CHNG1
|
[NCBI]
|
5.90209e-06
|
|
|
gilbert syndrome
|
[NCBI]
|
5.90209e-06
|
|
|
dent disease 1
|
[NCBI]
|
5.90209e-06
|
|
|
SCZD4
|
[NCBI]
|
5.90209e-06
|
|
|
CTHM
|
[NCBI]
|
5.90209e-06
|
|
|
CFTD
|
[NCBI]
|
5.90209e-06
|
|
|
holocarboxylase synthetase deficiency
|
[NCBI]
|
5.90209e-06
|
|
|
ichthyosis congenita, harlequin fetus type
|
[NCBI]
|
5.90209e-06
|
|
|
PPCD1
|
[NCBI]
|
5.90209e-06
|
|
|
XDH
|
[NCBI]
|
5.88069e-06
|
|
|
RDT
|
[NCBI]
|
5.87672e-06
|
|
|
CBX5
|
[NCBI]
|
5.84324e-06
|
|
|
SLC2A4
|
[NCBI]
|
5.82669e-06
|
|
|
PPIA
|
[NCBI]
|
5.82312e-06
|
|
|
FLG
|
[NCBI]
|
5.82001e-06
|
|
|
ATF1
|
[NCBI]
|
5.82001e-06
|
|
|
ANGPT1
|
[NCBI]
|
5.82001e-06
|
|
|
ALOX5
|
[NCBI]
|
5.82001e-06
|
|
|
PLIN
|
[NCBI]
|
5.82001e-06
|
|
|
IRF6
|
[NCBI]
|
5.82001e-06
|
|
|
CYP2C9
|
[NCBI]
|
5.82001e-06
|
|
|
LYST
|
[NCBI]
|
5.82001e-06
|
|
|
VIL2
|
[NCBI]
|
5.82001e-06
|
|
|
SLC19A1
|
[NCBI]
|
5.82001e-06
|
|
|
BMPR1A
|
[NCBI]
|
5.82001e-06
|
|
|
CYP1A2
|
[NCBI]
|
5.82001e-06
|
|
|
CYBA
|
[NCBI]
|
5.82001e-06
|
|
|
COL18A1
|
[NCBI]
|
5.82001e-06
|
|
|
MC3R
|
[NCBI]
|
5.82001e-06
|
|
|
ADRB1
|
[NCBI]
|
5.82001e-06
|
|
|
NPHS1
|
[NCBI]
|
5.82001e-06
|
|
|
CEBPA
|
[NCBI]
|
5.82001e-06
|
|
|
MTTS1
|
[NCBI]
|
5.82001e-06
|
|
|
FCGR3A
|
[NCBI]
|
5.82001e-06
|
|
|
CCL22
|
[NCBI]
|
5.70984e-06
|
|
|
MEB
|
[NCBI]
|
5.69259e-06
|
|
|
WFS1
|
[NCBI]
|
5.69259e-06
|
|
|
OPA1
|
[NCBI]
|
5.69259e-06
|
|
|
malaria, susceptibility to
|
[NCBI]
|
5.69259e-06
|
|
|
ADAM17
|
[NCBI]
|
5.63246e-06
|
|
|
COL6A1
|
[NCBI]
|
5.5826e-06
|
|
|
CRY1
|
[NCBI]
|
5.5826e-06
|
|
|
CETP
|
[NCBI]
|
5.5826e-06
|
|
|
CEBPD
|
[NCBI]
|
5.54298e-06
|
|
|
KLF9
|
[NCBI]
|
5.54298e-06
|
|
|
COL13A1
|
[NCBI]
|
5.54298e-06
|
|
|
AARS
|
[NCBI]
|
5.54298e-06
|
|
|
GLMN
|
[NCBI]
|
5.54298e-06
|
|
|
CLCNKA
|
[NCBI]
|
5.54298e-06
|
|
|
DIO3
|
[NCBI]
|
5.54298e-06
|
|
|
STK19
|
[NCBI]
|
5.54298e-06
|
|
|
hook, drosophila, homolog of, 1
|
[NCBI]
|
5.54298e-06
|
|
|
DRAP1
|
[NCBI]
|
5.54298e-06
|
|
|
HIF3A
|
[NCBI]
|
5.54298e-06
|
|
|
SQLE
|
[NCBI]
|
5.54298e-06
|
|
|
SCN11A
|
[NCBI]
|
5.54298e-06
|
|
|
lipin 1
|
[NCBI]
|
5.54298e-06
|
|
|
ADAM12
|
[NCBI]
|
5.54298e-06
|
|
|
ABCA12
|
[NCBI]
|
5.54298e-06
|
|
|
EIF5B
|
[NCBI]
|
5.54298e-06
|
|
|
ESRRA
|
[NCBI]
|
5.54298e-06
|
|
|
GANC
|
[NCBI]
|
5.54298e-06
|
|
|
MAN2A1
|
[NCBI]
|
5.54298e-06
|
|
|
rad54, s. cerevisiae, homolog of, b
|
[NCBI]
|
5.54298e-06
|
|
|
CPA4
|
[NCBI]
|
5.54298e-06
|
|
|
TTDN1
|
[NCBI]
|
5.54298e-06
|
|
|
MX1
|
[NCBI]
|
5.54298e-06
|
|
|
ATP5A1
|
[NCBI]
|
5.54298e-06
|
|
|
HPA-2
|
[NCBI]
|
5.54298e-06
|
|
|
SH3GLB1
|
[NCBI]
|
5.54298e-06
|
|
|
IPMK
|
[NCBI]
|
5.54298e-06
|
|
|
FOXE3
|
[NCBI]
|
5.54298e-06
|
|
|
PLXND1
|
[NCBI]
|
5.54298e-06
|
|
|
RDH12
|
[NCBI]
|
5.54298e-06
|
|
|
GIT1
|
[NCBI]
|
5.54298e-06
|
|
|
NYX
|
[NCBI]
|
5.54298e-06
|
|
|
SARDH
|
[NCBI]
|
5.54298e-06
|
|
|
OSTM1
|
[NCBI]
|
5.54298e-06
|
|
|
SLC25A32
|
[NCBI]
|
5.54298e-06
|
|
|
NBL1
|
[NCBI]
|
5.54298e-06
|
|
|
GPD1
|
[NCBI]
|
5.54298e-06
|
|
|
KLF8
|
[NCBI]
|
5.54298e-06
|
|
|
MAP2K6
|
[NCBI]
|
5.54298e-06
|
|
|
BCAP31
|
[NCBI]
|
5.54298e-06
|
|
|
ROCK2
|
[NCBI]
|
5.54298e-06
|
|
|
MIB2
|
[NCBI]
|
5.54298e-06
|
|
|
SLC27A2
|
[NCBI]
|
5.54298e-06
|
|
|
ARID5B
|
[NCBI]
|
5.54298e-06
|
|
|
anterior pharynx defective 1, c. elegans, homolog of, b
|
[NCBI]
|
5.54298e-06
|
|
|
SIM1
|
[NCBI]
|
5.54298e-06
|
|
|
CXXC1
|
[NCBI]
|
5.54298e-06
|
|
|
PACRG
|
[NCBI]
|
5.54298e-06
|
|
|
GIF
|
[NCBI]
|
5.54298e-06
|
|
|
minor histocompatibility antigen ha-1
|
[NCBI]
|
5.54298e-06
|
|
|
INSRR
|
[NCBI]
|
5.54298e-06
|
|
|
CA8
|
[NCBI]
|
5.54298e-06
|
|
|
DMC1
|
[NCBI]
|
5.54298e-06
|
|
|
SLC26A5
|
[NCBI]
|
5.54298e-06
|
|
|
TLX2
|
[NCBI]
|
5.54298e-06
|
|
|
PHF17
|
[NCBI]
|
5.54298e-06
|
|
|
LEFTY1
|
[NCBI]
|
5.54298e-06
|
|
|
DIAPH1
|
[NCBI]
|
5.54298e-06
|
|
|
SLC7A2
|
[NCBI]
|
5.54298e-06
|
|
|
VPS24
|
[NCBI]
|
5.54298e-06
|
|
|
SART1
|
[NCBI]
|
5.54298e-06
|
|
|
AGR2
|
[NCBI]
|
5.54298e-06
|
|
|
FANCF
|
[NCBI]
|
5.54298e-06
|
|
|
NDUFV2
|
[NCBI]
|
5.54298e-06
|
|
|
CTPS
|
[NCBI]
|
5.54298e-06
|
|
|
SKIIP
|
[NCBI]
|
5.54298e-06
|
|
|
FGF13
|
[NCBI]
|
5.54298e-06
|
|
|
ABCC11
|
[NCBI]
|
5.54298e-06
|
|
|
SPRED1
|
[NCBI]
|
5.54298e-06
|
|
|
TGM5
|
[NCBI]
|
5.54298e-06
|
|
|
DCDC2
|
[NCBI]
|
5.54298e-06
|
|
|
TSTA3
|
[NCBI]
|
5.54298e-06
|
|
|
ETFA
|
[NCBI]
|
5.54298e-06
|
|
|
ESX1L
|
[NCBI]
|
5.54298e-06
|
|
|
PHF8
|
[NCBI]
|
5.54298e-06
|
|
|
TAAR5
|
[NCBI]
|
5.54298e-06
|
|
|
CHMP1A
|
[NCBI]
|
5.54298e-06
|
|
|
DDX5
|
[NCBI]
|
5.54298e-06
|
|
|
ACTR1A
|
[NCBI]
|
5.54298e-06
|
|
|
COQ2
|
[NCBI]
|
5.54298e-06
|
|
|
RHEB2
|
[NCBI]
|
5.54298e-06
|
|
|
PHF6
|
[NCBI]
|
5.54298e-06
|
|
|
EIF2B2
|
[NCBI]
|
5.54298e-06
|
|
|
PUS1
|
[NCBI]
|
5.54298e-06
|
|
|
EVC
|
[NCBI]
|
5.54298e-06
|
|
|
ABAT
|
[NCBI]
|
5.54298e-06
|
|
|
MTX1
|
[NCBI]
|
5.54298e-06
|
|
|
VCX3A
|
[NCBI]
|
5.54298e-06
|
|
|
MYH3
|
[NCBI]
|
5.54298e-06
|
|
|
VPS35
|
[NCBI]
|
5.54298e-06
|
|
|
NTHL1
|
[NCBI]
|
5.54298e-06
|
|
|
STE
|
[NCBI]
|
5.54298e-06
|
|
|
ECEL1
|
[NCBI]
|
5.54298e-06
|
|
|
TJP2
|
[NCBI]
|
5.54298e-06
|
|
|
PDGFC
|
[NCBI]
|
5.54298e-06
|
|
|
NDC80
|
[NCBI]
|
5.54298e-06
|
|
|
ATXN10
|
[NCBI]
|
5.54298e-06
|
|
|
MEF2D
|
[NCBI]
|
5.54298e-06
|
|
|
GBP1
|
[NCBI]
|
5.54298e-06
|
|
|
ERMAP
|
[NCBI]
|
5.54298e-06
|
|
|
CDC45L
|
[NCBI]
|
5.54298e-06
|
|
|
NCK1
|
[NCBI]
|
5.54298e-06
|
|
|
YWHAG
|
[NCBI]
|
5.54298e-06
|
|
|
RPL9
|
[NCBI]
|
5.54298e-06
|
|
|
GDF9
|
[NCBI]
|
5.54298e-06
|
|
|
MYOG
|
[NCBI]
|
5.54298e-06
|
|
|
POU2F3
|
[NCBI]
|
5.54298e-06
|
|
|
CALB3
|
[NCBI]
|
5.54298e-06
|
|
|
KRTHB1
|
[NCBI]
|
5.54298e-06
|
|
|
PASK
|
[NCBI]
|
5.54298e-06
|
|
|
AP1S1
|
[NCBI]
|
5.54298e-06
|
|
|
gustducin, alpha polypeptide
|
[NCBI]
|
5.54298e-06
|
|
|
PLXNA2
|
[NCBI]
|
5.54298e-06
|
|
|
EMILIN1
|
[NCBI]
|
5.54298e-06
|
|
|
RABIF
|
[NCBI]
|
5.54298e-06
|
|
|
MSC
|
[NCBI]
|
5.54298e-06
|
|
|
TXN2
|
[NCBI]
|
5.54298e-06
|
|
|
CRK
|
[NCBI]
|
5.54298e-06
|
|
|
THBS2
|
[NCBI]
|
5.54298e-06
|
|
|
COMMD1
|
[NCBI]
|
5.54298e-06
|
|
|
CLN6
|
[NCBI]
|
5.54298e-06
|
|
|
GDF6
|
[NCBI]
|
5.54298e-06
|
|
|
CCNA1
|
[NCBI]
|
5.54298e-06
|
|
|
SLC6A5
|
[NCBI]
|
5.54298e-06
|
|
|
LAP3
|
[NCBI]
|
5.54298e-06
|
|
|
GSPT1
|
[NCBI]
|
5.54298e-06
|
|
|
ABCD3
|
[NCBI]
|
5.54298e-06
|
|
|
PTK7
|
[NCBI]
|
5.54298e-06
|
|
|
EIF3A
|
[NCBI]
|
5.54298e-06
|
|
|
FRK
|
[NCBI]
|
5.54298e-06
|
|
|
KNSL2
|
[NCBI]
|
5.54298e-06
|
|
|
PIP5K1B
|
[NCBI]
|
5.54298e-06
|
|
|
MTTL2
|
[NCBI]
|
5.54298e-06
|
|
|
PLA2G6
|
[NCBI]
|
5.54298e-06
|
|
|
SHOX2
|
[NCBI]
|
5.54298e-06
|
|
|
STX16
|
[NCBI]
|
5.54298e-06
|
|
|
SEPT2
|
[NCBI]
|
5.54298e-06
|
|
|
PIAS4
|
[NCBI]
|
5.54298e-06
|
|
|
MAF1
|
[NCBI]
|
5.54298e-06
|
|
|
FDH
|
[NCBI]
|
5.45703e-06
|
|
|
hyperekplexia, hereditary
|
[NCBI]
|
5.45703e-06
|
|
|
PAM
|
[NCBI]
|
5.43482e-06
|
|
|
HAE
|
[NCBI]
|
5.43109e-06
|
|
|
mental retardation, fra12a type
|
[NCBI]
|
5.42571e-06
|
|
|
ADCC
|
[NCBI]
|
5.42571e-06
|
|
|
charcot-marie-tooth disease, axonal, type 2b1
|
[NCBI]
|
5.42571e-06
|
|
|
PRTH
|
[NCBI]
|
5.42571e-06
|
|
|
scapuloperoneal syndrome, neurogenic, kaeser type
|
[NCBI]
|
5.42571e-06
|
|
|
DFNA1
|
[NCBI]
|
5.42571e-06
|
|
|
optic atrophy 1 and deafness
|
[NCBI]
|
5.42571e-06
|
|
|
basal ganglia disease, adult-onset
|
[NCBI]
|
5.42571e-06
|
|
|
creatine phosphokinase, elevated serum
|
[NCBI]
|
5.42571e-06
|
|
|
DFNA20
|
[NCBI]
|
5.42571e-06
|
|
|
l-2-hydroxyglutaric aciduria
|
[NCBI]
|
5.42571e-06
|
|
|
alternating hemiplegia of childhood
|
[NCBI]
|
5.42571e-06
|
|
|
ragweed sensitivity
|
[NCBI]
|
5.42571e-06
|
|
|
goldberg-shprintzen megacolon syndrome
|
[NCBI]
|
5.42571e-06
|
|
|
EVR4
|
[NCBI]
|
5.42571e-06
|
|
|
STHAG1
|
[NCBI]
|
5.42571e-06
|
|
|
DFNA5
|
[NCBI]
|
5.42571e-06
|
|
|
bartter syndrome, infantile, with sensorineural deafness
|
[NCBI]
|
5.42571e-06
|
|
|
buschke-ollendorff syndrome
|
[NCBI]
|
5.42571e-06
|
|
|
paget disease, juvenile
|
[NCBI]
|
5.42571e-06
|
|
|
DFNB10
|
[NCBI]
|
5.42571e-06
|
|
|
adenylosuccinase deficiency
|
[NCBI]
|
5.42571e-06
|
|
|
HOA
|
[NCBI]
|
5.42571e-06
|
|
|
stickler syndrome, type i, nonsyndromic ocular
|
[NCBI]
|
5.42571e-06
|
|
|
osseous heteroplasia, progressive
|
[NCBI]
|
5.42571e-06
|
|
|
DFNB8
|
[NCBI]
|
5.42571e-06
|
|
|
uniparental disomy, paternal, chromosome 14
|
[NCBI]
|
5.42571e-06
|
|
|
clark-baraitser syndrome
|
[NCBI]
|
5.42571e-06
|
|
|
SPG13
|
[NCBI]
|
5.42571e-06
|
|
|
ARVD2
|
[NCBI]
|
5.42571e-06
|
|
|
CCM2
|
[NCBI]
|
5.42571e-06
|
|
|
frasier syndrome
|
[NCBI]
|
5.42571e-06
|
|
|
arthrogryposis, renal dysfunction, and cholestasis
|
[NCBI]
|
5.42571e-06
|
|
|
amyloidosis vii
|
[NCBI]
|
5.42571e-06
|
|
|
DFNB18
|
[NCBI]
|
5.42571e-06
|
|
|
choreoathetosis, hypothyroidism, and neonatal respiratory distress
|
[NCBI]
|
5.42571e-06
|
|
|
HPE4
|
[NCBI]
|
5.42571e-06
|
|
|
CNA2
|
[NCBI]
|
5.42571e-06
|
|
|
charcot-marie-tooth disease and deafness
|
[NCBI]
|
5.42571e-06
|
|
|
fibular aplasia or hypoplasia, femoral bowing and poly-, syn-, and oligodactyly
|
[NCBI]
|
5.42571e-06
|
|
|
cataract, lamellar
|
[NCBI]
|
5.42571e-06
|
|
|
ectodermal dysplasia/skin fragility syndrome
|
[NCBI]
|
5.42571e-06
|
|
|
corticosterone methyloxidase type i deficiency
|
[NCBI]
|
5.42571e-06
|
|
|
EHBA
|
[NCBI]
|
5.42571e-06
|
|
|
fumarase deficiency
|
[NCBI]
|
5.42571e-06
|
|
|
RP17
|
[NCBI]
|
5.42571e-06
|
|
|
myotonia, potassium-aggravated
|
[NCBI]
|
5.42571e-06
|
|
|
ATXN7
|
[NCBI]
|
5.32584e-06
|
|
|
PAX1
|
[NCBI]
|
5.32584e-06
|
|
|
IL15
|
[NCBI]
|
5.32584e-06
|
|
|
CBFA2T1
|
[NCBI]
|
5.32584e-06
|
|
|
USH2A
|
[NCBI]
|
5.32584e-06
|
|
|
DNMT3A
|
[NCBI]
|
5.32584e-06
|
|
|
PAK2
|
[NCBI]
|
5.32584e-06
|
|
|
KCNQ1OT1
|
[NCBI]
|
5.32584e-06
|
|
|
RTN4
|
[NCBI]
|
5.32584e-06
|
|
|
MYO6
|
[NCBI]
|
5.32584e-06
|
|
|
COL11A1
|
[NCBI]
|
5.32584e-06
|
|
|
CYP11A1
|
[NCBI]
|
5.32584e-06
|
|
|
COL10A1
|
[NCBI]
|
5.25246e-06
|
|
|
TLR4
|
[NCBI]
|
5.15386e-06
|
|
|
CPI
|
[NCBI]
|
5.1219e-06
|
|
|
factor vii deficiency
|
[NCBI]
|
5.11659e-06
|
|
|
SMA2
|
[NCBI]
|
5.09825e-06
|
|
|
osteoarthritis
|
[NCBI]
|
5.09825e-06
|
|
|
JAK2
|
[NCBI]
|
5.02402e-06
|
|
|
IL3
|
[NCBI]
|
4.95051e-06
|
|
|
ATS
|
[NCBI]
|
4.94484e-06
|
|
|
nijmegen breakage syndrome
|
[NCBI]
|
4.94484e-06
|
|
|
CDG1A
|
[NCBI]
|
4.94484e-06
|
|
|
COH1
|
[NCBI]
|
4.94484e-06
|
|
|
SRC
|
[NCBI]
|
4.94001e-06
|
|
|
HMI
|
[NCBI]
|
4.93927e-06
|
|
|
hemophilia a
|
[NCBI]
|
4.87953e-06
|
|
|
MAP1B
|
[NCBI]
|
4.87315e-06
|
|
|
SURF1
|
[NCBI]
|
4.87307e-06
|
|
|
NEFL
|
[NCBI]
|
4.87307e-06
|
|
|
ITGB4
|
[NCBI]
|
4.87307e-06
|
|
|
GLDC
|
[NCBI]
|
4.87307e-06
|
|
|
UCHL1
|
[NCBI]
|
4.87307e-06
|
|
|
TGFBR1
|
[NCBI]
|
4.87307e-06
|
|
|
HBZ
|
[NCBI]
|
4.87307e-06
|
|
|
TSHB
|
[NCBI]
|
4.87307e-06
|
|
|
ADSL
|
[NCBI]
|
4.87307e-06
|
|
|
TAL1
|
[NCBI]
|
4.87307e-06
|
|
|
SPG7
|
[NCBI]
|
4.87307e-06
|
|
|
SQSTM1
|
[NCBI]
|
4.87307e-06
|
|
|
ACTA1
|
[NCBI]
|
4.87307e-06
|
|
|
USH1C
|
[NCBI]
|
4.87307e-06
|
|
|
NR0B2
|
[NCBI]
|
4.80167e-06
|
|
|
VCP
|
[NCBI]
|
4.80167e-06
|
|
|
CDK4
|
[NCBI]
|
4.77331e-06
|
|
|
myopathy, myofibrillar, desmin-related
|
[NCBI]
|
4.71354e-06
|
|
|
LIP
|
[NCBI]
|
4.71354e-06
|
|
|
ehlers-danlos syndrome, type vi
|
[NCBI]
|
4.71119e-06
|
|
|
DLB
|
[NCBI]
|
4.71119e-06
|
|
|
helicobacter pylori infection, susceptibility to
|
[NCBI]
|
4.71119e-06
|
|
|
pitt syndrome
|
[NCBI]
|
4.71119e-06
|
|
|
lecithin:cholesterol acyltransferase deficiency
|
[NCBI]
|
4.71119e-06
|
|
|
seckel syndrome 1
|
[NCBI]
|
4.71119e-06
|
|
|
VED
|
[NCBI]
|
4.71119e-06
|
|
|
exostoses, multiple, type ii
|
[NCBI]
|
4.71119e-06
|
|
|
HSAN2
|
[NCBI]
|
4.71119e-06
|
|
|
alexander disease
|
[NCBI]
|
4.71119e-06
|
|
|
DMD
|
[NCBI]
|
4.69409e-06
|
|
|
IFNA1
|
[NCBI]
|
4.68135e-06
|
|
|
MAPK1
|
[NCBI]
|
4.68135e-06
|
|
|
PENK
|
[NCBI]
|
4.6539e-06
|
|
|
PRKDC
|
[NCBI]
|
4.64202e-06
|
|
|
IKBKG
|
[NCBI]
|
4.64202e-06
|
|
|
FH
|
[NCBI]
|
4.63889e-06
|
|
|
CES
|
[NCBI]
|
4.62375e-06
|
|
|
ACP5
|
[NCBI]
|
4.58774e-06
|
|
|
KRTHA2
|
[NCBI]
|
4.57313e-06
|
|
|
IFRD1
|
[NCBI]
|
4.57313e-06
|
|
|
EIF2B4
|
[NCBI]
|
4.57313e-06
|
|
|
PSCD3
|
[NCBI]
|
4.57313e-06
|
|
|
MESP2
|
[NCBI]
|
4.57313e-06
|
|
|
CHRNB4
|
[NCBI]
|
4.57313e-06
|
|
|
ARMET
|
[NCBI]
|
4.57313e-06
|
|
|
LTB
|
[NCBI]
|
4.57313e-06
|
|
|
FRS2
|
[NCBI]
|
4.57313e-06
|
|
|
IGFBP4
|
[NCBI]
|
4.57313e-06
|
|
|
NDST1
|
[NCBI]
|
4.57313e-06
|
|
|
NPY5R
|
[NCBI]
|
4.57313e-06
|
|
|
LSS
|
[NCBI]
|
4.57313e-06
|
|
|
ALPPL2
|
[NCBI]
|
4.57313e-06
|
|
|
MYO9B
|
[NCBI]
|
4.57313e-06
|
|
|
ATOX1
|
[NCBI]
|
4.57313e-06
|
|
|
SPTBN1
|
[NCBI]
|
4.57313e-06
|
|
|
PLA2G1B
|
[NCBI]
|
4.57313e-06
|
|
|
NAB1
|
[NCBI]
|
4.57313e-06
|
|
|
NFIX
|
[NCBI]
|
4.57313e-06
|
|
|
TRIM37
|
[NCBI]
|
4.57313e-06
|
|
|
SOX5
|
[NCBI]
|
4.57313e-06
|
|
|
NIPA1
|
[NCBI]
|
4.57313e-06
|
|
|
WNT6
|
[NCBI]
|
4.57313e-06
|
|
|
TMEM142A
|
[NCBI]
|
4.57313e-06
|
|
|
BIK
|
[NCBI]
|
4.57313e-06
|
|
|
BAD
|
[NCBI]
|
4.57313e-06
|
|
|
KCNE2
|
[NCBI]
|
4.57313e-06
|
|
|
NPHS2
|
[NCBI]
|
4.57313e-06
|
|
|
DGKD
|
[NCBI]
|
4.57313e-06
|
|
|
SBF2
|
[NCBI]
|
4.57313e-06
|
|
|
CAMK2D
|
[NCBI]
|
4.57313e-06
|
|
|
FTSJ1
|
[NCBI]
|
4.57313e-06
|
|
|
KIF5A
|
[NCBI]
|
4.57313e-06
|
|
|
HLA-DMA
|
[NCBI]
|
4.57313e-06
|
|
|
RPS16
|
[NCBI]
|
4.57313e-06
|
|
|
CFC1
|
[NCBI]
|
4.57313e-06
|
|
|
anterior pharynx defective 1, c. elegans, homolog of, a
|
[NCBI]
|
4.57313e-06
|
|
|
VGF
|
[NCBI]
|
4.57313e-06
|
|
|
MYL2
|
[NCBI]
|
4.57313e-06
|
|
|
GNLY
|
[NCBI]
|
4.57313e-06
|
|
|
MIRN17
|
[NCBI]
|
4.57313e-06
|
|
|
CSDE1
|
[NCBI]
|
4.57313e-06
|
|
|
GJB4
|
[NCBI]
|
4.57313e-06
|
|
|
POU4F1
|
[NCBI]
|
4.57313e-06
|
|
|
BCOR
|
[NCBI]
|
4.57313e-06
|
|
|
ATP6V1B1
|
[NCBI]
|
4.57313e-06
|
|
|
KDELR1
|
[NCBI]
|
4.57313e-06
|
|
|
MTF1
|
[NCBI]
|
4.57313e-06
|
|
|
ARL6
|
[NCBI]
|
4.57313e-06
|
|
|
PFTK1
|
[NCBI]
|
4.57313e-06
|
|
|
GLI2
|
[NCBI]
|
4.57313e-06
|
|
|
GDF1
|
[NCBI]
|
4.57313e-06
|
|
|
SBDS
|
[NCBI]
|
4.57313e-06
|
|
|
GFRA2
|
[NCBI]
|
4.57313e-06
|
|
|
CTNND1
|
[NCBI]
|
4.57313e-06
|
|
|
GDA
|
[NCBI]
|
4.57313e-06
|
|
|
MYH8
|
[NCBI]
|
4.57313e-06
|
|
|
MAFK
|
[NCBI]
|
4.57313e-06
|
|
|
PCDH8
|
[NCBI]
|
4.57313e-06
|
|
|
GMNN
|
[NCBI]
|
4.57313e-06
|
|
|
TEGT
|
[NCBI]
|
4.57313e-06
|
|
|
PON3
|
[NCBI]
|
4.57313e-06
|
|
|
CHE2
|
[NCBI]
|
4.57313e-06
|
|
|
DNAH9
|
[NCBI]
|
4.57313e-06
|
|
|
activator of crem in testis
|
[NCBI]
|
4.57313e-06
|
|
|
CES2
|
[NCBI]
|
4.57313e-06
|
|
|
AVPR1B
|
[NCBI]
|
4.57313e-06
|
|
|
SUMF1
|
[NCBI]
|
4.57313e-06
|
|
|
RAB8A
|
[NCBI]
|
4.57313e-06
|
|
|
ATP1B1
|
[NCBI]
|
4.57313e-06
|
|
|
ST8SIA1
|
[NCBI]
|
4.57313e-06
|
|
|
GNA13
|
[NCBI]
|
4.57313e-06
|
|
|
P2RX4
|
[NCBI]
|
4.57313e-06
|
|
|
SMS
|
[NCBI]
|
4.57313e-06
|
|
|
VPS4A
|
[NCBI]
|
4.57313e-06
|
|
|
STX11
|
[NCBI]
|
4.57313e-06
|
|
|
MTTF
|
[NCBI]
|
4.57313e-06
|
|
|
CSN10
|
[NCBI]
|
4.57313e-06
|
|
|
LDB2
|
[NCBI]
|
4.57313e-06
|
|
|
FXR2
|
[NCBI]
|
4.57313e-06
|
|
|
ALG6
|
[NCBI]
|
4.57313e-06
|
|
|
POU4F3
|
[NCBI]
|
4.57313e-06
|
|
|
PSCD1
|
[NCBI]
|
4.57313e-06
|
|
|
HNRNPK
|
[NCBI]
|
4.57313e-06
|
|
|
MFRP
|
[NCBI]
|
4.57313e-06
|
|
|
BTNL2
|
[NCBI]
|
4.57313e-06
|
|
|
MPV17
|
[NCBI]
|
4.57313e-06
|
|
|
SYNJ1
|
[NCBI]
|
4.57313e-06
|
|
|
AIM1
|
[NCBI]
|
4.57313e-06
|
|
|
HSD17B3
|
[NCBI]
|
4.57313e-06
|
|
|
IGSF1
|
[NCBI]
|
4.57313e-06
|
|
|
regulatory associated protein of mtor
|
[NCBI]
|
4.57313e-06
|
|
|
TBX19
|
[NCBI]
|
4.57313e-06
|
|
|
SEPT6
|
[NCBI]
|
4.57313e-06
|
|
|
UBE2B
|
[NCBI]
|
4.57313e-06
|
|
|
BACE2
|
[NCBI]
|
4.57313e-06
|
|
|
FANCM
|
[NCBI]
|
4.57313e-06
|
|
|
VPS4B
|
[NCBI]
|
4.57313e-06
|
|
|
TGFB1I1
|
[NCBI]
|
4.57313e-06
|
|
|
SAI1
|
[NCBI]
|
4.57313e-06
|
|
|
COX10
|
[NCBI]
|
4.57313e-06
|
|
|
COQ7
|
[NCBI]
|
4.57313e-06
|
|
|
KALRN
|
[NCBI]
|
4.57313e-06
|
|
|
NDST2
|
[NCBI]
|
4.57313e-06
|
|
|
DACH1
|
[NCBI]
|
4.57313e-06
|
|
|
SEMA3E
|
[NCBI]
|
4.57313e-06
|
|
|
HOXB2
|
[NCBI]
|
4.57313e-06
|
|
|
NOD1
|
[NCBI]
|
4.57313e-06
|
|
|
C20ORF1
|
[NCBI]
|
4.57313e-06
|
|
|
bkm dna
|
[NCBI]
|
4.57313e-06
|
|
|
PITPNM1
|
[NCBI]
|
4.57313e-06
|
|
|
P2RY1
|
[NCBI]
|
4.57313e-06
|
|
|
CNTN4
|
[NCBI]
|
4.57313e-06
|
|
|
CRMP1
|
[NCBI]
|
4.57313e-06
|
|
|
RBL2
|
[NCBI]
|
4.57313e-06
|
|
|
ANKK1
|
[NCBI]
|
4.57313e-06
|
|
|
AGPAT2
|
[NCBI]
|
4.57313e-06
|
|
|
RFWD2
|
[NCBI]
|
4.57313e-06
|
|
|
PHF9
|
[NCBI]
|
4.57313e-06
|
|
|
krabbe disease
|
[NCBI]
|
4.57035e-06
|
|
|
PC
|
[NCBI]
|
4.55894e-06
|
|
|
IP
|
[NCBI]
|
4.49807e-06
|
|
|
3-@beta-hydroxysteroid dehydrogenase, type ii, deficiency of
|
[NCBI]
|
4.45719e-06
|
|
|
RETN
|
[NCBI]
|
4.45719e-06
|
|
|
FGF3
|
[NCBI]
|
4.45719e-06
|
|
|
FLT4
|
[NCBI]
|
4.45719e-06
|
|
|
HADHA
|
[NCBI]
|
4.45719e-06
|
|
|
TKT
|
[NCBI]
|
4.45719e-06
|
|
|
TNFRSF13B
|
[NCBI]
|
4.45719e-06
|
|
|
EP300
|
[NCBI]
|
4.45719e-06
|
|
|
DRD4
|
[NCBI]
|
4.44494e-06
|
|
|
B2M
|
[NCBI]
|
4.41343e-06
|
|
|
HNPP
|
[NCBI]
|
4.4081e-06
|
|
|
NF2
|
[NCBI]
|
4.4081e-06
|
|
|
CCR5
|
[NCBI]
|
4.36171e-06
|
|
|
INCENP
|
[NCBI]
|
4.3598e-06
|
|
|
PIGA
|
[NCBI]
|
4.3598e-06
|
|
|
IGKC
|
[NCBI]
|
4.3598e-06
|
|
|
FGFR1
|
[NCBI]
|
4.31362e-06
|
|
|
hypophosphatemic rickets, x-linked dominant
|
[NCBI]
|
4.27821e-06
|
|
|
DFNB1
|
[NCBI]
|
4.26884e-06
|
|
|
RCDP1
|
[NCBI]
|
4.26884e-06
|
|
|
HYPP
|
[NCBI]
|
4.26278e-06
|
|
|
mucolipidosis ii
|
[NCBI]
|
4.26278e-06
|
|
|
LOX
|
[NCBI]
|
4.25968e-06
|
|
|
HNF1A
|
[NCBI]
|
4.25679e-06
|
|
|
CCL2
|
[NCBI]
|
4.21734e-06
|
|
|
REG3A
|
[NCBI]
|
4.21734e-06
|
|
|
alopecia, androgenetic
|
[NCBI]
|
4.1793e-06
|
|
|
NLS
|
[NCBI]
|
4.1402e-06
|
|
|
AVPR2
|
[NCBI]
|
4.09177e-06
|
|
|
LRRK2
|
[NCBI]
|
4.08008e-06
|
|
|
CPB2
|
[NCBI]
|
4.07898e-06
|
|
|
udp-n-acetylglucosamine 2-epimerase/n-acetylmannosamine kinase
|
[NCBI]
|
4.07442e-06
|
|
|
RAG2
|
[NCBI]
|
4.07442e-06
|
|
|
NEU1
|
[NCBI]
|
4.07442e-06
|
|
|
WNK1
|
[NCBI]
|
4.07442e-06
|
|
|
AMELX
|
[NCBI]
|
4.07442e-06
|
|
|
ERCC6
|
[NCBI]
|
4.07442e-06
|
|
|
NCSTN
|
[NCBI]
|
4.07442e-06
|
|
|
GALK1
|
[NCBI]
|
4.07442e-06
|
|
|
PHOX2B
|
[NCBI]
|
4.07442e-06
|
|
|
CYP2C19
|
[NCBI]
|
4.07442e-06
|
|
|
CSNB1A
|
[NCBI]
|
4.00639e-06
|
|
|
DRD
|
[NCBI]
|
4.00639e-06
|
|
|
sudden infant death syndrome
|
[NCBI]
|
4.00639e-06
|
|
|
CDC2
|
[NCBI]
|
3.93224e-06
|
|
|
digeorge syndrome/velocardiofacial syndrome spectrum of malformation 2
|
[NCBI]
|
3.86535e-06
|
|
|
IBD2
|
[NCBI]
|
3.86535e-06
|
|
|
short rib-polydactyly syndrome, type iv
|
[NCBI]
|
3.86535e-06
|
|
|
constricting bands, congenital
|
[NCBI]
|
3.86535e-06
|
|
|
CDB2
|
[NCBI]
|
3.86535e-06
|
|
|
SLC6A3
|
[NCBI]
|
3.85337e-06
|
|
|
CCM
|
[NCBI]
|
3.85254e-06
|
|
|
MTCO1
|
[NCBI]
|
3.83718e-06
|
|
|
VNN1
|
[NCBI]
|
3.80502e-06
|
|
|
CLCN3
|
[NCBI]
|
3.80502e-06
|
|
|
LTBR
|
[NCBI]
|
3.80502e-06
|
|
|
PHKB
|
[NCBI]
|
3.80502e-06
|
|
|
CCL7
|
[NCBI]
|
3.80502e-06
|
|
|
TTID
|
[NCBI]
|
3.80502e-06
|
|
|
ABCD2
|
[NCBI]
|
3.80502e-06
|
|
|
CTNNA2
|
[NCBI]
|
3.80502e-06
|
|
|
SUFU
|
[NCBI]
|
3.80502e-06
|
|
|
PSMC3IP
|
[NCBI]
|
3.80502e-06
|
|
|
PRPS2
|
[NCBI]
|
3.80502e-06
|
|
|
ATP2B1
|
[NCBI]
|
3.80502e-06
|
|
|
PRB2
|
[NCBI]
|
3.80502e-06
|
|
|
ARIX
|
[NCBI]
|
3.80502e-06
|
|
|
KCNQ3
|
[NCBI]
|
3.80502e-06
|
|
|
MLYCD
|
[NCBI]
|
3.80502e-06
|
|
|
CRYM
|
[NCBI]
|
3.80502e-06
|
|
|
TRPV5
|
[NCBI]
|
3.80502e-06
|
|
|
MDH2
|
[NCBI]
|
3.80502e-06
|
|
|
LHX2
|
[NCBI]
|
3.80502e-06
|
|
|
CDKN2D
|
[NCBI]
|
3.80502e-06
|
|
|
DGCR14
|
[NCBI]
|
3.80502e-06
|
|
|
IL23A
|
[NCBI]
|
3.80502e-06
|
|
|
PCMT1
|
[NCBI]
|
3.80502e-06
|
|
|
ROBO2
|
[NCBI]
|
3.80502e-06
|
|
|
ESCO2
|
[NCBI]
|
3.80502e-06
|
|
|
NDUFS8
|
[NCBI]
|
3.80502e-06
|
|
|
TCF8
|
[NCBI]
|
3.80502e-06
|
|
|
PHKG2
|
[NCBI]
|
3.80502e-06
|
|
|
PCDH11Y
|
[NCBI]
|
3.80502e-06
|
|
|
RBMY1A1
|
[NCBI]
|
3.80502e-06
|
|
|
IL1R1
|
[NCBI]
|
3.80502e-06
|
|
|
locus control region, beta
|
[NCBI]
|
3.80502e-06
|
|
|
S100A9
|
[NCBI]
|
3.80502e-06
|
|
|
UNC5C
|
[NCBI]
|
3.80502e-06
|
|
|
TAP2
|
[NCBI]
|
3.80502e-06
|
|
|
CAPN1
|
[NCBI]
|
3.80502e-06
|
|
|
RABGGTA
|
[NCBI]
|
3.80502e-06
|
|
|
MYH10
|
[NCBI]
|
3.80502e-06
|
|
|
WHSC2
|
[NCBI]
|
3.80502e-06
|
|
|
SMC3
|
[NCBI]
|
3.80502e-06
|
|
|
XRCC3
|
[NCBI]
|
3.80502e-06
|
|
|
SNAI1
|
[NCBI]
|
3.80502e-06
|
|
|
E2F3
|
[NCBI]
|
3.80502e-06
|
|
|
RYK
|
[NCBI]
|
3.80502e-06
|
|
|
PMX1
|
[NCBI]
|
3.80502e-06
|
|
|
CSNK2A2
|
[NCBI]
|
3.80502e-06
|
|
|
PTPRZ1
|
[NCBI]
|
3.80502e-06
|
|
|
ITM2A
|
[NCBI]
|
3.80502e-06
|
|
|
TLR10
|
[NCBI]
|
3.80502e-06
|
|
|
DBY
|
[NCBI]
|
3.80502e-06
|
|
|
LHX4
|
[NCBI]
|
3.80502e-06
|
|
|
DYX1C1
|
[NCBI]
|
3.80502e-06
|
|
|
HLA-DPB1
|
[NCBI]
|
3.80502e-06
|
|
|
TNR
|
[NCBI]
|
3.80502e-06
|
|
|
PDE6G
|
[NCBI]
|
3.80502e-06
|
|
|
VPS13A
|
[NCBI]
|
3.80502e-06
|
|
|
SATB2
|
[NCBI]
|
3.80502e-06
|
|
|
UCHL3
|
[NCBI]
|
3.80502e-06
|
|
|
FTO
|
[NCBI]
|
3.80502e-06
|
|
|
RORB
|
[NCBI]
|
3.80502e-06
|
|
|
BCL11A
|
[NCBI]
|
3.80502e-06
|
|
|
MAFG
|
[NCBI]
|
3.80502e-06
|
|
|
FOSB
|
[NCBI]
|
3.80502e-06
|
|
|
TICAM1
|
[NCBI]
|
3.80502e-06
|
|
|
LCP2
|
[NCBI]
|
3.80502e-06
|
|
|
NHLH1
|
[NCBI]
|
3.80502e-06
|
|
|
IL24
|
[NCBI]
|
3.80502e-06
|
|
|
FBLN5
|
[NCBI]
|
3.80502e-06
|
|
|
FABP4
|
[NCBI]
|
3.80502e-06
|
|
|
WHRN
|
[NCBI]
|
3.80502e-06
|
|
|
NPPC
|
[NCBI]
|
3.80502e-06
|
|
|
ABCC4
|
[NCBI]
|
3.80502e-06
|
|
|
PPP1R3A
|
[NCBI]
|
3.80502e-06
|
|
|
TNNT1
|
[NCBI]
|
3.80502e-06
|
|
|
KLRA1
|
[NCBI]
|
3.80502e-06
|
|
|
HAGH
|
[NCBI]
|
3.80502e-06
|
|
|
XRCC4
|
[NCBI]
|
3.80502e-06
|
|
|
EPHB3
|
[NCBI]
|
3.80502e-06
|
|
|
DNMT3L
|
[NCBI]
|
3.80502e-06
|
|
|
NFKB1
|
[NCBI]
|
3.78677e-06
|
|
|
growth hormone insensitivity syndrome
|
[NCBI]
|
3.74071e-06
|
|
|
NRL
|
[NCBI]
|
3.7215e-06
|
|
|
CUBN
|
[NCBI]
|
3.7215e-06
|
|
|
CR1
|
[NCBI]
|
3.7215e-06
|
|
|
PYGM
|
[NCBI]
|
3.7215e-06
|
|
|
SLC2A1
|
[NCBI]
|
3.7215e-06
|
|
|
DSP
|
[NCBI]
|
3.7215e-06
|
|
|
CTSD
|
[NCBI]
|
3.7215e-06
|
|
|
TBX5
|
[NCBI]
|
3.7215e-06
|
|
|
HR
|
[NCBI]
|
3.7215e-06
|
|
|
GPR54
|
[NCBI]
|
3.7215e-06
|
|
|
CPT2
|
[NCBI]
|
3.7215e-06
|
|
|
refsum disease
|
[NCBI]
|
3.69961e-06
|
|
|
MVA
|
[NCBI]
|
3.69961e-06
|
|
|
thyroid hormonogenesis, genetic defect in, 2a
|
[NCBI]
|
3.69961e-06
|
|
|
hyperlipoproteinemia, type i
|
[NCBI]
|
3.69961e-06
|
|
|
TH
|
[NCBI]
|
3.67037e-06
|
|
|
PRLH
|
[NCBI]
|
3.65222e-06
|
|
|
mitochondrial myopathy with diabetes
|
[NCBI]
|
3.64907e-06
|
|
|
KNO
|
[NCBI]
|
3.64907e-06
|
|
|
xeroderma pigmentosum, complementation group e
|
[NCBI]
|
3.64907e-06
|
|
|
cardiomyopathy, familial hypertrophic, with wolff-parkinson-white syndrome
|
[NCBI]
|
3.64907e-06
|
|
|
SCA5
|
[NCBI]
|
3.64907e-06
|
|
|
MCOPS9
|
[NCBI]
|
3.64907e-06
|
|
|
MPD1
|
[NCBI]
|
3.64907e-06
|
|
|
HHRH
|
[NCBI]
|
3.64907e-06
|
|
|
hyperthyroidism, nonautoimmune
|
[NCBI]
|
3.64907e-06
|
|
|
winchester syndrome
|
[NCBI]
|
3.64907e-06
|
|
|
ichthyosis, bullous type
|
[NCBI]
|
3.64907e-06
|
|
|
mental health wellness 2
|
[NCBI]
|
3.64907e-06
|
|
|
myasthenic syndrome, congenital, fast-channel
|
[NCBI]
|
3.64907e-06
|
|
|
CCA2
|
[NCBI]
|
3.64907e-06
|
|
|
avascular necrosis of femoral head, primary
|
[NCBI]
|
3.64907e-06
|
|
|
PC1
|
[NCBI]
|
3.64907e-06
|
|
|
endometrial cancer
|
[NCBI]
|
3.64907e-06
|
|
|
SHEP3
|
[NCBI]
|
3.64907e-06
|
|
|
CZP3
|
[NCBI]
|
3.64907e-06
|
|
|
hand-foot-uterus syndrome
|
[NCBI]
|
3.64907e-06
|
|
|
charcot-marie-tooth disease, dominant intermediate b
|
[NCBI]
|
3.64907e-06
|
|
|
vater association
|
[NCBI]
|
3.64907e-06
|
|
|
HNSCC
|
[NCBI]
|
3.64907e-06
|
|
|
three m syndrome
|
[NCBI]
|
3.64907e-06
|
|
|
wolfram syndrome, mitochondrial form
|
[NCBI]
|
3.64907e-06
|
|
|
methylcobalamin deficiency, cblg type
|
[NCBI]
|
3.64907e-06
|
|
|
acromesomelic dysplasia, hunter-thompson type
|
[NCBI]
|
3.64907e-06
|
|
|
pierson syndrome
|
[NCBI]
|
3.64907e-06
|
|
|
FSGS1
|
[NCBI]
|
3.64907e-06
|
|
|
weill-marchesani syndrome, autosomal recessive
|
[NCBI]
|
3.64907e-06
|
|
|
AN1
|
[NCBI]
|
3.64907e-06
|
|
|
cerebral palsy, spastic, symmetric, autosomal recessive
|
[NCBI]
|
3.64907e-06
|
|
|
foveal hypoplasia and presenile cataract syndrome
|
[NCBI]
|
3.64907e-06
|
|
|
polymicrogyria, bilateral frontoparietal
|
[NCBI]
|
3.64907e-06
|
|
|
agammaglobulinemia, non-bruton type, autosomal recessive
|
[NCBI]
|
3.64907e-06
|
|
|
XRN
|
[NCBI]
|
3.64907e-06
|
|
|
EAD
|
[NCBI]
|
3.64907e-06
|
|
|
radioulnar synostosis
|
[NCBI]
|
3.64907e-06
|
|
|
TRPS2
|
[NCBI]
|
3.6428e-06
|
|
|
HGPS
|
[NCBI]
|
3.63021e-06
|
|
|
CHH
|
[NCBI]
|
3.63021e-06
|
|
|
KRT20
|
[NCBI]
|
3.61538e-06
|
|
|
MICA
|
[NCBI]
|
3.5953e-06
|
|
|
TPI1
|
[NCBI]
|
3.5953e-06
|
|
|
ADRB2
|
[NCBI]
|
3.5953e-06
|
|
|
DRD2
|
[NCBI]
|
3.59346e-06
|
|
|
HBG1
|
[NCBI]
|
3.5738e-06
|
|
|
HEMB
|
[NCBI]
|
3.53366e-06
|
|
|
POF1
|
[NCBI]
|
3.53227e-06
|
|
|
DAR
|
[NCBI]
|
3.53227e-06
|
|
|
SRF
|
[NCBI]
|
3.5185e-06
|
|
|
ESR1
|
[NCBI]
|
3.51504e-06
|
|
|
UGT1A1
|
[NCBI]
|
3.51421e-06
|
|
|
IRS1
|
[NCBI]
|
3.51421e-06
|
|
|
CHM
|
[NCBI]
|
3.45264e-06
|
|
|
CASP3
|
[NCBI]
|
3.39565e-06
|
|
|
DBH
|
[NCBI]
|
3.39565e-06
|
|
|
ADAMTS13
|
[NCBI]
|
3.39565e-06
|
|
|
AMPD1
|
[NCBI]
|
3.39565e-06
|
|
|
SLC5A5
|
[NCBI]
|
3.39565e-06
|
|
|
MPL
|
[NCBI]
|
3.39565e-06
|
|
|
PLOD1
|
[NCBI]
|
3.39565e-06
|
|
|
DLK1
|
[NCBI]
|
3.39565e-06
|
|
|
PRLR
|
[NCBI]
|
3.3901e-06
|
|
|
GRB2
|
[NCBI]
|
3.37758e-06
|
|
|
DSG1
|
[NCBI]
|
3.36548e-06
|
|
|
HNMT
|
[NCBI]
|
3.36548e-06
|
|
|
thrombocythemia, essential
|
[NCBI]
|
3.3389e-06
|
|
|
hepatitis c virus, susceptibility to
|
[NCBI]
|
3.3389e-06
|
|
|
pulmonary fibrosis, idiopathic
|
[NCBI]
|
3.3389e-06
|
|
|
donohue syndrome
|
[NCBI]
|
3.3389e-06
|
|
|
GTS
|
[NCBI]
|
3.31312e-06
|
|
|
HPRT1
|
[NCBI]
|
3.26805e-06
|
|
|
ST8
|
[NCBI]
|
3.23445e-06
|
|
|
megacystis-microcolon-intestinal hypoperistalsis syndrome
|
[NCBI]
|
3.23445e-06
|
|
|
myoclonic epilepsy of unverricht and lundborg
|
[NCBI]
|
3.23101e-06
|
|
|
CTNS
|
[NCBI]
|
3.23101e-06
|
|
|
aHUS
|
[NCBI]
|
3.23101e-06
|
|
|
KSR1
|
[NCBI]
|
3.1803e-06
|
|
|
SIL1
|
[NCBI]
|
3.1803e-06
|
|
|
HADHB
|
[NCBI]
|
3.1803e-06
|
|
|
FCGRT
|
[NCBI]
|
3.1803e-06
|
|
|
SMAD1
|
[NCBI]
|
3.1803e-06
|
|
|
ADAM15
|
[NCBI]
|
3.1803e-06
|
|
|
CAMK2G
|
[NCBI]
|
3.1803e-06
|
|
|
PROZ
|
[NCBI]
|
3.1803e-06
|
|
|
FSCN1
|
[NCBI]
|
3.1803e-06
|
|
|
AMOT
|
[NCBI]
|
3.1803e-06
|
|
|
HAND2
|
[NCBI]
|
3.1803e-06
|
|
|
GPR77
|
[NCBI]
|
3.1803e-06
|
|
|
PAI2
|
[NCBI]
|
3.1803e-06
|
|
|
ANGPTL3
|
[NCBI]
|
3.1803e-06
|
|
|
COL9A3
|
[NCBI]
|
3.1803e-06
|
|
|
HSD17B1
|
[NCBI]
|
3.1803e-06
|
|
|
GALR2
|
[NCBI]
|
3.1803e-06
|
|
|
SLC2A5
|
[NCBI]
|
3.1803e-06
|
|
|
VKORC1
|
[NCBI]
|
3.1803e-06
|
|
|
ATP2A3
|
[NCBI]
|
3.1803e-06
|
|
|
cocaine- and amphetamine-regulated transcript
|
[NCBI]
|
3.1803e-06
|
|
|
MAP2K4
|
[NCBI]
|
3.1803e-06
|
|
|
ELK3
|
[NCBI]
|
3.1803e-06
|
|
|
PSTPIP1
|
[NCBI]
|
3.1803e-06
|
|
|
TDP1
|
[NCBI]
|
3.1803e-06
|
|
|
GFRA1
|
[NCBI]
|
3.1803e-06
|
|
|
JAM1
|
[NCBI]
|
3.1803e-06
|
|
|
EVC2
|
[NCBI]
|
3.1803e-06
|
|
|
PDXK
|
[NCBI]
|
3.1803e-06
|
|
|
E2F4
|
[NCBI]
|
3.1803e-06
|
|
|
USP9Y
|
[NCBI]
|
3.1803e-06
|
|
|
TTK
|
[NCBI]
|
3.1803e-06
|
|
|
GCGR
|
[NCBI]
|
3.1803e-06
|
|
|
GATA6
|
[NCBI]
|
3.1803e-06
|
|
|
MAP3K14
|
[NCBI]
|
3.1803e-06
|
|
|
BMP5
|
[NCBI]
|
3.1803e-06
|
|
|
CHRM1
|
[NCBI]
|
3.1803e-06
|
|
|
TMC1
|
[NCBI]
|
3.1803e-06
|
|
|
ZFP36L1
|
[NCBI]
|
3.1803e-06
|
|
|
NT5C3
|
[NCBI]
|
3.1803e-06
|
|
|
tl antigen
|
[NCBI]
|
3.1803e-06
|
|
|
SLC25A13
|
[NCBI]
|
3.1803e-06
|
|
|
SMC1A
|
[NCBI]
|
3.1803e-06
|
|
|
SLC22A4
|
[NCBI]
|
3.1803e-06
|
|
|
SLC10A2
|
[NCBI]
|
3.1803e-06
|
|
|
LILRB1
|
[NCBI]
|
3.1803e-06
|
|
|
ACVR2B
|
[NCBI]
|
3.1803e-06
|
|
|
TBL1X
|
[NCBI]
|
3.1803e-06
|
|
|
CENPE
|
[NCBI]
|
3.1803e-06
|
|
|
NR1H2
|
[NCBI]
|
3.1803e-06
|
|
|
LAMP1
|
[NCBI]
|
3.1803e-06
|
|
|
GNB2L1
|
[NCBI]
|
3.1803e-06
|
|
|
PFKP
|
[NCBI]
|
3.1803e-06
|
|
|
RENT1
|
[NCBI]
|
3.1803e-06
|
|
|
SEPN1
|
[NCBI]
|
3.1803e-06
|
|
|
MLLT7
|
[NCBI]
|
3.1803e-06
|
|
|
TMPRSS3
|
[NCBI]
|
3.1803e-06
|
|
|
CLDN14
|
[NCBI]
|
3.1803e-06
|
|
|
YWHAE
|
[NCBI]
|
3.1803e-06
|
|
|
MOCS2
|
[NCBI]
|
3.1803e-06
|
|
|
INHBB
|
[NCBI]
|
3.1803e-06
|
|
|
ERRFI1
|
[NCBI]
|
3.1803e-06
|
|
|
PROM1
|
[NCBI]
|
3.1803e-06
|
|
|
EPB72
|
[NCBI]
|
3.1803e-06
|
|
|
CUL4B
|
[NCBI]
|
3.1803e-06
|
|
|
RLN1
|
[NCBI]
|
3.1803e-06
|
|
|
APLP1
|
[NCBI]
|
3.1803e-06
|
|
|
TST
|
[NCBI]
|
3.1803e-06
|
|
|
EDG3
|
[NCBI]
|
3.1803e-06
|
|
|
POFUT1
|
[NCBI]
|
3.1803e-06
|
|
|
ANPEP
|
[NCBI]
|
3.1803e-06
|
|
|
CHMP2B
|
[NCBI]
|
3.1803e-06
|
|
|
KIF1B
|
[NCBI]
|
3.1803e-06
|
|
|
MYST3
|
[NCBI]
|
3.1803e-06
|
|
|
ABCB11
|
[NCBI]
|
3.16941e-06
|
|
|
fucosidosis
|
[NCBI]
|
3.14712e-06
|
|
|
TNFRSF1B
|
[NCBI]
|
3.14712e-06
|
|
|
GRN
|
[NCBI]
|
3.14712e-06
|
|
|
SNCA
|
[NCBI]
|
3.11335e-06
|
|
|
CLTC
|
[NCBI]
|
3.09447e-06
|
|
|
FOS
|
[NCBI]
|
3.09447e-06
|
|
|
CASP8
|
[NCBI]
|
3.09447e-06
|
|
|
NKX2-1
|
[NCBI]
|
3.09447e-06
|
|
|
CPD
|
[NCBI]
|
3.09447e-06
|
|
|
TCOF1
|
[NCBI]
|
3.09447e-06
|
|
|
CTSB
|
[NCBI]
|
3.09447e-06
|
|
|
CRY2
|
[NCBI]
|
3.09447e-06
|
|
|
MTS
|
[NCBI]
|
3.08156e-06
|
|
|
FOP
|
[NCBI]
|
3.08156e-06
|
|
|
ASL
|
[NCBI]
|
3.05655e-06
|
|
|
IGF1
|
[NCBI]
|
3.05655e-06
|
|
|
MMP9
|
[NCBI]
|
3.05655e-06
|
|
|
ATF3
|
[NCBI]
|
2.97648e-06
|
|
|
HNF4A
|
[NCBI]
|
2.89112e-06
|
|
|
RP1
|
[NCBI]
|
2.88165e-06
|
|
|
PLTP
|
[NCBI]
|
2.84888e-06
|
|
|
OFD1
|
[NCBI]
|
2.84549e-06
|
|
|
EA2
|
[NCBI]
|
2.84549e-06
|
|
|
pituitary dwarfism i
|
[NCBI]
|
2.84549e-06
|
|
|
FTLDU
|
[NCBI]
|
2.84549e-06
|
|
|
ACOX1
|
[NCBI]
|
2.81585e-06
|
|
|
CASP1
|
[NCBI]
|
2.81585e-06
|
|
|
IRF1
|
[NCBI]
|
2.81585e-06
|
|
|
DRPLA
|
[NCBI]
|
2.81585e-06
|
|
|
LFS1
|
[NCBI]
|
2.75063e-06
|
|
|
TCRG
|
[NCBI]
|
2.7426e-06
|
|
|
VIM
|
[NCBI]
|
2.73263e-06
|
|
|
SLC2A2
|
[NCBI]
|
2.71688e-06
|
|
|
HSAN1
|
[NCBI]
|
2.71485e-06
|
|
|
MS
|
[NCBI]
|
2.70495e-06
|
|
|
DRPLA
|
[NCBI]
|
2.70105e-06
|
|
|
STAT6
|
[NCBI]
|
2.69535e-06
|
|
|
MTHFR
|
[NCBI]
|
2.69535e-06
|
|
|
AZGP1
|
[NCBI]
|
2.66277e-06
|
|
|
ST7
|
[NCBI]
|
2.66277e-06
|
|
|
CYP3A7
|
[NCBI]
|
2.66277e-06
|
|
|
VIL
|
[NCBI]
|
2.66277e-06
|
|
|
EDNRA
|
[NCBI]
|
2.66277e-06
|
|
|
CHX10
|
[NCBI]
|
2.66277e-06
|
|
|
PDE4A
|
[NCBI]
|
2.66277e-06
|
|
|
CFHR1
|
[NCBI]
|
2.66277e-06
|
|
|
TDGF1
|
[NCBI]
|
2.66277e-06
|
|
|
CASP10
|
[NCBI]
|
2.66277e-06
|
|
|
CLEC7A
|
[NCBI]
|
2.66277e-06
|
|
|
CHRD
|
[NCBI]
|
2.66277e-06
|
|
|
ARD1A
|
[NCBI]
|
2.66277e-06
|
|
|
SCYE1
|
[NCBI]
|
2.66277e-06
|
|
|
SIM2
|
[NCBI]
|
2.66277e-06
|
|
|
NOTCH4
|
[NCBI]
|
2.66277e-06
|
|
|
SDC3
|
[NCBI]
|
2.66277e-06
|
|
|
SIRT3
|
[NCBI]
|
2.66277e-06
|
|
|
MST1R
|
[NCBI]
|
2.66277e-06
|
|
|
DAB1
|
[NCBI]
|
2.66277e-06
|
|
|
ICMT
|
[NCBI]
|
2.66277e-06
|
|
|
SEMA7A
|
[NCBI]
|
2.66277e-06
|
|
|
IGFBP5
|
[NCBI]
|
2.66277e-06
|
|
|
CYSLTR1
|
[NCBI]
|
2.66277e-06
|
|
|
PGAM1
|
[NCBI]
|
2.66277e-06
|
|
|
LAMC2
|
[NCBI]
|
2.66277e-06
|
|
|
FACL2
|
[NCBI]
|
2.66277e-06
|
|
|
COL9A2
|
[NCBI]
|
2.66277e-06
|
|
|
GNAL
|
[NCBI]
|
2.66277e-06
|
|
|
AHI1
|
[NCBI]
|
2.66277e-06
|
|
|
HOXC8
|
[NCBI]
|
2.66277e-06
|
|
|
AK3
|
[NCBI]
|
2.66277e-06
|
|
|
TFAP2C
|
[NCBI]
|
2.66277e-06
|
|
|
ADORA2A
|
[NCBI]
|
2.66277e-06
|
|
|
SNAI2
|
[NCBI]
|
2.66277e-06
|
|
|
DUSP1
|
[NCBI]
|
2.66277e-06
|
|
|
TBCE
|
[NCBI]
|
2.66277e-06
|
|
|
SLC2A8
|
[NCBI]
|
2.66277e-06
|
|
|
CRLF1
|
[NCBI]
|
2.66277e-06
|
|
|
PKP2
|
[NCBI]
|
2.66277e-06
|
|
|
NRG2
|
[NCBI]
|
2.66277e-06
|
|
|
BCKDHB
|
[NCBI]
|
2.66277e-06
|
|
|
PDCD6IP
|
[NCBI]
|
2.66277e-06
|
|
|
NTS
|
[NCBI]
|
2.66277e-06
|
|
|
MKKS
|
[NCBI]
|
2.66277e-06
|
|
|
HBQ1
|
[NCBI]
|
2.66277e-06
|
|
|
LEPRE1
|
[NCBI]
|
2.66277e-06
|
|
|
IDH2
|
[NCBI]
|
2.66277e-06
|
|
|
CD34
|
[NCBI]
|
2.66277e-06
|
|
|
HCF2
|
[NCBI]
|
2.66277e-06
|
|
|
OPRD1
|
[NCBI]
|
2.66277e-06
|
|
|
GAB2
|
[NCBI]
|
2.66277e-06
|
|
|
CD3D
|
[NCBI]
|
2.66277e-06
|
|
|
IGFBP2
|
[NCBI]
|
2.66277e-06
|
|
|
VDAC1
|
[NCBI]
|
2.66277e-06
|
|
|
OPHN1
|
[NCBI]
|
2.66277e-06
|
|
|
PRLHR
|
[NCBI]
|
2.66277e-06
|
|
|
CITED2
|
[NCBI]
|
2.66277e-06
|
|
|
ADCY1
|
[NCBI]
|
2.66277e-06
|
|
|
PPP2R2B
|
[NCBI]
|
2.66277e-06
|
|
|
1-@aminocyclopropane-1-carboxylate synthase
|
[NCBI]
|
2.66277e-06
|
|
|
HOXD3
|
[NCBI]
|
2.66277e-06
|
|
|
MPG
|
[NCBI]
|
2.66277e-06
|
|
|
ACTN3
|
[NCBI]
|
2.66277e-06
|
|
|
SFRS1
|
[NCBI]
|
2.66277e-06
|
|
|
MLF1
|
[NCBI]
|
2.66277e-06
|
|
|
ACVR2
|
[NCBI]
|
2.66277e-06
|
|
|
MCP
|
[NCBI]
|
2.60373e-06
|
|
|
DWS
|
[NCBI]
|
2.59685e-06
|
|
|
CYP19A1
|
[NCBI]
|
2.57928e-06
|
|
|
BMD
|
[NCBI]
|
2.57602e-06
|
|
|
pyruvate kinase deficiency of red cells
|
[NCBI]
|
2.57602e-06
|
|
|
KITLG
|
[NCBI]
|
2.55806e-06
|
|
|
TGM1
|
[NCBI]
|
2.55794e-06
|
|
|
MYO5A
|
[NCBI]
|
2.55794e-06
|
|
|
SOCS1
|
[NCBI]
|
2.55542e-06
|
|
|
CDKN2A
|
[NCBI]
|
2.49312e-06
|
|
|
MITF
|
[NCBI]
|
2.49312e-06
|
|
|
A2M
|
[NCBI]
|
2.464e-06
|
|
|
ENG
|
[NCBI]
|
2.37769e-06
|
|
|
takayasu arteritis
|
[NCBI]
|
2.35529e-06
|
|
|
opitz syndrome
|
[NCBI]
|
2.35529e-06
|
|
|
vitiligo
|
[NCBI]
|
2.35529e-06
|
|
|
EPD
|
[NCBI]
|
2.35529e-06
|
|
|
CMT4B1
|
[NCBI]
|
2.35529e-06
|
|
|
GLYS1
|
[NCBI]
|
2.35529e-06
|
|
|
AITD3
|
[NCBI]
|
2.35529e-06
|
|
|
cystathioninuria
|
[NCBI]
|
2.35529e-06
|
|
|
MFS2
|
[NCBI]
|
2.35529e-06
|
|
|
vacterl association with hydrocephalus, x-linked
|
[NCBI]
|
2.35529e-06
|
|
|
progressive external ophthalmoplegia with mitochondrial dna deletions, autosomal dominant, 3
|
[NCBI]
|
2.35529e-06
|
|
|
hypertriglyceridemia, familial
|
[NCBI]
|
2.35529e-06
|
|
|
MRX9
|
[NCBI]
|
2.35529e-06
|
|
|
epiphyseal dysplasia, multiple, with early-onset diabetes mellitus
|
[NCBI]
|
2.35529e-06
|
|
|
monosomy 1p36 syndrome
|
[NCBI]
|
2.35529e-06
|
|
|
JBTS3
|
[NCBI]
|
2.35529e-06
|
|
|
MCKD2
|
[NCBI]
|
2.35529e-06
|
|
|
proteinuria, low molecular weight, with hypercalciuria and nephrocalcinosis
|
[NCBI]
|
2.35529e-06
|
|
|
EVR2
|
[NCBI]
|
2.35529e-06
|
|
|
OPLL
|
[NCBI]
|
2.35529e-06
|
|
|
myopathy, myosin storage
|
[NCBI]
|
2.35529e-06
|
|
|
ehlers-danlos syndrome, type iii
|
[NCBI]
|
2.35529e-06
|
|
|
RP10
|
[NCBI]
|
2.35529e-06
|
|
|
congenital hemidysplasia with ichthyosiform erythroderma and limb defects
|
[NCBI]
|
2.35529e-06
|
|
|
deafness, autosomal recessive
|
[NCBI]
|
2.35529e-06
|
|
|
TFRC
|
[NCBI]
|
2.34023e-06
|
|
|
FGF4
|
[NCBI]
|
2.31911e-06
|
|
|
KCNA1
|
[NCBI]
|
2.31911e-06
|
|
|
HPX
|
[NCBI]
|
2.31911e-06
|
|
|
SP7
|
[NCBI]
|
2.31911e-06
|
|
|
HHC1
|
[NCBI]
|
2.31082e-06
|
|
|
CLN3
|
[NCBI]
|
2.30123e-06
|
|
|
SI
|
[NCBI]
|
2.28451e-06
|
|
|
DDB1
|
[NCBI]
|
2.22846e-06
|
|
|
KCNJ6
|
[NCBI]
|
2.22846e-06
|
|
|
srebp cleavage-activating protein
|
[NCBI]
|
2.22846e-06
|
|
|
NRP2
|
[NCBI]
|
2.22846e-06
|
|
|
PLCB3
|
[NCBI]
|
2.22846e-06
|
|
|
PHKA1
|
[NCBI]
|
2.22846e-06
|
|
|
MT2A
|
[NCBI]
|
2.22846e-06
|
|
|
LITAF
|
[NCBI]
|
2.22846e-06
|
|
|
PRKG1
|
[NCBI]
|
2.22846e-06
|
|
|
TNNI2
|
[NCBI]
|
2.22846e-06
|
|
|
GBE1
|
[NCBI]
|
2.22846e-06
|
|
|
KRTHA1
|
[NCBI]
|
2.22846e-06
|
|
|
IMPDH1
|
[NCBI]
|
2.22846e-06
|
|
|
GRHL3
|
[NCBI]
|
2.22846e-06
|
|
|
TNFSF13
|
[NCBI]
|
2.22846e-06
|
|
|
TUB
|
[NCBI]
|
2.22846e-06
|
|
|
ITGA5
|
[NCBI]
|
2.22846e-06
|
|
|
AKT2
|
[NCBI]
|
2.22846e-06
|
|
|
ACACB
|
[NCBI]
|
2.22846e-06
|
|
|
RB1CC1
|
[NCBI]
|
2.22846e-06
|
|
|
KIF5B
|
[NCBI]
|
2.22846e-06
|
|
|
PABPN1
|
[NCBI]
|
2.22846e-06
|
|
|
TACSTD2
|
[NCBI]
|
2.22846e-06
|
|
|
SFN
|
[NCBI]
|
2.22846e-06
|
|
|
RP1
|
[NCBI]
|
2.22846e-06
|
|
|
CDH3
|
[NCBI]
|
2.22846e-06
|
|
|
FZD4
|
[NCBI]
|
2.22846e-06
|
|
|
EPHX2
|
[NCBI]
|
2.22846e-06
|
|
|
SETX
|
[NCBI]
|
2.22846e-06
|
|
|
NUMA1
|
[NCBI]
|
2.22846e-06
|
|
|
SCO2
|
[NCBI]
|
2.22846e-06
|
|
|
DSCAM
|
[NCBI]
|
2.22846e-06
|
|
|
KLK4
|
[NCBI]
|
2.22846e-06
|
|
|
EYA2
|
[NCBI]
|
2.22846e-06
|
|
|
PTGER3
|
[NCBI]
|
2.22846e-06
|
|
|
MGAT1
|
[NCBI]
|
2.22846e-06
|
|
|
ICSBP1
|
[NCBI]
|
2.22846e-06
|
|
|
CDKL5
|
[NCBI]
|
2.22846e-06
|
|
|
MYCBP2
|
[NCBI]
|
2.22846e-06
|
|
|
ACVR1
|
[NCBI]
|
2.22846e-06
|
|
|
LDB3
|
[NCBI]
|
2.22846e-06
|
|
|
GAS1
|
[NCBI]
|
2.22846e-06
|
|
|
WHSC1
|
[NCBI]
|
2.22846e-06
|
|
|
APOA5
|
[NCBI]
|
2.22846e-06
|
|
|
CD151
|
[NCBI]
|
2.22846e-06
|
|
|
PHYH
|
[NCBI]
|
2.22846e-06
|
|
|
OXTR
|
[NCBI]
|
2.22846e-06
|
|
|
CSNK2A1
|
[NCBI]
|
2.22846e-06
|
|
|
CD19
|
[NCBI]
|
2.22846e-06
|
|
|
ASPN
|
[NCBI]
|
2.22846e-06
|
|
|
LARGE
|
[NCBI]
|
2.22846e-06
|
|
|
TNFRSF13C
|
[NCBI]
|
2.22846e-06
|
|
|
REG1A
|
[NCBI]
|
2.22846e-06
|
|
|
WNT7A
|
[NCBI]
|
2.22846e-06
|
|
|
CDH13
|
[NCBI]
|
2.22846e-06
|
|
|
LGALS1
|
[NCBI]
|
2.22846e-06
|
|
|
MIRN155
|
[NCBI]
|
2.22846e-06
|
|
|
ABL1
|
[NCBI]
|
2.21833e-06
|
|
|
PROCR
|
[NCBI]
|
2.21833e-06
|
|
|
GSR
|
[NCBI]
|
2.20899e-06
|
|
|
RUNX1
|
[NCBI]
|
2.20899e-06
|
|
|
CD36
|
[NCBI]
|
2.15611e-06
|
|
|
severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-negative, nk cell-positive
|
[NCBI]
|
2.13858e-06
|
|
|
KTCN1
|
[NCBI]
|
2.13858e-06
|
|
|
PLOSL
|
[NCBI]
|
2.13858e-06
|
|
|
CLN2
|
[NCBI]
|
2.13077e-06
|
|
|
IBM2
|
[NCBI]
|
2.13077e-06
|
|
|
osteogenesis imperfecta, type iv
|
[NCBI]
|
2.13077e-06
|
|
|
HIDS
|
[NCBI]
|
2.13077e-06
|
|
|
CBAVD
|
[NCBI]
|
2.13077e-06
|
|
|
HNA
|
[NCBI]
|
2.13077e-06
|
|
|
bethlem myopathy
|
[NCBI]
|
2.13077e-06
|
|
|
UNG
|
[NCBI]
|
2.09836e-06
|
|
|
IL4R
|
[NCBI]
|
2.09793e-06
|
|
|
CD44
|
[NCBI]
|
2.09793e-06
|
|
|
SFRP1
|
[NCBI]
|
2.09793e-06
|
|
|
CRYAB
|
[NCBI]
|
2.09793e-06
|
|
|
OPA1
|
[NCBI]
|
2.09793e-06
|
|
|
CREB1
|
[NCBI]
|
2.09793e-06
|
|
|
UCP3
|
[NCBI]
|
2.0849e-06
|
|
|
porphyria cutanea tarda
|
[NCBI]
|
2.04892e-06
|
|
|
CCL21
|
[NCBI]
|
2.04892e-06
|
|
|
MAPK14
|
[NCBI]
|
2.04892e-06
|
|
|
VLDLR
|
[NCBI]
|
2.04892e-06
|
|
|
CSF3
|
[NCBI]
|
1.98039e-06
|
|
|
LCT
|
[NCBI]
|
1.95261e-06
|
|
|
OSM
|
[NCBI]
|
1.94045e-06
|
|
|
maple syrup urine disease
|
[NCBI]
|
1.90309e-06
|
|
|
HHF2
|
[NCBI]
|
1.90309e-06
|
|
|
TNFRSF6
|
[NCBI]
|
1.89711e-06
|
|
|
TPT1
|
[NCBI]
|
1.89711e-06
|
|
|
AICDA
|
[NCBI]
|
1.8931e-06
|
|
|
PTCH1
|
[NCBI]
|
1.8931e-06
|
|
|
ITGA2B
|
[NCBI]
|
1.8931e-06
|
|
|
FCAS
|
[NCBI]
|
1.88461e-06
|
|
|
meningioma, familial
|
[NCBI]
|
1.88461e-06
|
|
|
PVR
|
[NCBI]
|
1.86451e-06
|
|
|
FHL2
|
[NCBI]
|
1.86063e-06
|
|
|
WARS
|
[NCBI]
|
1.86063e-06
|
|
|
GRIA3
|
[NCBI]
|
1.86063e-06
|
|
|
NODAL
|
[NCBI]
|
1.86063e-06
|
|
|
GP9
|
[NCBI]
|
1.86063e-06
|
|
|
RORC
|
[NCBI]
|
1.86063e-06
|
|
|
SPRY2
|
[NCBI]
|
1.86063e-06
|
|
|
INPPL1
|
[NCBI]
|
1.86063e-06
|
|
|
EDG1
|
[NCBI]
|
1.86063e-06
|
|
|
KPNB1
|
[NCBI]
|
1.86063e-06
|
|
|
TBPL1
|
[NCBI]
|
1.86063e-06
|
|
|
CSPG2
|
[NCBI]
|
1.86063e-06
|
|
|
HOXA10
|
[NCBI]
|
1.86063e-06
|
|
|
HTR1A
|
[NCBI]
|
1.86063e-06
|
|
|
COL5A2
|
[NCBI]
|
1.86063e-06
|
|
|
PRMT1
|
[NCBI]
|
1.86063e-06
|
|
|
FGF6
|
[NCBI]
|
1.86063e-06
|
|
|
PRND
|
[NCBI]
|
1.86063e-06
|
|
|
BARD1
|
[NCBI]
|
1.86063e-06
|
|
|
SMAD7
|
[NCBI]
|
1.86063e-06
|
|
|
RAP1A
|
[NCBI]
|
1.86063e-06
|
|
|
AMN
|
[NCBI]
|
1.86063e-06
|
|
|
POT1
|
[NCBI]
|
1.86063e-06
|
|
|
AAAS
|
[NCBI]
|
1.86063e-06
|
|
|
IQGAP1
|
[NCBI]
|
1.86063e-06
|
|
|
MXI1
|
[NCBI]
|
1.86063e-06
|
|
|
APH
|
[NCBI]
|
1.86063e-06
|
|
|
RGS9
|
[NCBI]
|
1.86063e-06
|
|
|
SGKL
|
[NCBI]
|
1.86063e-06
|
|
|
BUB1B
|
[NCBI]
|
1.86063e-06
|
|
|
RORA
|
[NCBI]
|
1.86063e-06
|
|
|
FOXF1
|
[NCBI]
|
1.86063e-06
|
|
|
SLC8A1
|
[NCBI]
|
1.86063e-06
|
|
|
CSF2RA
|
[NCBI]
|
1.86063e-06
|
|
|
TREM2
|
[NCBI]
|
1.86063e-06
|
|
|
TNFSF4
|
[NCBI]
|
1.86063e-06
|
|
|
HMGCR
|
[NCBI]
|
1.86063e-06
|
|
|
TLX1
|
[NCBI]
|
1.86063e-06
|
|
|
SGCB
|
[NCBI]
|
1.86063e-06
|
|
|
CYLD1
|
[NCBI]
|
1.86063e-06
|
|
|
SORD
|
[NCBI]
|
1.86063e-06
|
|
|
CASP8AP2
|
[NCBI]
|
1.86063e-06
|
|
|
LIM2
|
[NCBI]
|
1.86063e-06
|
|
|
NID
|
[NCBI]
|
1.86063e-06
|
|
|
HOXA13
|
[NCBI]
|
1.86063e-06
|
|
|
TGIF
|
[NCBI]
|
1.86063e-06
|
|
|
ATP2B2
|
[NCBI]
|
1.86063e-06
|
|
|
PDPK1
|
[NCBI]
|
1.86063e-06
|
|
|
VANGL2
|
[NCBI]
|
1.86063e-06
|
|
|
HTR1B
|
[NCBI]
|
1.86063e-06
|
|
|
EPHA4
|
[NCBI]
|
1.86063e-06
|
|
|
LAMB1
|
[NCBI]
|
1.86063e-06
|
|
|
GAS6
|
[NCBI]
|
1.86063e-06
|
|
|
ZFP36
|
[NCBI]
|
1.86045e-06
|
|
|
PRKCM
|
[NCBI]
|
1.85305e-06
|
|
|
CHS
|
[NCBI]
|
1.84499e-06
|
|
|
APOD
|
[NCBI]
|
1.7822e-06
|
|
|
BLM
|
[NCBI]
|
1.78019e-06
|
|
|
CGD
|
[NCBI]
|
1.78019e-06
|
|
|
HMBS
|
[NCBI]
|
1.77811e-06
|
|
|
TNFRSF1A
|
[NCBI]
|
1.76607e-06
|
|
|
CD47
|
[NCBI]
|
1.75323e-06
|
|
|
MTAP
|
[NCBI]
|
1.75078e-06
|
|
|
chiari malformation type i
|
[NCBI]
|
1.72886e-06
|
|
|
VUR1
|
[NCBI]
|
1.72886e-06
|
|
|
RTS
|
[NCBI]
|
1.72093e-06
|
|
|
SPTB
|
[NCBI]
|
1.70348e-06
|
|
|
DLG1
|
[NCBI]
|
1.70348e-06
|
|
|
IKBKB
|
[NCBI]
|
1.70348e-06
|
|
|
TAF1
|
[NCBI]
|
1.70348e-06
|
|
|
TCRB
|
[NCBI]
|
1.70348e-06
|
|
|
SMPD1
|
[NCBI]
|
1.70348e-06
|
|
|
BACE1
|
[NCBI]
|
1.70348e-06
|
|
|
COL17A1
|
[NCBI]
|
1.70348e-06
|
|
|
IGF2R
|
[NCBI]
|
1.70348e-06
|
|
|
OMP
|
[NCBI]
|
1.68277e-06
|
|
|
DDC
|
[NCBI]
|
1.68277e-06
|
|
|
CMH
|
[NCBI]
|
1.66287e-06
|
|
|
AKT1
|
[NCBI]
|
1.6393e-06
|
|
|
NTRK1
|
[NCBI]
|
1.6393e-06
|
|
|
PRF1
|
[NCBI]
|
1.61695e-06
|
|
|
FGF23
|
[NCBI]
|
1.61695e-06
|
|
|
PCLD
|
[NCBI]
|
1.61512e-06
|
|
|
pseudohypoparathyroidism, type ib
|
[NCBI]
|
1.61512e-06
|
|
|
HRPT1
|
[NCBI]
|
1.61512e-06
|
|
|
TTDP
|
[NCBI]
|
1.61512e-06
|
|
|
ESCS
|
[NCBI]
|
1.61512e-06
|
|
|
ARG1
|
[NCBI]
|
1.54713e-06
|
|
|
SUZ12
|
[NCBI]
|
1.54713e-06
|
|
|
CKM
|
[NCBI]
|
1.54713e-06
|
|
|
RDH5
|
[NCBI]
|
1.54713e-06
|
|
|
IGHMBP2
|
[NCBI]
|
1.54713e-06
|
|
|
BMI1
|
[NCBI]
|
1.54713e-06
|
|
|
GOT2
|
[NCBI]
|
1.54713e-06
|
|
|
AKR1A1
|
[NCBI]
|
1.54713e-06
|
|
|
DKK1
|
[NCBI]
|
1.54713e-06
|
|
|
NNAT
|
[NCBI]
|
1.54713e-06
|
|
|
ITPA
|
[NCBI]
|
1.54713e-06
|
|
|
CXORF5
|
[NCBI]
|
1.54713e-06
|
|
|
MSH3
|
[NCBI]
|
1.54713e-06
|
|
|
DGUOK
|
[NCBI]
|
1.54713e-06
|
|
|
CD55
|
[NCBI]
|
1.54713e-06
|
|
|
RAB7
|
[NCBI]
|
1.54713e-06
|
|
|
DGAT1
|
[NCBI]
|
1.54713e-06
|
|
|
TFAP2A
|
[NCBI]
|
1.54713e-06
|
|
|
MMP14
|
[NCBI]
|
1.54713e-06
|
|
|
TTPA
|
[NCBI]
|
1.54713e-06
|
|
|
CCND3
|
[NCBI]
|
1.54713e-06
|
|
|
AL-A1
|
[NCBI]
|
1.54713e-06
|
|
|
RANBP1
|
[NCBI]
|
1.54713e-06
|
|
|
IRF5
|
[NCBI]
|
1.54713e-06
|
|
|
PROK1
|
[NCBI]
|
1.54713e-06
|
|
|
GAD1
|
[NCBI]
|
1.54713e-06
|
|
|
POLB
|
[NCBI]
|
1.54713e-06
|
|
|
BCAR1
|
[NCBI]
|
1.54713e-06
|
|
|
ASPM
|
[NCBI]
|
1.54713e-06
|
|
|
HPS1
|
[NCBI]
|
1.54713e-06
|
|
|
SOST
|
[NCBI]
|
1.54713e-06
|
|
|
OPN4
|
[NCBI]
|
1.54713e-06
|
|
|
RPL3
|
[NCBI]
|
1.54713e-06
|
|
|
IL12RB1
|
[NCBI]
|
1.54713e-06
|
|
|
ITPR1
|
[NCBI]
|
1.54713e-06
|
|
|
BFSP2
|
[NCBI]
|
1.54713e-06
|
|
|
PTGDS
|
[NCBI]
|
1.54713e-06
|
|
|
FBXO32
|
[NCBI]
|
1.54713e-06
|
|
|
FMN
|
[NCBI]
|
1.54713e-06
|
|
|
NLRP3
|
[NCBI]
|
1.54713e-06
|
|
|
WNT3A
|
[NCBI]
|
1.54713e-06
|
|
|
MATN1
|
[NCBI]
|
1.54713e-06
|
|
|
ERAF
|
[NCBI]
|
1.54713e-06
|
|
|
DIO2
|
[NCBI]
|
1.54713e-06
|
|
|
TRIM24
|
[NCBI]
|
1.54713e-06
|
|
|
DNM2
|
[NCBI]
|
1.54713e-06
|
|
|
SMARCA4
|
[NCBI]
|
1.54713e-06
|
|
|
PRKCE
|
[NCBI]
|
1.54713e-06
|
|
|
CHRNA3
|
[NCBI]
|
1.54713e-06
|
|
|
phosphoglycerate mutase, muscle, deficiency of
|
[NCBI]
|
1.54713e-06
|
|
|
SLIT2
|
[NCBI]
|
1.54713e-06
|
|
|
mucopolysaccharidosis type iiib
|
[NCBI]
|
1.54031e-06
|
|
|
canavan disease
|
[NCBI]
|
1.54031e-06
|
|
|
PARK8
|
[NCBI]
|
1.54031e-06
|
|
|
porphyria, congenital erythropoietic
|
[NCBI]
|
1.54031e-06
|
|
|
epidermolysis bullosa letalis
|
[NCBI]
|
1.54031e-06
|
|
|
MSS
|
[NCBI]
|
1.54031e-06
|
|
|
TLR5
|
[NCBI]
|
1.53015e-06
|
|
|
CHGA
|
[NCBI]
|
1.52804e-06
|
|
|
RYR2
|
[NCBI]
|
1.52804e-06
|
|
|
PROS1
|
[NCBI]
|
1.52804e-06
|
|
|
HSPB1
|
[NCBI]
|
1.52804e-06
|
|
|
TTN
|
[NCBI]
|
1.52804e-06
|
|
|
BSG
|
[NCBI]
|
1.50792e-06
|
|
|
STC1
|
[NCBI]
|
1.50792e-06
|
|
|
SLC18A3
|
[NCBI]
|
1.45251e-06
|
|
|
ALS1
|
[NCBI]
|
1.44655e-06
|
|
|
MTR
|
[NCBI]
|
1.42401e-06
|
|
|
HRG
|
[NCBI]
|
1.42401e-06
|
|
|
ERBB2
|
[NCBI]
|
1.42344e-06
|
|
|
methemoglobinemia due to deficiency of methemoglobin reductase
|
[NCBI]
|
1.42344e-06
|
|
|
PLSJ
|
[NCBI]
|
1.42254e-06
|
|
|
fructose-1,6-bisphosphatase deficiency
|
[NCBI]
|
1.42254e-06
|
|
|
HFE3
|
[NCBI]
|
1.42254e-06
|
|
|
OCA3
|
[NCBI]
|
1.42254e-06
|
|
|
granulomatous disease, chronic, autosomal recessive, cytochrome b-negative
|
[NCBI]
|
1.42254e-06
|
|
|
CLPED1
|
[NCBI]
|
1.42254e-06
|
|
|
growth hormone insensitivity with immunodeficiency
|
[NCBI]
|
1.42254e-06
|
|
|
SPG11
|
[NCBI]
|
1.42254e-06
|
|
|
vitamin k-dependent clotting factors, combined deficiency of, 1
|
[NCBI]
|
1.42254e-06
|
|
|
morquio syndrome b
|
[NCBI]
|
1.42254e-06
|
|
|
OPTA2
|
[NCBI]
|
1.42254e-06
|
|
|
caffey disease
|
[NCBI]
|
1.42254e-06
|
|
|
INAD1
|
[NCBI]
|
1.42254e-06
|
|
|
macular dystrophy, vitelliform, adult-onset
|
[NCBI]
|
1.42254e-06
|
|
|
DFNA9
|
[NCBI]
|
1.42254e-06
|
|
|
RNS
|
[NCBI]
|
1.42254e-06
|
|
|
dyskeratosis congenita, autosomal dominant
|
[NCBI]
|
1.42254e-06
|
|
|
IS
|
[NCBI]
|
1.42254e-06
|
|
|
HHF6
|
[NCBI]
|
1.42254e-06
|
|
|
xx male syndrome
|
[NCBI]
|
1.42254e-06
|
|
|
c syndrome
|
[NCBI]
|
1.42254e-06
|
|
|
RMS1
|
[NCBI]
|
1.42254e-06
|
|
|
SYNS1
|
[NCBI]
|
1.42254e-06
|
|
|
CMH4
|
[NCBI]
|
1.42254e-06
|
|
|
GS2
|
[NCBI]
|
1.42254e-06
|
|
|
DMC
|
[NCBI]
|
1.42254e-06
|
|
|
NIDDM1
|
[NCBI]
|
1.42254e-06
|
|
|
progressive external ophthalmoplegia with mitochondrial dna deletions, autosomal dominant, 2
|
[NCBI]
|
1.42254e-06
|
|
|
HPP
|
[NCBI]
|
1.42254e-06
|
|
|
hexokinase deficiency hemolytic anemia
|
[NCBI]
|
1.42254e-06
|
|
|
mitochondrial myopathy
|
[NCBI]
|
1.42254e-06
|
|
|
HMN2A
|
[NCBI]
|
1.42254e-06
|
|
|
MODY2
|
[NCBI]
|
1.42254e-06
|
|
|
emanuel syndrome
|
[NCBI]
|
1.42254e-06
|
|
|
PDP
|
[NCBI]
|
1.42254e-06
|
|
|
SCA12
|
[NCBI]
|
1.42254e-06
|
|
|
XPB
|
[NCBI]
|
1.42254e-06
|
|
|
TNFSF11
|
[NCBI]
|
1.40359e-06
|
|
|
BCGF
|
[NCBI]
|
1.39468e-06
|
|
|
FGF1
|
[NCBI]
|
1.39153e-06
|
|
|
gastric cancer
|
[NCBI]
|
1.38701e-06
|
|
|
LAD
|
[NCBI]
|
1.36633e-06
|
|
|
ADH5
|
[NCBI]
|
1.36584e-06
|
|
|
CD40LG
|
[NCBI]
|
1.36584e-06
|
|
|
CSTB
|
[NCBI]
|
1.36584e-06
|
|
|
DST
|
[NCBI]
|
1.36584e-06
|
|
|
MSH6
|
[NCBI]
|
1.36584e-06
|
|
|
ACVRL1
|
[NCBI]
|
1.36584e-06
|
|
|
IL1B
|
[NCBI]
|
1.36584e-06
|
|
|
DPYD
|
[NCBI]
|
1.36584e-06
|
|
|
SOD2
|
[NCBI]
|
1.30053e-06
|
|
|
RECK
|
[NCBI]
|
1.27888e-06
|
|
|
PIN1
|
[NCBI]
|
1.27888e-06
|
|
|
WWOX
|
[NCBI]
|
1.27888e-06
|
|
|
GDF11
|
[NCBI]
|
1.27888e-06
|
|
|
SFTPD
|
[NCBI]
|
1.27888e-06
|
|
|
AEBP1
|
[NCBI]
|
1.27888e-06
|
|
|
MSN
|
[NCBI]
|
1.27888e-06
|
|
|
SKP1A
|
[NCBI]
|
1.27888e-06
|
|
|
PITX1
|
[NCBI]
|
1.27888e-06
|
|
|
KLK1
|
[NCBI]
|
1.27888e-06
|
|
|
CNTFR
|
[NCBI]
|
1.27888e-06
|
|
|
ATP2A1
|
[NCBI]
|
1.27888e-06
|
|
|
SFRP4
|
[NCBI]
|
1.27888e-06
|
|
|
OLIG2
|
[NCBI]
|
1.27888e-06
|
|
|
COL6A3
|
[NCBI]
|
1.27888e-06
|
|
|
ATP5O
|
[NCBI]
|
1.27888e-06
|
|
|
CHRNB2
|
[NCBI]
|
1.27888e-06
|
|
|
PRDX5
|
[NCBI]
|
1.27888e-06
|
|
|
PAK3
|
[NCBI]
|
1.27888e-06
|
|
|
SOX3
|
[NCBI]
|
1.27888e-06
|
|
|
TREX1
|
[NCBI]
|
1.27888e-06
|
|
|
FES
|
[NCBI]
|
1.27888e-06
|
|
|
ASCL1
|
[NCBI]
|
1.27888e-06
|
|
|
EZH2
|
[NCBI]
|
1.27888e-06
|
|
|
CSE1L
|
[NCBI]
|
1.27888e-06
|
|
|
STMN1
|
[NCBI]
|
1.27888e-06
|
|
|
XRN1
|
[NCBI]
|
1.27888e-06
|
|
|
NR1H3
|
[NCBI]
|
1.27888e-06
|
|
|
SCGF
|
[NCBI]
|
1.27888e-06
|
|
|
RPGRIP1
|
[NCBI]
|
1.27888e-06
|
|
|
ERBB4
|
[NCBI]
|
1.27888e-06
|
|
|
GADD45A
|
[NCBI]
|
1.27888e-06
|
|
|
HDAC5
|
[NCBI]
|
1.27888e-06
|
|
|
RBPSUH
|
[NCBI]
|
1.27888e-06
|
|
|
SEMA3F
|
[NCBI]
|
1.27888e-06
|
|
|
NRF1
|
[NCBI]
|
1.27888e-06
|
|
|
NCOA6
|
[NCBI]
|
1.27888e-06
|
|
|
SILV
|
[NCBI]
|
1.27888e-06
|
|
|
GFI1
|
[NCBI]
|
1.27888e-06
|
|
|
PRKCZ
|
[NCBI]
|
1.27888e-06
|
|
|
SLC11A2
|
[NCBI]
|
1.26155e-06
|
|
|
TSHR
|
[NCBI]
|
1.26155e-06
|
|
|
MVP
|
[NCBI]
|
1.25736e-06
|
|
|
IGHG1
|
[NCBI]
|
1.25073e-06
|
|
|
REST
|
[NCBI]
|
1.2177e-06
|
|
|
FTL
|
[NCBI]
|
1.21604e-06
|
|
|
glycogen storage disease ixa
|
[NCBI]
|
1.21604e-06
|
|
|
SMAD4
|
[NCBI]
|
1.21604e-06
|
|
|
LCAT
|
[NCBI]
|
1.16267e-06
|
|
|
PGL1
|
[NCBI]
|
1.15768e-06
|
|
|
properdin deficiency, x-linked
|
[NCBI]
|
1.15035e-06
|
|
|
glycogen storage disease iv
|
[NCBI]
|
1.15035e-06
|
|
|
bladder cancer
|
[NCBI]
|
1.15035e-06
|
|
|
FPGS
|
[NCBI]
|
1.14591e-06
|
|
|
RLBP1
|
[NCBI]
|
1.14196e-06
|
|
|
UCP1
|
[NCBI]
|
1.11795e-06
|
|
|
MKS1
|
[NCBI]
|
1.11628e-06
|
|
|
FASN
|
[NCBI]
|
1.07788e-06
|
|
|
MTND5
|
[NCBI]
|
1.07788e-06
|
|
|
MAOB
|
[NCBI]
|
1.07788e-06
|
|
|
EDMD2
|
[NCBI]
|
1.06134e-06
|
|
|
RIEG1
|
[NCBI]
|
1.06134e-06
|
|
|
APL
|
[NCBI]
|
1.06134e-06
|
|
|
NHS
|
[NCBI]
|
1.06134e-06
|
|
|
SCIDX1
|
[NCBI]
|
1.0573e-06
|
|
|
GARS
|
[NCBI]
|
1.04889e-06
|
|
|
ACTG1
|
[NCBI]
|
1.04889e-06
|
|
|
TPH2
|
[NCBI]
|
1.04889e-06
|
|
|
MCOLN1
|
[NCBI]
|
1.04889e-06
|
|
|
MBTPS1
|
[NCBI]
|
1.04889e-06
|
|
|
IKBKAP
|
[NCBI]
|
1.04889e-06
|
|
|
MTHFD1
|
[NCBI]
|
1.04889e-06
|
|
|
ATP1A1
|
[NCBI]
|
1.04889e-06
|
|
|
RGS2
|
[NCBI]
|
1.04889e-06
|
|
|
ONECUT1
|
[NCBI]
|
1.04889e-06
|
|
|
NCF2
|
[NCBI]
|
1.04889e-06
|
|
|
BLMH
|
[NCBI]
|
1.04889e-06
|
|
|
COL9A1
|
[NCBI]
|
1.04889e-06
|
|
|
NQO1
|
[NCBI]
|
1.04889e-06
|
|
|
KCNJ1
|
[NCBI]
|
1.04889e-06
|
|
|
PDE4D
|
[NCBI]
|
1.04889e-06
|
|
|
XRCC2
|
[NCBI]
|
1.04889e-06
|
|
|
SFTPC
|
[NCBI]
|
1.04889e-06
|
|
|
TCIRG1
|
[NCBI]
|
1.04889e-06
|
|
|
FEN1
|
[NCBI]
|
1.04889e-06
|
|
|
CSPG5
|
[NCBI]
|
1.04889e-06
|
|
|
MEST
|
[NCBI]
|
1.04889e-06
|
|
|
prekallikrein deficiency
|
[NCBI]
|
1.04889e-06
|
|
|
ACAT1
|
[NCBI]
|
1.04889e-06
|
|
|
WNK4
|
[NCBI]
|
1.04889e-06
|
|
|
RANBP2
|
[NCBI]
|
1.04889e-06
|
|
|
HOXB5
|
[NCBI]
|
1.04889e-06
|
|
|
CDX2
|
[NCBI]
|
1.04889e-06
|
|
|
GOT1
|
[NCBI]
|
1.04889e-06
|
|
|
ARRB2
|
[NCBI]
|
1.04889e-06
|
|
|
KRT9
|
[NCBI]
|
1.04889e-06
|
|
|
ITGB2
|
[NCBI]
|
1.03944e-06
|
|
|
LHCGR
|
[NCBI]
|
1.03944e-06
|
|
|
PKS
|
[NCBI]
|
1.02458e-06
|
|
|
APOA1
|
[NCBI]
|
9.95686e-07
|
|
|
FGA
|
[NCBI]
|
9.59333e-07
|
|
|
CLCN1
|
[NCBI]
|
9.50658e-07
|
|
|
CDKN1A
|
[NCBI]
|
9.50658e-07
|
|
|
CFI
|
[NCBI]
|
9.50658e-07
|
|
|
DNMT3B
|
[NCBI]
|
9.50658e-07
|
|
|
MSH2
|
[NCBI]
|
9.42936e-07
|
|
|
INSL3
|
[NCBI]
|
9.42936e-07
|
|
|
CTLA4
|
[NCBI]
|
9.30082e-07
|
|
|
SEMA3A
|
[NCBI]
|
9.30082e-07
|
|
|
HLA-DRA
|
[NCBI]
|
9.30082e-07
|
|
|
TRAF2
|
[NCBI]
|
9.30082e-07
|
|
|
UGB
|
[NCBI]
|
9.16641e-07
|
|
|
PTN
|
[NCBI]
|
8.97141e-07
|
|
|
microcephaly, autosomal dominant
|
[NCBI]
|
8.89186e-07
|
|
|
poland syndrome
|
[NCBI]
|
8.89186e-07
|
|
|
DYT2
|
[NCBI]
|
8.89186e-07
|
|
|
dermatitis, atopic
|
[NCBI]
|
8.63252e-07
|
|
|
SHFLD1
|
[NCBI]
|
8.63252e-07
|
|
|
ZLS
|
[NCBI]
|
8.63252e-07
|
|
|
centralopathic epilepsy
|
[NCBI]
|
8.63252e-07
|
|
|
BULN1
|
[NCBI]
|
8.63252e-07
|
|
|
LBR
|
[NCBI]
|
8.52231e-07
|
|
|
STARD3
|
[NCBI]
|
8.51678e-07
|
|
|
MAP1A
|
[NCBI]
|
8.51678e-07
|
|
|
S100A8
|
[NCBI]
|
8.51678e-07
|
|
|
GGH
|
[NCBI]
|
8.51678e-07
|
|
|
AHCY
|
[NCBI]
|
8.51678e-07
|
|
|
SMOH
|
[NCBI]
|
8.51678e-07
|
|
|
SLC27A1
|
[NCBI]
|
8.51678e-07
|
|
|
MTMR2
|
[NCBI]
|
8.51678e-07
|
|
|
BID
|
[NCBI]
|
8.51678e-07
|
|
|
NDN
|
[NCBI]
|
8.51678e-07
|
|
|
EPM2A
|
[NCBI]
|
8.51678e-07
|
|
|
TNNI3
|
[NCBI]
|
8.51678e-07
|
|
|
JUP
|
[NCBI]
|
8.51678e-07
|
|
|
ACO1
|
[NCBI]
|
8.51678e-07
|
|
|
FOLR1
|
[NCBI]
|
8.51678e-07
|
|
|
AGTR2
|
[NCBI]
|
8.51678e-07
|
|
|
HSPD1
|
[NCBI]
|
8.51678e-07
|
|
|
SMARCB1
|
[NCBI]
|
8.51678e-07
|
|
|
NEFH
|
[NCBI]
|
8.51678e-07
|
|
|
FOXE1
|
[NCBI]
|
8.51678e-07
|
|
|
SUMO1
|
[NCBI]
|
8.51678e-07
|
|
|
DVL1
|
[NCBI]
|
8.51678e-07
|
|
|
HIC1
|
[NCBI]
|
8.51678e-07
|
|
|
POLH
|
[NCBI]
|
8.51678e-07
|
|
|
HTATIP
|
[NCBI]
|
8.51678e-07
|
|
|
CCL3
|
[NCBI]
|
8.51678e-07
|
|
|
NOTCH3
|
[NCBI]
|
8.51678e-07
|
|
|
BTD
|
[NCBI]
|
8.51678e-07
|
|
|
CSF2
|
[NCBI]
|
8.40317e-07
|
|
|
CDA
|
[NCBI]
|
8.40317e-07
|
|
|
LIFR
|
[NCBI]
|
8.40317e-07
|
|
|
SCP2
|
[NCBI]
|
8.40317e-07
|
|
|
CCND1
|
[NCBI]
|
8.38454e-07
|
|
|
PPOX
|
[NCBI]
|
8.33746e-07
|
|
|
FABP3
|
[NCBI]
|
8.33746e-07
|
|
|
NBS1
|
[NCBI]
|
8.33746e-07
|
|
|
PNPLA6
|
[NCBI]
|
8.12061e-07
|
|
|
SLPI
|
[NCBI]
|
8.12061e-07
|
|
|
TP53
|
[NCBI]
|
7.94038e-07
|
|
|
HBA1
|
[NCBI]
|
7.80659e-07
|
|
|
XPG
|
[NCBI]
|
7.7004e-07
|
|
|
sialuria
|
[NCBI]
|
7.7004e-07
|
|
|
EBS2
|
[NCBI]
|
7.7004e-07
|
|
|
alzheimer disease 4
|
[NCBI]
|
7.7004e-07
|
|
|
afibrinogenemia, congenital
|
[NCBI]
|
7.7004e-07
|
|
|
renal tubular acidosis, distal, autosomal dominant
|
[NCBI]
|
7.7004e-07
|
|
|
BRIC1
|
[NCBI]
|
7.7004e-07
|
|
|
hypoparathyroidism, sensorineural deafness, and renal disease
|
[NCBI]
|
7.7004e-07
|
|
|
severe cutaneous adverse reaction, susceptibility to
|
[NCBI]
|
7.7004e-07
|
|
|
erythermalgia, primary
|
[NCBI]
|
7.7004e-07
|
|
|
hydrocephalus
|
[NCBI]
|
7.7004e-07
|
|
|
gm1-gangliosidosis, type ii
|
[NCBI]
|
7.7004e-07
|
|
|
SXI1
|
[NCBI]
|
7.7004e-07
|
|
|
PBT
|
[NCBI]
|
7.7004e-07
|
|
|
hyperornithinemia-hyperammonemia-homocitrullinuria syndrome
|
[NCBI]
|
7.7004e-07
|
|
|
aspermiogenesis factor
|
[NCBI]
|
7.7004e-07
|
|
|
renal tubular acidosis, distal, with progressive nerve deafness
|
[NCBI]
|
7.7004e-07
|
|
|
ATLD
|
[NCBI]
|
7.7004e-07
|
|
|
argininemia
|
[NCBI]
|
7.7004e-07
|
|
|
epstein syndrome
|
[NCBI]
|
7.7004e-07
|
|
|
CSNB2A
|
[NCBI]
|
7.7004e-07
|
|
|
hyperostosis corticalis generalisata
|
[NCBI]
|
7.7004e-07
|
|
|
DFNB9
|
[NCBI]
|
7.7004e-07
|
|
|
CMT4D
|
[NCBI]
|
7.7004e-07
|
|
|
SPG17
|
[NCBI]
|
7.7004e-07
|
|
|
hepatitis b virus, susceptibility to
|
[NCBI]
|
7.7004e-07
|
|
|
IDE
|
[NCBI]
|
7.6837e-07
|
|
|
PSEN2
|
[NCBI]
|
7.67123e-07
|
|
|
F2R
|
[NCBI]
|
7.54151e-07
|
|
|
longevity
|
[NCBI]
|
7.51189e-07
|
|
|
DHRD
|
[NCBI]
|
7.51189e-07
|
|
|
hydatidiform mole
|
[NCBI]
|
7.51189e-07
|
|
|
diarrhea 1, secretory chloride, congenital
|
[NCBI]
|
7.51189e-07
|
|
|
EVR1
|
[NCBI]
|
7.51189e-07
|
|
|
DYT3
|
[NCBI]
|
7.51189e-07
|
|
|
ICP
|
[NCBI]
|
7.51189e-07
|
|
|
infantile spasm syndrome, x-linked
|
[NCBI]
|
7.51189e-07
|
|
|
mucopolysaccharidosis type iiia
|
[NCBI]
|
7.51189e-07
|
|
|
SCZD1
|
[NCBI]
|
7.51189e-07
|
|
|
GACI
|
[NCBI]
|
7.51189e-07
|
|
|
OPTB3
|
[NCBI]
|
7.51189e-07
|
|
|
dopamine beta-hydroxylase deficiency, congenital
|
[NCBI]
|
7.51189e-07
|
|
|
MTCO2
|
[NCBI]
|
7.26561e-07
|
|
|
TNFSF13B
|
[NCBI]
|
7.26561e-07
|
|
|
GHRL
|
[NCBI]
|
7.26561e-07
|
|
|
aspartylglucosaminuria
|
[NCBI]
|
7.26561e-07
|
|
|
CHAC
|
[NCBI]
|
6.82944e-07
|
|
|
ehlers-danlos syndrome, type i
|
[NCBI]
|
6.82944e-07
|
|
|
mucolipidosis iv
|
[NCBI]
|
6.82944e-07
|
|
|
epidermolysis bullosa with pyloric atresia
|
[NCBI]
|
6.82944e-07
|
|
|
DTNBP1
|
[NCBI]
|
6.82865e-07
|
|
|
SEMA4D
|
[NCBI]
|
6.82865e-07
|
|
|
EPAS1
|
[NCBI]
|
6.82865e-07
|
|
|
ALOX5AP
|
[NCBI]
|
6.82865e-07
|
|
|
PLAU
|
[NCBI]
|
6.82865e-07
|
|
|
MMP13
|
[NCBI]
|
6.82865e-07
|
|
|
TULP1
|
[NCBI]
|
6.82865e-07
|
|
|
HOXA7
|
[NCBI]
|
6.82865e-07
|
|
|
SOCS2
|
[NCBI]
|
6.82865e-07
|
|
|
NLK
|
[NCBI]
|
6.82865e-07
|
|
|
PFC
|
[NCBI]
|
6.82865e-07
|
|
|
AGL
|
[NCBI]
|
6.82865e-07
|
|
|
RPS3
|
[NCBI]
|
6.82865e-07
|
|
|
JARID1D
|
[NCBI]
|
6.82865e-07
|
|
|
CNP
|
[NCBI]
|
6.82865e-07
|
|
|
GPHN
|
[NCBI]
|
6.82865e-07
|
|
|
SPG3A
|
[NCBI]
|
6.82865e-07
|
|
|
PRDM1
|
[NCBI]
|
6.82865e-07
|
|
|
COCH
|
[NCBI]
|
6.82865e-07
|
|
|
FOXP2
|
[NCBI]
|
6.82865e-07
|
|
|
ACTB
|
[NCBI]
|
6.82865e-07
|
|
|
C4BPA
|
[NCBI]
|
6.82865e-07
|
|
|
GAMT
|
[NCBI]
|
6.70837e-07
|
|
|
ATF2
|
[NCBI]
|
6.70837e-07
|
|
|
GH1
|
[NCBI]
|
6.60378e-07
|
|
|
IL4
|
[NCBI]
|
6.60378e-07
|
|
|
PCD
|
[NCBI]
|
6.58866e-07
|
|
|
DNMT1
|
[NCBI]
|
6.5308e-07
|
|
|
TERT
|
[NCBI]
|
6.45915e-07
|
|
|
COMT
|
[NCBI]
|
6.45802e-07
|
|
|
factor v deficiency
|
[NCBI]
|
6.38648e-07
|
|
|
coproporphyria
|
[NCBI]
|
6.28569e-07
|
|
|
GATA1
|
[NCBI]
|
6.28569e-07
|
|
|
AQP2
|
[NCBI]
|
6.28439e-07
|
|
|
DBA
|
[NCBI]
|
6.11427e-07
|
|
|
PTGS2
|
[NCBI]
|
6.08966e-07
|
|
|
GRIA2
|
[NCBI]
|
5.91454e-07
|
|
|
CHEK2
|
[NCBI]
|
5.91454e-07
|
|
|
HDGF
|
[NCBI]
|
5.91454e-07
|
|
|
PGK1
|
[NCBI]
|
5.43498e-07
|
|
|
FOXO1A
|
[NCBI]
|
5.39278e-07
|
|
|
APOC2
|
[NCBI]
|
5.39278e-07
|
|
|
BAX
|
[NCBI]
|
5.39278e-07
|
|
|
RAG1
|
[NCBI]
|
5.39278e-07
|
|
|
MAZ
|
[NCBI]
|
5.38894e-07
|
|
|
CRYBB2
|
[NCBI]
|
5.38894e-07
|
|
|
PCSK1
|
[NCBI]
|
5.38894e-07
|
|
|
SNX1
|
[NCBI]
|
5.38894e-07
|
|
|
GABRB3
|
[NCBI]
|
5.38894e-07
|
|
|
PPP3CA
|
[NCBI]
|
5.38894e-07
|
|
|
STIM1
|
[NCBI]
|
5.38894e-07
|
|
|
PPARBP
|
[NCBI]
|
5.38894e-07
|
|
|
FST
|
[NCBI]
|
5.38894e-07
|
|
|
NFKBIA
|
[NCBI]
|
5.38894e-07
|
|
|
UGDH
|
[NCBI]
|
5.38894e-07
|
|
|
PRKCA
|
[NCBI]
|
5.38894e-07
|
|
|
SNAP25
|
[NCBI]
|
5.38894e-07
|
|
|
CAMK2A
|
[NCBI]
|
5.38894e-07
|
|
|
TRIM25
|
[NCBI]
|
5.38894e-07
|
|
|
SELE
|
[NCBI]
|
5.38894e-07
|
|
|
NCOR2
|
[NCBI]
|
5.38894e-07
|
|
|
CDH2
|
[NCBI]
|
5.38894e-07
|
|
|
NR4A1
|
[NCBI]
|
5.38894e-07
|
|
|
ZEB2
|
[NCBI]
|
5.38894e-07
|
|
|
APAF1
|
[NCBI]
|
5.38894e-07
|
|
|
TXNIP
|
[NCBI]
|
5.38894e-07
|
|
|
BAK1
|
[NCBI]
|
5.38894e-07
|
|
|
IKZF1
|
[NCBI]
|
5.38894e-07
|
|
|
BEST1
|
[NCBI]
|
5.38894e-07
|
|
|
CD99
|
[NCBI]
|
5.38894e-07
|
|
|
RCC1
|
[NCBI]
|
5.38894e-07
|
|
|
CPS1
|
[NCBI]
|
5.38894e-07
|
|
|
MYC
|
[NCBI]
|
5.2127e-07
|
|
|
ornithine aminotransferase deficiency
|
[NCBI]
|
5.15888e-07
|
|
|
PSCA
|
[NCBI]
|
5.15888e-07
|
|
|
FGG
|
[NCBI]
|
5.15888e-07
|
|
|
glycogen storage disease i
|
[NCBI]
|
5.15888e-07
|
|
|
ADRP
|
[NCBI]
|
5.15888e-07
|
|
|
LTA
|
[NCBI]
|
5.15888e-07
|
|
|
FN1
|
[NCBI]
|
5.15888e-07
|
|
|
KLF1
|
[NCBI]
|
4.78941e-07
|
|
|
AQP4
|
[NCBI]
|
4.78941e-07
|
|
|
NOS3
|
[NCBI]
|
4.78941e-07
|
|
|
OCA2
|
[NCBI]
|
4.78331e-07
|
|
|
AQP1
|
[NCBI]
|
4.67686e-07
|
|
|
CPE
|
[NCBI]
|
4.65486e-07
|
|
|
PDE6B
|
[NCBI]
|
4.58238e-07
|
|
|
GCCR
|
[NCBI]
|
4.57764e-07
|
|
|
FGF2
|
[NCBI]
|
4.52709e-07
|
|
|
NTRK2
|
[NCBI]
|
4.44339e-07
|
|
|
BCL6
|
[NCBI]
|
4.44339e-07
|
|
|
MDM2
|
[NCBI]
|
4.44339e-07
|
|
|
INHBA
|
[NCBI]
|
4.44339e-07
|
|
|
PDGFB
|
[NCBI]
|
4.44339e-07
|
|
|
NRG1
|
[NCBI]
|
4.29551e-07
|
|
|
CMDD
|
[NCBI]
|
4.2584e-07
|
|
|
IVA
|
[NCBI]
|
4.2584e-07
|
|
|
PFIC1
|
[NCBI]
|
4.2584e-07
|
|
|
infantile sialic acid storage disorder
|
[NCBI]
|
4.2584e-07
|
|
|
hartnup disorder
|
[NCBI]
|
4.2584e-07
|
|
|
GSD
|
[NCBI]
|
4.2584e-07
|
|
|
ITGB3
|
[NCBI]
|
4.19108e-07
|
|
|
ANGPTL4
|
[NCBI]
|
4.16838e-07
|
|
|
MEF2A
|
[NCBI]
|
4.16838e-07
|
|
|
CALM1
|
[NCBI]
|
4.16838e-07
|
|
|
MAN2B1
|
[NCBI]
|
4.16838e-07
|
|
|
CCR2
|
[NCBI]
|
4.16838e-07
|
|
|
APOBEC3G
|
[NCBI]
|
4.16838e-07
|
|
|
ANKRD1
|
[NCBI]
|
4.16838e-07
|
|
|
IL7R
|
[NCBI]
|
4.16838e-07
|
|
|
RAD51
|
[NCBI]
|
4.16838e-07
|
|
|
PEG3
|
[NCBI]
|
4.16838e-07
|
|
|
SLC45A2
|
[NCBI]
|
4.16838e-07
|
|
|
orotic aciduria i
|
[NCBI]
|
4.16838e-07
|
|
|
NR5A2
|
[NCBI]
|
4.16838e-07
|
|
|
TAZ
|
[NCBI]
|
4.16838e-07
|
|
|
SLC22A8
|
[NCBI]
|
4.16838e-07
|
|
|
GABRG2
|
[NCBI]
|
4.16838e-07
|
|
|
THY1
|
[NCBI]
|
4.16838e-07
|
|
|
SCNN1B
|
[NCBI]
|
4.16838e-07
|
|
|
FGB
|
[NCBI]
|
4.16838e-07
|
|
|
LIPC
|
[NCBI]
|
4.05925e-07
|
|
|
SPP1
|
[NCBI]
|
4.02305e-07
|
|
|
CLN1
|
[NCBI]
|
3.95739e-07
|
|
|
bartter syndrome, type 3
|
[NCBI]
|
3.95739e-07
|
|
|
CHNG2
|
[NCBI]
|
3.95739e-07
|
|
|
TGD
|
[NCBI]
|
3.95739e-07
|
|
|
niemann-pick disease, type a
|
[NCBI]
|
3.95739e-07
|
|
|
HDAC1
|
[NCBI]
|
3.87175e-07
|
|
|
PKLR
|
[NCBI]
|
3.85029e-07
|
|
|
SLC1A2
|
[NCBI]
|
3.85029e-07
|
|
|
LNS
|
[NCBI]
|
3.83338e-07
|
|
|
ABCC2
|
[NCBI]
|
3.79167e-07
|
|
|
PSIP1
|
[NCBI]
|
3.77023e-07
|
|
|
FHIT
|
[NCBI]
|
3.77023e-07
|
|
|
EPHX1
|
[NCBI]
|
3.77023e-07
|
|
|
CXCR4
|
[NCBI]
|
3.77023e-07
|
|
|
ICAM1
|
[NCBI]
|
3.77023e-07
|
|
|
STAT5B
|
[NCBI]
|
3.77023e-07
|
|
|
NRCLP1
|
[NCBI]
|
3.68406e-07
|
|
|
SPTA1
|
[NCBI]
|
3.63848e-07
|
|
|
MMP2
|
[NCBI]
|
3.63848e-07
|
|
|
ALPS
|
[NCBI]
|
3.55249e-07
|
|
|
NGFR
|
[NCBI]
|
3.51631e-07
|
|
|
ALB
|
[NCBI]
|
3.48952e-07
|
|
|
IRID2
|
[NCBI]
|
3.41417e-07
|
|
|
DGI1
|
[NCBI]
|
3.41417e-07
|
|
|
SLSN1
|
[NCBI]
|
3.41417e-07
|
|
|
WSS
|
[NCBI]
|
3.41417e-07
|
|
|
SPG6
|
[NCBI]
|
3.41417e-07
|
|
|
IFD
|
[NCBI]
|
3.41417e-07
|
|
|
HNPCC2
|
[NCBI]
|
3.41417e-07
|
|
|
LGMD1A
|
[NCBI]
|
3.41417e-07
|
|
|
phosphoglycerate kinase 1 deficiency
|
[NCBI]
|
3.41417e-07
|
|
|
myeloperoxidase deficiency
|
[NCBI]
|
3.41417e-07
|
|
|
3-@methylcrotonyl-coa carboxylase 1 deficiency
|
[NCBI]
|
3.41417e-07
|
|
|
OSMED
|
[NCBI]
|
3.41417e-07
|
|
|
SCZD2
|
[NCBI]
|
3.41417e-07
|
|
|
MEN1
|
[NCBI]
|
3.38925e-07
|
|
|
STAT5A
|
[NCBI]
|
3.20511e-07
|
|
|
LIF
|
[NCBI]
|
3.19264e-07
|
|
|
F2RL1
|
[NCBI]
|
3.14257e-07
|
|
|
GLUD1
|
[NCBI]
|
3.14257e-07
|
|
|
EPB42
|
[NCBI]
|
3.14257e-07
|
|
|
NCOA1
|
[NCBI]
|
3.14257e-07
|
|
|
TCF3
|
[NCBI]
|
3.14257e-07
|
|
|
SPHK1
|
[NCBI]
|
3.14257e-07
|
|
|
CD40
|
[NCBI]
|
3.14257e-07
|
|
|
TGM2
|
[NCBI]
|
3.14257e-07
|
|
|
SREBF1
|
[NCBI]
|
3.14257e-07
|
|
|
HSD17B4
|
[NCBI]
|
3.14257e-07
|
|
|
CDK6
|
[NCBI]
|
3.14177e-07
|
|
|
GSN
|
[NCBI]
|
3.14177e-07
|
|
|
RARA
|
[NCBI]
|
3.14177e-07
|
|
|
DNTT
|
[NCBI]
|
3.10285e-07
|
|
|
BTC
|
[NCBI]
|
3.10285e-07
|
|
|
MAOA
|
[NCBI]
|
3.09694e-07
|
|
|
FIH
|
[NCBI]
|
2.87454e-07
|
|
|
kartagener syndrome
|
[NCBI]
|
2.87454e-07
|
|
|
vitamin d-dependent rickets, type ii
|
[NCBI]
|
2.87454e-07
|
|
|
LAT
|
[NCBI]
|
2.85568e-07
|
|
|
APP
|
[NCBI]
|
2.82165e-07
|
|
|
ACADM
|
[NCBI]
|
2.72401e-07
|
|
|
LCN2
|
[NCBI]
|
2.6665e-07
|
|
|
BCL2
|
[NCBI]
|
2.66483e-07
|
|
|
SPARC
|
[NCBI]
|
2.66483e-07
|
|
|
EGR1
|
[NCBI]
|
2.60586e-07
|
|
|
MST1
|
[NCBI]
|
2.60586e-07
|
|
|
GRPR
|
[NCBI]
|
2.56055e-07
|
|
|
DNAJC5
|
[NCBI]
|
2.56055e-07
|
|
|
ADORA3
|
[NCBI]
|
2.56055e-07
|
|
|
BTK
|
[NCBI]
|
2.47731e-07
|
|
|
SPR
|
[NCBI]
|
2.29098e-07
|
|
|
PTPN22
|
[NCBI]
|
2.29098e-07
|
|
|
KRIT1
|
[NCBI]
|
2.29098e-07
|
|
|
FGF9
|
[NCBI]
|
2.29098e-07
|
|
|
ECM1
|
[NCBI]
|
2.29098e-07
|
|
|
ERCC3
|
[NCBI]
|
2.29098e-07
|
|
|
NR4A2
|
[NCBI]
|
2.29098e-07
|
|
|
G6PT1
|
[NCBI]
|
2.29098e-07
|
|
|
BMP7
|
[NCBI]
|
2.29098e-07
|
|
|
CEBPB
|
[NCBI]
|
2.29098e-07
|
|
|
DNM1L
|
[NCBI]
|
2.29098e-07
|
|
|
ACACA
|
[NCBI]
|
2.29098e-07
|
|
|
IL9
|
[NCBI]
|
2.29098e-07
|
|
|
KCNE1
|
[NCBI]
|
2.29098e-07
|
|
|
gaucher disease, type i
|
[NCBI]
|
2.0839e-07
|
|
|
MTND6
|
[NCBI]
|
2.02936e-07
|
|
|
IL8
|
[NCBI]
|
2.02936e-07
|
|
|
CFLAR
|
[NCBI]
|
2.02936e-07
|
|
|
HGS
|
[NCBI]
|
2.02936e-07
|
|
|
IL12B
|
[NCBI]
|
2.02936e-07
|
|
|
CXCL12
|
[NCBI]
|
2.02936e-07
|
|
|
mycobacterium tuberculosis, susceptibility to
|
[NCBI]
|
1.96741e-07
|
|
|
CNTF
|
[NCBI]
|
1.95387e-07
|
|
|
CRMO
|
[NCBI]
|
1.91603e-07
|
|
|
biotinidase deficiency
|
[NCBI]
|
1.91603e-07
|
|
|
glycogen storage disease ib
|
[NCBI]
|
1.91603e-07
|
|
|
glycogen storage disease v
|
[NCBI]
|
1.91603e-07
|
|
|
KRAS
|
[NCBI]
|
1.88194e-07
|
|
|
CCL17
|
[NCBI]
|
1.8578e-07
|
|
|
alpha-thalassemia/mental retardation syndrome, deletion-type
|
[NCBI]
|
1.84166e-07
|
|
|
MTS
|
[NCBI]
|
1.84166e-07
|
|
|
complement factor h deficiency
|
[NCBI]
|
1.84166e-07
|
|
|
lipoid congenital adrenal hyperplasia
|
[NCBI]
|
1.84166e-07
|
|
|
nondisjunction
|
[NCBI]
|
1.84166e-07
|
|
|
muckle-wells syndrome
|
[NCBI]
|
1.84166e-07
|
|
|
progressive external ophthalmoplegia with mitochondrial dna deletions, autosomal dominant, 1
|
[NCBI]
|
1.84166e-07
|
|
|
omenn syndrome
|
[NCBI]
|
1.84166e-07
|
|
|
danon disease
|
[NCBI]
|
1.84166e-07
|
|
|
HMS1
|
[NCBI]
|
1.84166e-07
|
|
|
SCZD
|
[NCBI]
|
1.70341e-07
|
|
|
polycystic kidneys
|
[NCBI]
|
1.6344e-07
|
|
|
ADIPOQ
|
[NCBI]
|
1.63174e-07
|
|
|
ABCC8
|
[NCBI]
|
1.62487e-07
|
|
|
GJA1
|
[NCBI]
|
1.60281e-07
|
|
|
CCNE1
|
[NCBI]
|
1.59617e-07
|
|
|
SFTPB
|
[NCBI]
|
1.59617e-07
|
|
|
PHB
|
[NCBI]
|
1.59617e-07
|
|
|
GAD2
|
[NCBI]
|
1.59617e-07
|
|
|
CEACAM6
|
[NCBI]
|
1.59617e-07
|
|
|
tay-sachs disease, ab variant
|
[NCBI]
|
1.59617e-07
|
|
|
CA2
|
[NCBI]
|
1.59617e-07
|
|
|
PPARD
|
[NCBI]
|
1.59617e-07
|
|
|
MME
|
[NCBI]
|
1.59617e-07
|
|
|
DBT
|
[NCBI]
|
1.59617e-07
|
|
|
HSD11B1
|
[NCBI]
|
1.59617e-07
|
|
|
KLF2
|
[NCBI]
|
1.59617e-07
|
|
|
NFATC1
|
[NCBI]
|
1.59617e-07
|
|
|
MET
|
[NCBI]
|
1.55123e-07
|
|
|
GCH1
|
[NCBI]
|
1.55123e-07
|
|
|
ALDH3A2
|
[NCBI]
|
1.55123e-07
|
|
|
CDH1
|
[NCBI]
|
1.53563e-07
|
|
|
SLC11A1
|
[NCBI]
|
1.53563e-07
|
|
|
NR5A1
|
[NCBI]
|
1.51368e-07
|
|
|
protein c deficiency, congenital thrombotic disease due to
|
[NCBI]
|
1.51368e-07
|
|
|
CTNNB1
|
[NCBI]
|
1.51368e-07
|
|
|
BCR
|
[NCBI]
|
1.45959e-07
|
|
|
CYP17A1
|
[NCBI]
|
1.23841e-07
|
|
|
USF1
|
[NCBI]
|
1.23841e-07
|
|
|
HBD
|
[NCBI]
|
1.22133e-07
|
|
|
THPO
|
[NCBI]
|
1.20763e-07
|
|
|
DSPP
|
[NCBI]
|
1.20763e-07
|
|
|
MEN2A
|
[NCBI]
|
1.16006e-07
|
|
|
NCOA3
|
[NCBI]
|
1.12947e-07
|
|
|
E2F1
|
[NCBI]
|
1.12947e-07
|
|
|
IFNB1
|
[NCBI]
|
1.12947e-07
|
|
|
RBP4
|
[NCBI]
|
1.12947e-07
|
|
|
APS1
|
[NCBI]
|
1.05869e-07
|
|
|
CHRNA1
|
[NCBI]
|
1.04319e-07
|
|
|
CLN3
|
[NCBI]
|
1.04319e-07
|
|
|
FLT3
|
[NCBI]
|
1.04319e-07
|
|
|
MAP4
|
[NCBI]
|
1.04319e-07
|
|
|
EIF5A
|
[NCBI]
|
1.04319e-07
|
|
|
CLCN5
|
[NCBI]
|
1.04319e-07
|
|
|
HLA-G
|
[NCBI]
|
1.04319e-07
|
|
|
PTGS1
|
[NCBI]
|
1.04319e-07
|
|
|
HIP1
|
[NCBI]
|
1.04319e-07
|
|
|
DRD3
|
[NCBI]
|
1.04319e-07
|
|
|
RXRA
|
[NCBI]
|
1.04319e-07
|
|
|
EPHB2
|
[NCBI]
|
1.04319e-07
|
|
|
PI3
|
[NCBI]
|
1.04319e-07
|
|
|
SSTR2
|
[NCBI]
|
1.04319e-07
|
|
|
SLC6A4
|
[NCBI]
|
1.01799e-07
|
|
|
von willebrand disease, recessive form
|
[NCBI]
|
9.57852e-08
|
|
|
gaucher disease, type ii
|
[NCBI]
|
9.57852e-08
|
|
|
leiomyoma, hereditary multiple, of skin
|
[NCBI]
|
9.57852e-08
|
|
|
CYLD
|
[NCBI]
|
9.57852e-08
|
|
|
RHS
|
[NCBI]
|
9.57852e-08
|
|
|
glutathione synthetase deficiency
|
[NCBI]
|
9.57852e-08
|
|
|
HHS
|
[NCBI]
|
9.57852e-08
|
|
|
sarcoidosis
|
[NCBI]
|
9.57852e-08
|
|
|
methylmalonic aciduria and homocystinuria, cblc type
|
[NCBI]
|
9.57852e-08
|
|
|
pycnodysostosis
|
[NCBI]
|
9.57852e-08
|
|
|
abdominal muscles, absence of, with urinary tract abnormality and cryptorchidism
|
[NCBI]
|
9.57852e-08
|
|
|
XPF
|
[NCBI]
|
9.57852e-08
|
|
|
corticosterone methyloxidase type ii deficiency
|
[NCBI]
|
9.57852e-08
|
|
|
tight skin contracture syndrome, lethal
|
[NCBI]
|
9.57852e-08
|
|
|
myotonia congenita, autosomal recessive
|
[NCBI]
|
9.57852e-08
|
|
|
IHPS1
|
[NCBI]
|
9.57852e-08
|
|
|
carnitine palmitoyltransferase ii deficiency, late-onset
|
[NCBI]
|
9.57852e-08
|
|
|
CEL
|
[NCBI]
|
9.40101e-08
|
|
|
MAPK3
|
[NCBI]
|
9.3857e-08
|
|
|
ZNF145
|
[NCBI]
|
9.03887e-08
|
|
|
MBL2
|
[NCBI]
|
9.03578e-08
|
|
|
XPC
|
[NCBI]
|
7.67723e-08
|
|
|
ETV6
|
[NCBI]
|
7.67723e-08
|
|
|
DHH
|
[NCBI]
|
7.67723e-08
|
|
|
GSTP1
|
[NCBI]
|
7.67723e-08
|
|
|
NCOA2
|
[NCBI]
|
7.67723e-08
|
|
|
neural tube defects
|
[NCBI]
|
7.63064e-08
|
|
|
ABCC1
|
[NCBI]
|
7.40935e-08
|
|
|
F2
|
[NCBI]
|
6.93079e-08
|
|
|
DCC
|
[NCBI]
|
6.93079e-08
|
|
|
OCRL
|
[NCBI]
|
6.34508e-08
|
|
|
NEM3
|
[NCBI]
|
6.34508e-08
|
|
|
GHSR
|
[NCBI]
|
6.19142e-08
|
|
|
CPM
|
[NCBI]
|
6.19142e-08
|
|
|
SELP
|
[NCBI]
|
6.19142e-08
|
|
|
GATA4
|
[NCBI]
|
6.19142e-08
|
|
|
ARNTL
|
[NCBI]
|
6.19142e-08
|
|
|
ERCC1
|
[NCBI]
|
6.19142e-08
|
|
|
IL1RN
|
[NCBI]
|
6.19142e-08
|
|
|
CYP27B1
|
[NCBI]
|
6.19142e-08
|
|
|
homocystinuria due to deficiency of n(5,10)-methylenetetrahydrofolate reductase activity
|
[NCBI]
|
5.4793e-08
|
|
|
AMH
|
[NCBI]
|
5.30832e-08
|
|
|
LPI
|
[NCBI]
|
5.10635e-08
|
|
|
PARG
|
[NCBI]
|
4.81453e-08
|
|
|
FABP2
|
[NCBI]
|
4.69994e-08
|
|
|
SLC22A6
|
[NCBI]
|
4.69994e-08
|
|
|
CD2AP
|
[NCBI]
|
4.69994e-08
|
|
|
TFF1
|
[NCBI]
|
4.69994e-08
|
|
|
HLA-DQA1
|
[NCBI]
|
4.69994e-08
|
|
|
SLC25A4
|
[NCBI]
|
4.69994e-08
|
|
|
HMGA2
|
[NCBI]
|
4.69994e-08
|
|
|
ABCA1
|
[NCBI]
|
4.01323e-08
|
|
|
TCF7L2
|
[NCBI]
|
4.01323e-08
|
|
|
CTSC
|
[NCBI]
|
4.01323e-08
|
|
|
SCZD9
|
[NCBI]
|
3.81459e-08
|
|
|
erythrocytosis, familial, 2
|
[NCBI]
|
3.81459e-08
|
|
|
mitochondrial dna depletion syndrome, hepatocerebral form
|
[NCBI]
|
3.81459e-08
|
|
|
cerebrotendinous xanthomatosis
|
[NCBI]
|
3.81459e-08
|
|
|
HSCR2
|
[NCBI]
|
3.81459e-08
|
|
|
EA1
|
[NCBI]
|
3.81459e-08
|
|
|
ISS
|
[NCBI]
|
3.81459e-08
|
|
|
SGD
|
[NCBI]
|
3.81459e-08
|
|
|
methionine adenosyltransferase deficiency
|
[NCBI]
|
3.81459e-08
|
|
|
niemann-pick disease, type b
|
[NCBI]
|
3.81459e-08
|
|
|
JME
|
[NCBI]
|
3.81459e-08
|
|
|
BHD
|
[NCBI]
|
3.81459e-08
|
|
|
pineal hyperplasia, insulin-resistant diabetes mellitus, and somatic abnormalities
|
[NCBI]
|
3.81459e-08
|
|
|
HMN5
|
[NCBI]
|
3.81459e-08
|
|
|
langer mesomelic dysplasia
|
[NCBI]
|
3.81459e-08
|
|
|
FSHR
|
[NCBI]
|
3.43061e-08
|
|
|
ABCB1
|
[NCBI]
|
3.17062e-08
|
|
|
PAX8
|
[NCBI]
|
3.12793e-08
|
|
|
SDHD
|
[NCBI]
|
3.12793e-08
|
|
|
NRP1
|
[NCBI]
|
3.12793e-08
|
|
|
NRTN
|
[NCBI]
|
3.12793e-08
|
|
|
LTC4S
|
[NCBI]
|
3.12793e-08
|
|
|
SLC5A7
|
[NCBI]
|
3.12793e-08
|
|
|
AACT
|
[NCBI]
|
3.12793e-08
|
|
|
NR3C2
|
[NCBI]
|
3.12793e-08
|
|
|
LCK
|
[NCBI]
|
3.12793e-08
|
|
|
MAP4K1
|
[NCBI]
|
3.12793e-08
|
|
|
ANXA5
|
[NCBI]
|
3.12793e-08
|
|
|
ATR
|
[NCBI]
|
3.12793e-08
|
|
|
SLC18A2
|
[NCBI]
|
3.06477e-08
|
|
|
EIG
|
[NCBI]
|
2.44863e-08
|
|
|
SLC17A7
|
[NCBI]
|
2.40699e-08
|
|
|
CES1
|
[NCBI]
|
2.40699e-08
|
|
|
TIMP3
|
[NCBI]
|
2.40699e-08
|
|
|
TNFRSF6B
|
[NCBI]
|
2.40699e-08
|
|
|
MYCN
|
[NCBI]
|
2.40699e-08
|
|
|
ENPP2
|
[NCBI]
|
2.28683e-08
|
|
|
KSS
|
[NCBI]
|
2.28335e-08
|
|
|
SLC4A1
|
[NCBI]
|
2.11926e-08
|
|
|
hypercholesterolemia, autosomal dominant
|
[NCBI]
|
2.02927e-08
|
|
|
BL
|
[NCBI]
|
1.63356e-08
|
|
|
ALK
|
[NCBI]
|
1.21018e-08
|
|
|
COL4A1
|
[NCBI]
|
1.1433e-08
|
|
|
DDIT3
|
[NCBI]
|
1.1433e-08
|
|
|
OSBP
|
[NCBI]
|
1.1433e-08
|
|
|
TRAF6
|
[NCBI]
|
1.1433e-08
|
|
|
CRYAA
|
[NCBI]
|
1.1433e-08
|
|
|
MTND3
|
[NCBI]
|
1.1433e-08
|
|
|
SLC17A6
|
[NCBI]
|
1.1433e-08
|
|
|
CYP11B1
|
[NCBI]
|
1.1433e-08
|
|
|
BIRC5
|
[NCBI]
|
1.1433e-08
|
|
|
OPTB1
|
[NCBI]
|
1.09726e-08
|
|
|
FHM1
|
[NCBI]
|
1.09726e-08
|
|
|
HCRT
|
[NCBI]
|
1.05642e-08
|
|
|
AANAT
|
[NCBI]
|
1.05642e-08
|
|
|
CTSL
|
[NCBI]
|
1.05642e-08
|
|
|
MLL
|
[NCBI]
|
1.05642e-08
|
|
|
CP
|
[NCBI]
|
9.02453e-09
|
|
|
CHM
|
[NCBI]
|
8.47262e-09
|
|
|
PPARGC1A
|
[NCBI]
|
8.47262e-09
|
|
|
PPID
|
[NCBI]
|
8.47262e-09
|
|
|
HM13
|
[NCBI]
|
8.47262e-09
|
|
|
TSG101
|
[NCBI]
|
8.47262e-09
|
|
|
GZMA
|
[NCBI]
|
8.47262e-09
|
|
|
FOXO3A
|
[NCBI]
|
8.47262e-09
|
|
|
PER1
|
[NCBI]
|
8.47262e-09
|
|
|
HHF1
|
[NCBI]
|
7.60287e-09
|
|
|
ALMS
|
[NCBI]
|
5.06766e-09
|
|
|
diaphragmatic hernia, congenital
|
[NCBI]
|
2.69988e-09
|
|
|
cyclic hematopoiesis
|
[NCBI]
|
2.53337e-09
|
|
|
erythrocytosis, familial, 1
|
[NCBI]
|
2.53337e-09
|
|
|
indifference to pain, congenital, autosomal recessive
|
[NCBI]
|
2.53337e-09
|
|
|
THC2
|
[NCBI]
|
2.53337e-09
|
|
|
CMT2A1
|
[NCBI]
|
2.53337e-09
|
|
|
argininosuccinic aciduria
|
[NCBI]
|
2.53337e-09
|
|
|
ALS2
|
[NCBI]
|
2.53337e-09
|
|
|
d-bifunctional protein deficiency
|
[NCBI]
|
2.53337e-09
|
|
|
pick disease of brain
|
[NCBI]
|
2.53337e-09
|
|
|
autoimmune disease
|
[NCBI]
|
2.53337e-09
|
|
|
amyloidosis v
|
[NCBI]
|
2.53337e-09
|
|
|
synovitis, granulomatous, with uveitis and cranial neuropathies
|
[NCBI]
|
2.53337e-09
|
|
|
sacral defect with anterior meningocele
|
[NCBI]
|
2.53337e-09
|
|
|
NSF
|
[NCBI]
|
1.96264e-09
|
|
|
MIP
|
[NCBI]
|
1.51158e-09
|
|
|
GSK3B
|
[NCBI]
|
1.51158e-09
|
|
|
FGFR4
|
[NCBI]
|
1.51158e-09
|
|
|
AQP5
|
[NCBI]
|
1.51158e-09
|
|
|
MTCO3
|
[NCBI]
|
1.51158e-09
|
|
|
SLC12A3
|
[NCBI]
|
1.51158e-09
|
|
|
DFFA
|
[NCBI]
|
1.51158e-09
|
|
|
RIPK1
|
[NCBI]
|
1.50242e-09
|
|
|
MTND1
|
[NCBI]
|
1.50242e-09
|
|
|
ACG1A
|
[NCBI]
|
1.34797e-09
|
|
|
sjogren syndrome
|
[NCBI]
|
1.34797e-09
|
|
|
epilepsy, myoclonic, benign adult familial, type 1
|
[NCBI]
|
1.34797e-09
|
|
|
OTSC1
|
[NCBI]
|
1.34797e-09
|
|
|
alzheimer disease 6
|
[NCBI]
|
1.34797e-09
|
|
|
LDHB
|
[NCBI]
|
7.51128e-10
|
|
|
LYZ
|
[NCBI]
|
7.51128e-10
|
|
|
HTR2A
|
[NCBI]
|
7.51128e-10
|
|
|
CACNA1C
|
[NCBI]
|
7.51128e-10
|
|
|
MAPK7
|
[NCBI]
|
7.51128e-10
|
|
|
EXT1
|
[NCBI]
|
7.51128e-10
|
|
|
DAG1
|
[NCBI]
|
7.51128e-10
|
|
|
SH2D1A
|
[NCBI]
|
6.10261e-11
|
|
|
HS
|
[NCBI]
|
6.10261e-11
|
|